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ABSTRACT
Hepatitis B virus (HBV) pers istently infects approx imately 400 mill ion people
wor1dwide . It has severa l natural histories includ ing silen t infect ion. acute hepatitis
and a sero logically detectable chronic carrier state . wh ich commonly leads to liver
ci rrhosis and hepa tocellular carcinom a. Woodchucks infected with woodchuck.
hepatitis virus (VVHV) have remark ably similar spectra of prog ress ion of infection
and live r d isease. This model is. therefore . invaluable for in vivo studies that are
d ifficu lt or impossible to conduct in humans. The studies that co mpris e this thesis
were aime d at determining some of the viral and host factor s that may influence the
outc ome of experime ntal hepadnavi rus infection of adult wo odc hucks. However . due
to the re latively poor characterization of the woodch uck model. we first established
a number of gene sequences relevant to the woodchuck imm une system . This led
to a ge ne discovery program that ident ified 14 novel wood chuck gen es . Our first set
of expenments stud ied Fas and perfotin·mediated lymp hocyte cytotox icity to seeit
differences in the types of invn une cell act ivation could predict the outcome of viral
hepa tit is. Our results demo nstrate that Iymphotd cells from woodchucks with acute
WHY infection have an augmented capacity to el icit pertcnn-cepenc ent cell killing
when compared 10 woodchucks with chronic hep atitis (CH) . This suggests that
nonspecific cellu lar immunity. presumab ly NK cells . may playa role in early recovery
from INHV infection. A secon d set of experiments investigated the hepatic and
sple nic expressio n of MHC class I in acute and chronic WH V infections. We have
found that CH is acco mpanied by severely diminished hep atocyte and lymphoid cell
MHC class I surface expression despite upregulated tran scription of affiliated genes .
Th is prov ides evide nce that the virus posttranscri ptionally disru pts MHC class I
d isp lay and . this may protect infected cells from T cell-media ted immune clearance
Th is wou ld contribute to viral persistence and possibly de regula te the MHC e rase 1-
de pendent functions of the host's immun e system. Our final set of experiments
stud ied intrahepatic cyt okine expression and T cell influx in the course of, or after ,
experimental VVHVinfect ion.Thi s work demo nstrated a pos itive correlation between
reco very from adult VVHV hep atitis and upregulated interferon V (IFNy). tumor
necrosis fact or a (TN FO) and CD3 gene express ion . In add it ion . the same marke rs
of immune ecnve no n we re found to endure for years after resolution of acute
infect ion. ThISsuggest s that antiv iral cvt okme s. such as IFNy and TNFa. may play
a centra l role in recov ery from acute hepa titis. as well as in the long term contro l of
oc cult hepadnavirus persistence . The processes ide ntified in the present studie s
could be Critica l for perpetuation of liver damag e and evasion of ant i-viral
immunologica l surveillance In Chronic hec acna veus infection. The data obtained
and the Investig ative tools generated should enable a better understanding of the
lmmunopathog enesls of HBV infec"Jon and a id in the developme nt of more effective
anti-viral agents .
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CHAP TER ONE:
INTRODUCTION
1.1 EPIDEMIOLOGY OF HEPATIT1S B INFECTION
The term ' virus" (Latin: poison ) is defi ned as an infective agen t that
depe nds on living host cells for its replication . Hepat itis is de rived fro m the
Greek "hepar" (liver) and ~ · itis · (inflammation). It is most commonty caused by
one of 5 necetct rccc viruses. called hepat itis A. B. C. O. and E. although a
number of othe r VIruses can also Induce hepatit is (e.q.. aden oviru s . hum an
cytomeg alovirus (HCMV] . ecnovsuses. Epste in-Ba rr viru s (EBV] . rube lla virus .
and vence na zoster VIruS [VZV]). Vi ral nec enns is cna ractenzec by hepatocyte
InJUry. lymphomononuclear ce ll infiltratio ns. and liver ce ll regeneration . It is well
recognize d that chronic infection WIth the hepatitis B virus (HBV) is a majo r
worldwide cause of mOrbidity and mo nali ty . primaril y due to the developme nt of
live r crrrnosrs and hepatoce llular carcin oma (He e) . This is des pite the
ava ua bjl rty of a prophylactic vaccme that is high ly effect ive in preventlng HBV
infectio n of healthy Individ uals . Curren tly . of the more than 2 bill ion living peop le
who have bee n Infect ed with the vnus . the es tim ated globa l number of Chron ic
HBV earners (ie.. serum HBV surface antigen (HBsAg )-pos itive ind ividuals) is
app roaching 400 mill ion (World Health Orga nizat ion . 2000 ). Of the people
Chronica lly infected . about 25% terminate in untreatable HCC (Beasley, 1988 )
The geographic distr ibution of HBV infect ion vanes gre atly . Endemic
areas include Southeast Asia and sub- Saharan Afr ica where up to 15% of the
tota l po pu lation are chronically infec ted w ith HB V (M aynard e t at., 1989). In
these endermc areas. HBV is prim aril y transm itted vertical ly from mother to ch ild
tn the developed wo rld . inc lud ing North America and westem Europe . w he re
infe ct ion rates are usually bel ow 1% , veus tra nsmission occurs large ly due to
mn avenous drug use and se xua l co ntact , alt houg h occupational exposure IS sti ll
a co nce rn (Ge rbe rd ing . 1996). It rs es t imated tha t a t leas t 270.000 Can ac nans
are ch ron ica lly Infected w ith HB V , but the pre va lence of HB V Infect ion vane s
co nSiderably due to the heterogeneity of our popu lation . There is an estimated
cnrcrnccarrier rate of 4 % among nat ives. 4 .3% amon g immigrants, and 0 .2-0 .5%
In non -Imm igrants (Canadian consensus on the management of viral hepatit is.
1999)
1.2 NA TURAL HIS TO RY O F HBV INFECT IO N
HB V Infection can be clasS ifie d into five cl in ica lly distinct appearances : ( 1)
asymptoma tic 'subclinica l' infe ction , (2) acut e hepatitis (AH). (3) fulminant
hepa t itis . (4) chr ome he patit is (CH) . and (5) a HB sAg-posltl\le healthy chr on ic
earne r state . It IS esnrnateo tha t up to 70% of adults infect ed with HBV de ve lop
clinically asymp tomatic jntecno n. Thrs is usually identified by COincidenta l blood
tes ting . a lthoug h some of these Ind ivid uals do demonstrate mild nc n-soecrnc
manifes tations . such as fatigue and flu -like sym pto m s (revie wed by Hoofnagle et
al.. 1987 ). The remai n ing 30 % of th e exposed individuals wil l develop clin ically
eviden t liver disease and experience flu- like sym ptom s , jaund ice . abdom ina l
pain . fatigue and anorexia , diagno sed as AH . App roximate ly 1% of peop le with
acu te HBV infectio n will develop a very severe form of liver dam age. termed
fulminant hepatitis (Sarraco et al., 1988). This form of liver d isease is assccetee
with severe and rapid ly progress ing hepatocyte necrosis accompanied by the
deve lopment of ence phalopathy and is almost alw ays fatal (Kumar and Pound.
1992).
After the acut e phase of disease . abou t 90% of adults spont aneously
recover (self-limiled acute hepat itis: SLAH) and enter the convalescent stage
wilh apparent perm anent immunity (Hoofnagle et af., 1987 ). Howeve r, recent
studies have demonstrated that recov ery . which is characterized by the
eeacpearance of climcal symptoms. the normalizatio n of biochemica l indica tors
of liver functi on (e .g .. alanine amin ctransammase (Al n and asparta te
aminotra nsferase (ASn ), the disappe arance of serum HBsAg , and the rise of
Circulating antibod ies to HBsAg (anti-HBs). does no t reflect the complete
eurr aneuon of the replicallng VIruS (Micha!ak et el., 1994 , Rehermann et s t..
1996 )
Pat ients wit h a continued presence of serologica l markers of active HBV
infection (i .e ., pos itive for HBsAg and antibodies to HBV core antig en (ant i-HBcl)
and With biochemical indicat ors of live r injury (e.g .. A l T, ASn for longer than six
mo nths are deemed to have chronic hepa titis type B. Intere stingly, the
prop ortion of individual s who beco me chronic carriers is predo minantly
determined by the age ot the pa tie nt wh en infected . For example. g reater than
90% of infect ed neon ates become symctcmeuc Chronic carrie rs , as compared to
30-60 % of Children infected befor e the age of 4 years . This is in contrast to the
5-10% of ind ividua ls infected with HBV as adults (Moy er and Mast 1994 ). In
these chron ica lly infe cted patients , the pattern of CH can be variable . Acco rding
to classical serol ogica l and histological diagnostic criteria , it incl udes chronic
active (aggr essiv e) hepat itis . chro nic pers istent (mild ) hepat itis. and a HBsAg-
positive healthy crvomc earne r stat e with out appare nt morph ological features of
liver inJUry(Hoofnagle et al .. 1987).
Chronically Infected Individuals usually have progres sive liver inflammati on
wh ich often leads to liver cirrhosis. the most common precu rsor of HCC (Beasley.
1988 ). Import antly . the nsk of developing HCC IS almost 100 times greater In
chro nic HBV earners than in uninfected individuals (Beasley. 1988) . It is
hypot hesized that at least three independent fact ors contribute to the
develo pmen t of HCC. One of them appears to be Integ ration of HBV DNA into
hepatocyte chromosomes . wh ICh potentia lly disrupts tumo ur suppressor gene
functions or activ ate s cellul ar genes (e.9 .. oncog enes and growth factorslleading
to uncontrolled cell prolifer ation. The second factor is related to the conti nuo us
nver cell death and regeneration that increases the Chance of muta ncn e and
subs equent tumour deve lopmen t (Robinson. 1994 ). Additiona lly. HBV X prote in
has been imp licated. due to its transactivating capabilities. in the development of
HCC (reviewed by Murakami. 1999 ).
HBV can also induce extrahepatic disorders through the cepcsuon of
complexes of viral antigens and their specific antibod ies The pathoge nic role of
these immune comp le xes has been documented in glomerulonephritis and
polyaneritis nodosa . vescnms and arthritis , and is descnbed in Section 1.8.1.
1.3 CHARACTERISTICS OF HBV
1.3.1 Molecul.ar org an lu tion
The infect ious virion of HBV is refe rred to as the Dane pani cle (Dane et
al .. 1970 ). Ttns complete virus is a sphe rical struct ure 42 nanometers (nm) in
dia meter. It cons ists of a lipoprote in outer envelope made of three virus surface
pro teins all of which carry HBsA9 specificity . The envelo pe protein surrou nds an
electron dense nucleocapsid (core) which cont ains the genome (Kaplan et a/..
19731- In addition to Dane panicles , subvi ra l particles composed of enve lope
prote ins. In the form of sphe res and tubules . are also produced in large quantmes
and CIrculate In HBV-mfect ed ind ividualS. These pe rnces do not conta in gene tic
matenar and are. therefore . no t Infectious (Gavilanes et al.. 1982 ). Prio r to the
Introduct ion of recomnm ant DNA tech nology these subviral HBsAg particles were
punfied from the plasma of infected indiv idu als and used as HBV vaccines
(Hollinger et al. 1986 )
The virus genome . is a circular 3.2 kitobase (kbHong . part ially double
stranded DNA structur e . commo nly referred to as re laxed ci rcular DNA (rcONA).
The circular structu re is ma intain ed by a short cohes ive overl ap betwee n the 5'
ends of plus and minus DNA strands. The S'-end of the DNA minus stra nd
contains a covalently linked prote in, where as the plus strand has a 5' RNA
oligo nucleotide primer atta ched . Both the prote in and the primer appear to be
essentia l for viral replication (Ganem. 1991 ). The genome co ntains four
overl apping open reading frames (ORF) enCOding the four princ ipal transl at ion
prod ucts . the virus enve lope or surface (5), co re (C) , polymerase (P) and X
prote ins . The three envelope prote ins are encoded by the same ORF containing
three in-frame start coco ns. but they are de rived from two differen t overlap ping
mR NA species (2.4 and 2.1 kb). These protei ns have a co mmo n carb oxy-
termi nus , but differ at thei r amino-ends. and are referred to as large (pre51 ),
midd le (preS2), and majo r or small.
The C ORF encod es the viru s nud eocapsid prote in (HBcAg) and a
protein. which. due to post -translat ional mod ificat ions , disp lays e antigen
speCIficity (HBeAg) (Uy et al.. 1986). Alt hough the amino aCId seq uences of the
core and e prctem s are nea rty ide ntica l, they stimu late dist inct an tibodies (Satfeld
et al.. 1989). In contrast to the core , wh ich on ly occ urs in infected hepat ocytes
and virions (Schlicht and Sch auer. 1989) . HBeAg is also dete ctable in
nepetocytes and in a soluble fonn in the circul ation . but not on virions.
Transcripti on of the P QRF results in form ation of a multidom ain
polypeptide with vua r reverse transcnptase (RD , RNase, and DNA polymerase
activit ies (Bavend and Laub , 1988 : Mack et al., 1988). Add itionally, this protein
contains a packaging signa l (Barte nsc hlager et al.. 1990) and acts as a prim er for
reverse transcription of the viral preg enome (Wang and Seege r, 1992).
The smalles t ORF and its derived mR NA (0 .7 kb) encodes the X protein .
This prote in has transcnpuon er trans-activ ating propert ies that may playa role in
....true tumo r genesis (reviewed by Murakami, 1999). Addit ion ally , the
transactiv ating propert ies of the x -croteln affect man y other ce llular proteins.
inc lud ing the express ion of major histocompa tibility complex (MHC) class l in
cult ured hepatocvtee (Zhou et a/., 1990)
1.3.2 Repl ica tion cy cle
Aft er ....Irion recognition of a putat i....e cell surface receptor and its
pene tratio n into the cytoplasm. It is postulated tha t onry the virus nucleocap sid
migrates to the nucleus . Here H8 V rcD NA is repaired by host DNA polyme rases
and Iigases to form covalenll y closed circu lar DNA (cccDNA) . Th is is considered
to be the first step of bececna....mrs rep lication (Tuttleman et af.• 1986). Four
HBV mRNA transcnp ts u.e..3.5. 2.4 , 2 .1. and 0.7 kb) are transcnbed fro m the
cceDNA uSing host RNA po lyme rase . The y are exported from the nucleus and
translated into the aforementio ned vira l prote ins (Seetion1.3.1). In addition to
be ing a template for polyme rase translation. the 3 .5 kb RNA is also packed into
core part icles together With the viral po lymerase. This process occurs with in the
nucleus of the Infected cell , The pregen om ie RNA is the n re....ers e transcri bed
into minus strand DNA. which subsequently serve s as a template for plus strand
DNA svntneers . Once the plu s strand is synthesized. HBV rcDNA is tcrrnec . The
mature nucleoca ps id particles con taining reDNA are eithe r pack aged into virions .
whiCh are expo rted from the ce ll, or recycled to the nud eus. Presently .
hepadna.... iruses are the only known mamm alian DNA viruses that use re....erse
transcription in their replicat ion cycle
Al though the primary site of HBV replicat ion is the li....er , HBV can also
replicat e in the lymphatic syste m. HBV mR NA wa s detected by PCR wrth a
reverse transcription step (RT-PCR) in PBM C from peue nte with CH type B
(Baginski et al.. 1991J. More recently, the presence of HBV ccc DNA and all HBV
mRNA transc ripts were Iden tified in circulating lympho id cells from patient s with
act!ve chronic HBV infection using PCR (Stoll·Becker et et., 1997). Interest ingly.
the X mRN A (0.7 kb) was detected at the highest amount in these cells . The
detection of HBV nucierc acre sequences in lymphoid cells wa s suppo rted by
identifica tion of vIral ennqens in or on the cells . In one of the reports . most of the
mdi....iduals wrth CH type B were reported to express HBsAg and HBcAg on their
PBMC (Parvaz et al .. 1987). Additlonally. trace amounts of HBV-spectfic DNA
and RNA sequences were identified in PBMC from patients years after complete
clinical and serolog ical reco ....ery from AH type B. indica ting the persistence of
replica ting vnu s in lymphoid cel ls in con....alescent, ant i-HBs posrtive mdividu als
(MiChalak et el ., 1994 : Rehe rman n et at.. 1996 : Penna etal.. 1996 : Yotsuyanagi
et al .. 1998), It was also reporte d that HBV DNA sequences can persis t in PBMC
of pat ients wi th either spon taneous or therap y-indu ced recc very from CH type B
(Trippler et et.. 1996 : Oes terreic her et aI., 1995).
Taken toge ther. these find ings demonstrat e that H 8V also infects
lymphoid ce lls and that these cells can suppo rt lon g-term virus replication .
Therefo re, as in other pers isten t viral infections. the lymphoid system may play
an important role in the esta blishment and mai nten ance of hep adn aviral
pers istence (reviewed by Michalak. 2000). However. the molecular basis of HBV
Iymph otropism and its pa thogen ic implica tions for the outco me of infection are
not yet fully recognized
1.4 HEPA DNAV IRUS FAMilY
HBV is the crotctvcrc vmrs of the bepacne.... irus family . This family is
divIded into two genera : Or1hOhepadnavind ae (mammalian viruses ) and
Avmeosanevmaee (avian vnu sesj . As molecular techn iques improve and
simplify . new hepadnav iruses are being discoverec with increasing freque ncy
Key members of the mammalian genus are HBV . woodchuck hepatitis VIruS
(V\lHV) . and ground squ irrel hep atrtis VIruS (G SHV) (Mario n et al .. 1980). The
best cne recteneec member of the avian hepa dnav iruses is the duck hepatrtis B
VIruS (DHBV) (Mason et al.. 1980 ). Although the duck mocet is commonly used
to study the hep adnav rrus replication cycle and putat ive cell ular recep tors , it is
not generally utilized as a mccet for analys is of the immuno pathog enic
mech anisms of liver injury and ....nat pers isten ce (see be low ).
With some exceptio ns. the mamma lian nepecnav iruses ha ....e similar
molecu lar . structural. ant igen ic. and pathogenic prope rties . This inc ludes virion
ultrastructure and molec ular organization. rep lication strategy . and an overall
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simi lar course and patholog ical terms of virus-i nd uced liver disea se (Michalak.
1998 ). Howe ver. mammalian and avian hepadnaviruses also have distin ct
charact eri stics . induding th e fact that avian bececnaviruses lack an X gene, only
synthesize two enve lope proteins (pre-S an d 5 ) and their e nve lope proteins do
no t fo rm freely CIrcu lat ing fi laments . Furthe rm ore. live r disease induced by avran
necaen evnuees do no l appea r to be associated with the deve lopment of HCC
(Cove et al.. 1994 ).
1.5 THE WOODCHUCK MODEL OF HEPATITIS B
1.5.1 W oodchuck he patitis virus
A high frequency of HCC in North American woodchucks (Marmota
mon ax ) housed In the Ph ilade lphia Zoologica l Gardens led to the discovery of the
INHV as the fi rst emmet necetms B-Iike VIruS (Summers et al.. 197 8). Am ong
neceonaveuees . VVHVha s the most sim ilar genomic org anizat ion . and overall
nud eot ide sequence hom olog y (- 70% ) to HBV (Rog gendorf and Tolle. 199 5:
revewec by Michala k. 199 81. The high leve l of amino acid sequence similarity
allow s the use of comme rcial immunoassays deSigned fo r de tection of HBV
ennqens and annboc es to Identify corr espon ding marxers of WHV infect ion
(e .g.. WHV surface antigen [\f'JHsA9l and ant ibod ies to IJVHsAg [anti-VVHsI and
WHV core ant igen [WH cA g) and antibodies to WH cAg [anti- WH eD. The great est
diff erences in sequence homology between WHV and HBV lie within the X gene
and pre S1 region of th e S gene . Inter estingly . the X gene is apparently
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ind ispe nsable in INHV rep lication and infect ion, but not in HBV replicat ion (Chen
et al .. 1993 ; Zoulim et al., 1994 ). Add itionally only two RNA tran scripts . with
mo lecular sizes of 3.7 and 2.1. ha....e been dete cted in IJVHV-infected
woodchucks (Mc roy et st.. 1985).
1.5 .2 Char.acteristics ofWHV infection
The progr ession of VVHV and HBV-induced liver dise ase para llel each
othe r. Adult wood chuck s infected w ith Vl/HV ha ve simi lar cou rse s of infectio n
and comparable histolog ical ch aract erist ics of liver disease as humans infect ed
w ith HBV. Both Vv'HV and HBV induce AH . wh ich in 10- 15% of adu lt cases
prog resses to serol ogically evid ent chro nic liver disease. Both viruses ca n be
transmitted by blood or body fluids , as well as vertica lly from infected moth ers to
thei r offspring (Kulc ne n and Millman , 1988 . Co ffin and Michalak. 1999 ).
Althou gh VVHV is highly necetc trc ec. WH V DNA and mR NA seq uence s
hav e bee n de tected in tymphoid cells from the ea rliest stages of virus infecti on
(Korb a et aL 1989: revewee by Micha lak. 1998 ). It has been repo ned that even
trans ient 'NHV hepatiti s resu lts in latent in fecti on that involves both the liver ancl
the tym phatic syst em (Michalak et al ., 1999 ; Coffin and Michalak. t999).
Rece ntly. our laboratory dem onst rated that w ood chuck moth ers convalesce nt
from AH can sti ll be infectiou s to th eir offspri ng . as well as to healt hy an imals
(Coffin and M ichalak . 1999 ; reviewed by M ichalak , 2000).
On a ce llular level VVHV ancl HB V s urface and co re antigens have
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essen tia lly the same distributio n pattems in infect ed hep atocytes (reviewed by
Michalak . 1998 ). Hepatocyt e plasma membranes (HPM) purif ied from WH V·
infected wood chucks were shown 10 expres s both enve lope and co re spec ific
polypeptides as periphera l and integ ral mem brane prote ins (Michalak and
Chur chi ll , 1988 : Micha lak at al., 1990: M ich alak and Lin , 1994 ). These protei ns
Incorporated into the lipid bi layer ma y help the virus evade both cyto tox ic T
lymphocyt e (CT l ) and natural killer (N K) ce ll based killing (Sect ion 1.6 .2) .
Among ne pacna veuse s . 'II'IIliV has the highest oncog enic poten tia l,
believed to be caused by the pre fe ren tia l integ ration of the viral genome ne ar the
proto-on cogenes c-myc and N-myc lea d ing to their constit utive expression
(Fouret et al., 1990 : Wei et st.. 1992 ). InevItab ly, almost all serum IJVHsAg-
react ive . chronica lly infected anima ls will pro gress to HCC: a situati on that occurs
much less frequ ently in huma ns (c c va er et.. 1994) , Analogo us to HBV-infected
humans. wood chucks per sistent ly infected With WH V can have chronic liver
Inflamm ation With drfferent deg rees of hepatocyt e Injury and Iymphomononudear
ce ll infi ltratlons (revewec by Micha lak. 1998 ). Howe ver , in contrast to CH type B.
wood chucks ch roni cally ."fected with WHV rare ly de ve lop liver fibros is or
CIrrhOSIS (Sum mers. 1981). Ov erall . due to the exis ting snnnenues. the
wood chu ck model is accepted as the most val uable natural syste m to study
immunobiological events . pathogenesis of live r injury and HCC in hepadna virus
infection. molecular mecha nisms of hep adna virus pers isten ce , and to test th e
effica cy of nove l ant i-HBV drugs . Th is model overcomes se veral of the
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tsmt anons posed by the use of ch impanzees for hepatitis B rese arch .
1.6 GENERAL CONSIDERATIONS REGARDING THE ANTIVIRAL IMMUNE
RESPONSES
The prima ry funetKm of the immune syste m is the recog nitio n an d
elim ina tion of pathogens. incl uding viruses . The im mune syst em of higher
vertebrates cons ists of natu ra l (innate) and adap tive (speci fiC) imm unity . Afte r a
virus firs t enters a host. rt en counters the innate im mune system that includes
mo nocytes and ma crophages. NK cells. NKT cells and po lymorph on uclear ce lls
(Section 1.6). The se ce lls recog nize pemcq en -essocrated mo lecu les causing the
actrvatior . of ce llu lar proce sses incl uding phag ocyt osiS. induction an d synthes is
of enurwcroma t agents (e .q.. mtnc cod e . Iysomsome s). and cytokines (e.q ..
Interferons [IFN] and tumor necros is factor alpha (TNFa)). If the primary defence
mechanisms do n01eliminate the virus. the adac nve (speofic) Immune response
becomes Involved . This response exhibits the prope rties of memory and antigen
specificity . Fund ament ally , the adapti ve immune responses can be divided into
humoral. which mainty target extr ace llular pathogen s. and cellular . wh tctl
pnmarily combats those inside the cell. Pathogen-specifi c cell ular immunity is
mediated by two main groups of effecto r cells; CD4+ T helper ce lls , which
provide help to B lymp hocytes and to other immune effect or cells . and CDS+
CTL. whose main funct ion is elimination of infected host ce lls. In many cases of
infect ions with noncvtcpattucviru ses, the clinical symptoms are a result of the
,.
host's immune response against the virus-infected cells and the subsequent
des truct ion of these cell s.
1.6.1 Hu mora l immune responses
Spectfic humoral ltT\mumty is med iated by antibodies produced by plasma
ce lls de rived from annqen -snmutateo B ce lls . Ant ibod ies are essential in the
earl y defence agains t viral infections. Neutralizing antibod ies can help red uce
the amount of freely circu lating virus by preventing viral attachment and en try into
host ce lls . They may also act as opsonins and enhan ce phagocytosis .
Furthermore. ant i-viru s scecmc anti bodi es can be involved in the elimin at ion of
Infect ed ce lls that ex press viral ant igens on their surface by complement
de pendent cytotOXiCIty (CDC ) and annooo v-ceceneent cellu lar cyt otoxicrty
(A OCe) (review ed by Lecnmenn an d Davies 1997). scecac antibody respon ses
are also very Importa nt In prev enti ng re- infection WIth the same virus. although
tms has bee n report ed to be Ineffective in some vir al infections (e. g.. hepa trtlS C
ViruS) (Faro et al.. 1992). Stimul ation of specific memory B ce lls wh ich pers ist
after the initial infection results in a rapid seconda ry im mune response and
production of large amo unts of specrfic antibod ie s w ith incre ased affinity for the
parti cular VIral antigen (Abbas et et.. 2000).
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1.6.2 Cellular immune responses
1.6.2.1 C04+ T cell s
The activa tion of C04 + cells req uires recognition by the highly
po lymorphic 't-een receptor (TC R) of e xcqe nous viral pep tides presen ted by
MHC class II mcecuies. These molecules are loca ted on the surface of
professional antigen prese nt ing cells (A PC), inc ludi ng dendntic ce lls .
macrophages (designated in the liver as Kupffer cells ). and activated B
lymphocytes (Abbas et al. 200 0). The 18-22 amino acid-long antigenic peptides
prese nted by MH C class II are usually der ive d from extr acell ul ar antigens tha t
are proteolytica lly proce ssed in acidified endosomes or tysos omes afte r
endocytosis by tne APe (Cresswell . 1996 ).
There are two ctsunct subs ets of CD4 + cells . each associa ted WIth a
different arm of the immune syst em (Bo ttom ty . 1988). The T-he lpe r type 1 (Ttl1)
subset. wmcn produce cytok lnes such as inteneukm (IL)-2 and IFNy. are known
to be Involved In the Classic ce ll-mediat ed functions . such as donal exca ns.cn of
CTL In contrast, T-he lper type 2 (Th 2) cells. whIch sec rete IL-4. IL-5 and IL-10.
are primanly invo lved In the matu ration and differenti at ion of B cells (Mosmann
and Sad. 1996) . Results trom a murine model of leishm aniasis and from hum an
leprosy demonst rate that Th1 responses are particularly effectiv e aga inst
intrace llular pathogens. whereas prote ction ag ainst extracellular microbes requir e
a Th2 profile (rev iewed by Paul and Sede r. 1994 ),
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1.6.2.2 C0 8+ T cells
It is important to note tha t because vira l encoded peptides are synthesized
intracellular1ythey are processed by the class I MHC presentation pathwa y.
Therefore. the princ iple mechanism of specinc immunity against esta blished viral
infecti ons is a virus-specifi c MHC class t-restncted . CDS+ CTL-med ialed
respon se (VJhitton and Oldstone. 1989). The funct ion of COS+ CTL requires the
interaction of the TCR with viral peptides associated with MHC class I molecules
on the surface of infected cells.
MHC class I molecules consist of a transmembrane glyco protein heavy
chain . a soluble light cha in. termed (31-microglobulin (132m). and a proce ssed
pept ide (Hill and Ploegh . 1995 ). Generation of viral pept ides for loading of the
MHC class I molecu les is primarily through proteasome degra dat ion . The
resu lt ing 8- 12 am ino aCid -long peptid es are translocated into the lumen of the
endop lasm ic reticulum (ER) to empty d ass I heavy-light chain neteronmers by
the transmembrane transporter prote ins . referred to as TAP1 and TAP 2 (Spies et
a/.. 1990). The created trime ric complexes are transported through the Golg i
apparatus to the cell surface where they are recog nized by the TCR on CD8+ T.
lymphocytes (Fig . 1-1).
Onc e trigge red CTL can kill the targeted cell by two principal. contact
dependent mechanisms. These cyt otoxic pathways are mediated by Fas/Fa s
liga nd (FasL) inter action and by perforin -gra nzyme release (Sh resta et al., 1998 ;
Ando et et.. 1993). In the FasJFas L pat hwa y. ligat ion and trime rizat ion of Fas
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(C0 9S) receptors on target eeus by effector cells (i.e .. CTL) expressin g FasL
causes secondary messenger-induced programmed death (epcc tosrs) of the
infect ed ce lls (Fig . 1-1 ). In the perf orin-d ependent pathw ay. eTLsecre te the
pore form ing prot ein . perlann. that acts on the target cell mem br ane providing
access for granzymes . After entering the cell, the granzymes are thought to pass
into the cyto plasm whe re they may act on specific substrates involved in the
ultimate de ath of the ce ll and/or they are transported to the nu cleus wh ere they
may act ivate death substr ates (S hresta et st., 1998) . In addit ion , activated CTL
secr ete antiv iral cyto kines (s uch as TNFa and IFNy) wh ich can directly kill the
larget cell (K agi et al.. 1996 ) (Fig 1-1 )
The CTL-med iated kill ing has an advanta ge over ennbocies in that they
can recog nize low leve ls of viral pe ptides . Including intern al regul atory and
nons tructu ra! prote ins which are not normally exposed on virions (Kagi and
Hengartner . 1996 ). Since non-structural prote ins are usually mad e th e ea rliest
after mvaaon . eTLcan theoretically elim inat e infected cells before th ey can
assemble com plete 'l ine ns and a re . ther efore. of pfimary impo rta nce in
preventing virus pe rsistence (Olc stcne . 1994 ).
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Figure 1·1. Major histocompatibility complex class I processing and
presentation pathway. Following the synthesis of antigenic proteins, peptides
are generated after proteasome degradation. Newly synthesized MHC class I
heavy chain assembles with p2·microglobulin then with TAP. Viral peptides
transported into the ER by TAP associate with MHC class I molecules. This
stable 'trimolecular' complex is expressed on the hepatocyte surface where it is
recognized by the CTL (via TCR). In response to activation by Th and NK cells,
CTL release cytolytic granules and cytokines, and express Fas ligand.
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1.6 .2.3 Natural kille r (NK) and NKT cells
The peak of NK cel l cytolytic act iv ity and prolif eration usu ally occu rs
shortly after vea t infectIon and is . therefore . an importa nt element of natural
resi stence to many viruses (See et et., 1997) . NK cells lyse infected targets . but
the k.iIIing is not MHC restricted nor directed towa rd a specific antigen. Rather ,
NK cell s dete ct reduced or abe rra nt expression of MH C class I molecules (Karre
et al.. ' 986). NK cells are normally preve nted from kill ing thei r tar gets by
inhib itory signals provided th ro ugh interactio n of receptors on NK cells with self-
M HC products (Karre and We lsh , 199 7). Therefore , virus-infect ed ce lls with
decr eased surface expression of MH C class I re nders th em susceptible to NK -
mediated elimmation (Miller and Sedmak. 1999). Co nsid erab le evide nce has
acc umu lated to ccncrcce that the pnncicar rrecnemsm by wh ich NK cells
eurmnate targeted cell s IS th rough perfonn-dependent cyt oto xICity (Ka gi et aJ..
1994 : Sayers et af..1998), Sev eral reports indi cat e thaI the ab ility of the hos t to
mo unt a strong cvtctoxc NK ce ll respo nse very ea rly in infection plays a decis ive
ro le in controlling virus spre ad and limit mg pr ogr es sion of the di sease (Biron .
1997: Welsh and Zinke magel. 197 9) . Add itiona lly . it is known th at IFNy .
secr eted by activat ed NK ce lls. ma y dramatica lly enha nce the def ence ag ainst
ce rtain VIrUSmtecnons (O range et et., 1995) . includ ing m urine cyto m eg alov irus
iCMV)
A secon d type of NK ce ll . which expre sse s both NK and T cell markers is
the NKT cell . Although the exact character ist ics of this cell subset remain
20
contr overs ial the key features are sug gested to include a biased VaNp TCR
repertoire . the presence of one of the defined NK ce ll markers (e .g.• CQ16 and
Ly4 9) and high levels of cyt okine produ ction , incl uding lL4 and IFNy (Takahashi
et a/.. 2000). The IFNy product ion suggests that these ce lls have the potential 10
control vira l infections if the y become activated . In addition to cvtc kme
produc tion. NKT cells also exhibi t bo th Fas and certcnn dependent lytic act ivity
(Arase et et.. 1994 : Smyth et al.. 2000)_ Both human and mo use NKT cell s
recog nize non-creesicar MHC class I-like 132mic rog lobulin-assoo ated molecu les
(COl d) present on professional APe (Burdin and Kro nenber g , 1999) via their
TeR. Interestmg ly. NKT cells represent up to 50% of the mature T cells In the
liver (W atanabe e t et., 1995 ). therefore . this cell type could be instrumen tal in the
outcome of liver specific di seases
1.7 STRA TEGIES OF VIRUS ESCAPE FROM HOST IMMUNE RESPONSES
The outcome of any vrrat infecti on IS influenced by a strugg le be tween the
host Immune response, which acts to recog nize and destroy the viru s. and
mecn amsms adapted by the VIruS to avoid recognition and killing . Vi ruses that
evade Imm une elimina tion and estab lish ch ronic infect ions (e .g .. AIDS caused by
human Immunodefici ency VIruS[HIV] and CH ca used by HBV and hepatitis C
virus (HCVJ) are cons idered 10be among the most deadly infectious agents
worldw ide accounting for milli ons of fatalities per yea r (Worl d Health
Organization. 2000) . In genera l. viruses tha t pers ist in a host need to possess
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two fun damental characteri stics . First. they must not be overly cyt olytic and be
able to maintain the geno me in the host ce lls for a prolonged period of time.
Secon d . the virus has to avoid detectio n and elimination by the hosts immun e
response (Oldstone. 1998). Viru ses have evolved multiple mech anisms to avoid
recog mtion by immune effector ce lls and antibody immune response s. Most
virus es that per sist have estab lish ed a com plex vsus-nost rela tions h ip an d often
us e mul t ip le me chani sms to avoid the anti v iral immune res po nse . The following
sections w ill briefl y outline some e xamples of the strategies used by viruses 10
evade host Immu ne survei llance .
1.7.1 In fecti o n of im m unolog ica ll y priv i leg ed si tes
On e Immun e esc ape strateg y used by virus es is the mfecticn of tis sues
and cell types that are not readily accessible to the immune syst em. A site of
cers .stence favored by many viruses. including herpes Simp le x vi rus (HSV) ,
lymphocyt ic chonomeningrtis virus in mice (LCMV) , varicell a zost e r virus (IIZV)
and measles. IS tn.. centr e! nerv ous system (reviewed by Oldstone and Rail.
1993 ). Cells in the central nervous sys tem are favored for at least two reas ons :
the presence of the blood -brain berner that limjt~ lymphocyte trafficking and the
lack of MHC c rass I expression on neur ons wh ich. consequently , cannot be
recognized by virus-s pecflc CTL (Joly et a/.. 199 1).
Several ....iruses also infect lymcnocytes . the effector cells which ncrmeny
cernccate in viral clearance (Oldstone, 1989 ). This may disru pt the function of
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these ce lls and result in virus-specific or ev en generalized im munosuppression.
HIV is a re lat ive ly well characterized ex ample of a Iymphotropic virus whi ch
persistently infects CD4 + T helper cells an d mac rophages lead ing to their
decline , ge neralize d immunosu ppres sion and ult imately death due to seco ndary
infections (Embretson er et., 1993). T he mea sles vi rus is ano ther ex ample of a
rvmc notrooic virus wh ich caus es gene ralized immunosu pp ression . althoug h the
mo lecul ar ba sis of this event is not yet ch arac te rized . It has recen tly bee n
sug ges ted that mea sle s virus imp airs bot h the prima ry and seco ndary T cell
responses by inhi biting their pro lifera tion. but not the effe ctor funct ion s (e.q .•
cytolysis o r cytok ine secre tion ) of the T cells (Niew iesk er et.. 2000)
1.7.2 Antigenic var iatio n
The eme rgence of vir al variants is another ch aracteri stic feat ure of man y
viruses that cause persistent Infect ion . particularly those with high geno mic
mut ation rates (Holland et at.. 1992 ). Th is usually occ urs in viruses which
replicate through rev erse transcription due to the lack of proofreading abi lity of
the reverse transcriptase . This mechanis m can lead to signific ant genom ic
Changes in the VIruS. causing pro tei n mo d ifications and providing a me an s for
evadin g virus-specific B and 'r-ceu med iated respo nses .
The muta tion of viral prote ins at epu opes crit ical for ant ibod y recog nit ion
allows an effective escap e of the virus from humoral immune respon ses . For
example. mutations in hype rva riab le reg ion 1 of the HCV E2 glycop rotein may
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gener ate viral speces able to escape recognrtion by specific antibod ies (van
Doo m et et., 1995 ). In HIV infection. a single amino acid substitution in the
conserved reqon of the envelope glycoprote in. gp 120. can lead to a loss of
recog nition by antibod ies (W atkins et al., 1993 ).
In an ana logous ma nner . muta tio ns in ep itopes involved in the bind ing of
viral pep tides to the MH C mo lecules or in recognition of MH Clv iral pep tide
complex by the TCR can cre ate esc ape m utan ts . The pre sence of ell escape
mutants was first demonstrated in LCM V infection in tran sgenic mice carry ing a
TCR for a sing le LCM V eprtope (Pirche r et aI., 1990). Thi s stud y revealed that a
sing le amino acid subsntunc n in the peptide that constitutes the TCR contact site
resu lted in suppression of the e l l respon se and virus pers istence. \Nheth er a
SImilar advantage occu rs when the CTL response is polycl onal and rnumspecn c
IS not yet known . However. it has been shown th at CTL escape variants occur
dUring natural HIV in fectio n (Borrow et a/.. 1997) and HBV infection (Bertoletti et
a/.. 1994 1.
Anot her rrecnernsm by which antigenic variation can aid in viral esca pe of
Immune reccq runcn is TCR anta gonism . This involves interacti on of mutant viral
pecnoee with the rece ptor and . in this case . the pep tide renders the 'r-cen
unresponsive by an unknown mec hanism. This situation has been suggested to
occu r in influenza (Os trov et al.. 1993) and HIV infe ctions (KJe nenn an et al..
1994 ). A lthou gh the exa ct me chan ism of this even t is not yet understood. it can
provid e a high ly effect ive means of evad ing the virus spe cific CTL response. An
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interesting aspect of this strategy is that the varia nts co uld block CTl.mediated
IyS!S of cells that are co-i nfected with wild type virus . Th is could allow the
surv ival of the wild type virus in the presence of an ongoing eTLresponse .
1.7,3 Induction of immune tol erance
The effectiveness of the host immune response against viruses also
depe nds upon the rnat unty of the imm une sys tem at the time of exposu re . The
hypo thes is that has e ndured umesuggests that an tigens e nco untered in earty
stages of develo pme nt are more likely to be regarded as self , whereas the same
exogen ous antige ns see n by a mature immune system wi ll be immunogenic
(Ahmed . 1989) . In this reg ard. cong en ita lly acqu ired LCM V infection in mice is
one of the best stud ied models of tole rance . Mice infected since birth beco me
life-long earne rs and fail to develop a virus-specific CTL resp onse (Jamieson et
al.. 1991)
In adu lt virarmrecnc n. vuat antig ens ma y inItially indu ce a strong antigen.
eoectc effector T ce ll respo nse . Howe ver. in later ph ases of the in fection . the
VIruS can overwh elm the Co B+c n vuu s-ececfic response caus ing their clonal
exhausucn (delet ion) from the repertoire (Ahmed et al., 1996 ; Zinkemagel.
1996). This has been suggested to occ ur during l CMV infection in adult mice
who fail to era dicate the viru s leadi ng to its persis tence (Moskophid is et al.,
1993 ).
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1.7.4 Interference with cytokine fun ction
Cytokines are an impo na nt part of antivi ral im munity . The y act in a
complex network to inhibit viral repli cation. inh ibit prolifera tion of infected cell s.
med iate the inflammatory respon se and activate other im mune effector
mecnams ms . Stud ies hav e demon str ated that proteins from severa l viru ses can
interfere with these cyto klne functions . Th ree adenovirus ea rty pro teins (i .e.• E3-
14 .7K. E3-1 0.4K114 .5K and e1B-19K ) can protect mouse cell s wh ich are
sensi tive to TNF a - indu ced aooptosie . The me ch anis m by wh ich these
adenovirus proteins counteract TNFa appea rs to be thr ou gh inhibit ion of
cvtcscnc phospholipase A2 (Krajcsi et a l., 19 96 ).
A different mecnarusm. used by Epstein-Barr virus (EBV) . is to block
anuqen pres en tation. EBV expres ses the pr ote in SCRF 1 wh ich is simi lar in
sequence to the human Il · 1O. It was shown th at SCRFl inhibits the expression
of TAPl to a Simila r ext ent as huma n Il -l 0 (Zeidle r et a/.. 1997) . Th is would
hamper the transport of peptide ant igens into the ER caUSIng a general red uction
of MHC class I molecules on the su rface of infected cell s (Sect ion 1.6.2.2 l .
Viral pep tide s that m imic host cyto kine rece ptors or inh ibit activation of
cytokines hav e also bee n des cribed . For example . vacc inia viruses encode
prote ins capable of binding IL-1 (Spriggs et al.. 1992). IFNa (Liptakcva et et..
1997), and TNFa or TNF I3 (Hu et et.. 1994 : Smit h et st .. 1996). Additio nally .
vaccinia also encodes a protease inh ibito r (ermA) tha t prevents the cleavage of
Il.l 13precursor to its active fonn by inhibiting the IL-113convert ing enzyme (Ray
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et al.. 1992)
Recen tly. it was demonstrated that HCM V is capable of inhibiting IFNa ·
stimul ated ant iviral and immuno regulatory responses in infected fibrobla sts and
endot he lial cells by block ing mult iple levels in the IFNo signa l transduction
pathw ay (Miller er OIl .. 1999). For example . HCMV inhibits the expre ssion of
IFNa -stimulated MHC d ass I and 2'.S'-o ligoa denyt ate synthetase (OAS) genes
by decrea sing the espressicn of Jak 1 and p48 . two essen tial components of the
IFNa sig nal tra nsduction. This mecn amsm may be a pnncipal mean s by which
HCMV is capable of esca ping host immunity and est abl ishi ng pers istence .
1.7.5 In hi bition of MHC class II and acc es sory mole c ule fu nc tion
Among the veu ses infect ing humans. HCMV. HIV and measles viruses
have been shown to interf ere with MHC class II ex pression. Most of the viruse s
inhibit the IFNY-Indu ced upregulation of MHC clas s II tran scription rather tha n
affecting the basal level of MHC class [I gen e exp ress ion. 'rtus mechan ism has
been report ed for infection with me asles VINS (l eopard i et al., 1993) and HCMV
(Miller et st.. 1999 ). For example . inh ibition of MHC class II expr esston in HCMV
InfectIon is due to d isrupt ion of the IFNy-stimu lated JakJSTAT signal transduction
pathway (Miller et et; 1999 ). Because the ind uced express ion of MHC class II by
lFNy is likely to pla ya key role in ant igen pre sentation . interference with this step
could prevent the gene ration of an effective immune respo nse agains t the virus.
Oth er studies have shown that acce ssory mo lecu leS. sucn as lymphocyte
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function associated antigen· 3 (l FA-3) and intercellular adhesio n mclecue-t
(lCAM-l). are involved in viral escape from CTL recog nition . Specifically, a
reduced level of l FA·3 and ICAM·' on EBV-positive Burkitt 's lymphoma cells
allowed escape of the cell s from virus-specific CTL lysis (Gregory et et; 1988 ).
How ever . the mech an ism of suppression of these adhesion mo lecu les IS not
curr ently known
1.7.6 In terf ere nce wi th MH C c las s I an tigen pr es entation
One of the major mechanisms of vira l persistence is to prevent the
presentat ion of vira l pept ides by MHC clas s I molecules on the surf ace of
infected cells . Because the stable ce ll surfa ce expression of MH C class I
mo lecu les requires as soc iat ion be tween the he avy chain and 13:m. as we ll as an
endogenous ly synthesiz ed vir a l pe pt ide (section 1.6 .2.2 : F ig . '.1). any
Interf erence wit h antigen processing or presentat ion wi ll interfere with CTl
surveillance. Rega rd ing th is . numerous viral proteins have been reported to
interact with TAP and other components of MHC c rassI an tigen presentation
lsectlon 1.7.6 .2). How ever. rela tIVely few viruses have been fou nd to inhibit
prcteoiyse of Viral pe pt ides by proteasomes or by oecrees.rq MHC cress I hea vy
chai n or 13:fTl tran scnption. The follow ing se ct ions will briefl y summ arize key
me chamsrns used by virus es to modify MH C class I ant igen presentat ion
because this subject is direct ly re late d to one of the aims of the present study.
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1.7.6.1 Decrease in MHC class I m RNA transcri pti on
11 has been documen ted that the oncogenic adenovirus type 12 can
supp ress the ce ll surf ace expression of class I molecules by aff ect ing MH C
class I mRNA . Cells transformed with this virus have decreased levels of MHC
class I transcripts (SChrier et st.. 1983; Ackrill et et.. 1988; Shem esh et et.. 199 1).
Th is process appears to be depende nt on the presence of the virus E1A
oncog ene and can be rev ers ed by treatment with IFNy (Eager et al.. 1989 ).
Ano ther exa mple of a virus decreasing MH C cla ss I mRNA has been
demonstrated in huma n derm al fibro blasts transformed with th e Rous sarcoma
virus . The vi rus Induced a redu ctio n of ce ll-su rfa ce M HC class I a nd 13zm
exp ression. and ttus reduction co rrel ated w ith a marxedl y diminish ed am oun t of
MH C class I trans cripts in the in fected cells (Gogusev . 1988 ). Furt her. it has
been shown tha t the C-termi'h al domai n of the HIV Tat protei n . a tra nsac tivator of
HIV transcn ption. represses tran scnpt ion of MH C class I gene s. The inhibit ion
resu lts from the Interaction of Tat w ith a component of th e gen eral transcription
facto r refe rred to as TAF I12 50 (We issman e t al .. 1998 ) th at acts on the MH C
class I promo te r. Thus . Tat-depe ndent repr ession of MH C cla ss I transcri pt ion
could be one of the mechanisms by wh ich HIV avoids immune surv eillance
(Howcroft er et.. 1983 : Weissma n et et., 199B).
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1.7.6.2 Modulation of intra cell ular pepti de tra ns po rt
It was noticed tha t infection w ith the HSV reduces surf ace lev els of MHC
c rass I molecules (Jennings et et.. 1985)_ The decrease in the express ion was
due to pept ide transport inte rfe rence by a 9-kOa prot ei n produ ct of the immedi ate
early virus gene . US12 . referred to as infected cell protein 4 7 (IC P47) (Yo rk et
af.. 1994 ). Th is cytosolic protein phys icall y associate s with the peptide bind ing
dom ain of TAP. Inh ibi ting peptide transloca tion to the ER. The lack of viral
pep tides in the ER resu lts in em pty and thus. unstable MH C class I molecules
(Hill et al.. 1995). This effect is repo rted to be species spe cific . as ICP4 7 o nly
min imally inhibits pe ptide translocation by murine TAP (Tamazin et ei., 1998).
Ttus is an exce llent exa mple of virus adapt ation to its natur al hos t. A second
prote in known to targe l the TA P complex is U56. a produ ct of HCMV . USB is a
type I membr ane glyco protein th at binds the TAP com plex and inhibits its
peplide-transporting functicn (Ahn e t af.. 1997).
1.7.6.3 Rap id degra dati o n of MHC class I heavy c hai ns
Anoth er know n mechanis m of viral downregu lation of su rface MH C class I
expression is through the degradatio n of the hea vy chai n in the cyt os ol of
Infected cells . For example , prima ry infecti on with the HCM V is usually
asymptomatic and followed by lifel on g persisten ce . un less the host is
immunocompromised or infe ction occu rs in a fetus . in which cas e th e infect ion is
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quite sever e. even fatal (Erlich . 1997). It is commonly acce pted that MHC class I
expression is dec reased on HCMV infected cells and tha t the red uction
corre lates with resrstence of the infected cells to viru s-specrac CTL-mediated
lysis . Because the level of class I heavy chain mRNA is not decr eased in He MV-
infected cells. this sugges ts that the down regu latio n IS ccsnre nscnotonar.
Recent studies have show n that two HCMV·e ncod ed pro teins are involved in the
degr adation of MHC class I in HCMV- infeeted cells . The VIral eeny genes US2
and US1 1 enco de glycop roleins th at me diate translocatio n of MH C class I heavy
chains from the ER 10 the cyto sol, where the heavy chains are rapidly degraded
by the proteasome s (Jones and Sun, 1997; W ertz et st.. 1996 ).
1.7.6 .4 Disruption of MHC clns I ass emb ly
In the case of aden oviruses be long ing to groups B. C. O. E and F. a pnme
mmbnor of class I MHC expression ts the earty region 3 transmembrane
glyco protein termed E3/19K. This prote in binds to the alpha 1 and alpha 2
helices of the MHC c ress I heavy chain (Flome nberg . 1994) . prev enting Its
transport and cell surface expression (Andersson et al.. 1985 : Burgert and Kvist.
1385). Importantly . trus protein has also bee n shown 10 cause a drastic
suppress ion of MHC class I expressio n when transtectec into huma n lymphoid
cells . which are the site of adenov irus persistence (Komer and Burgert. 1994 ).
Ano ther example is the HCMV US3 gene prod uct (Jones et et.. 1996 ). US3 is
transcribed abunda ntly imm edi ately after HCMV infection and forms a complex
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wrth t3:m-associ aled class I heavy chains . which then accumulate in the ER.
In teresting ly. the product of the US3 gene has a sho rt half- life , but is followed by
the translation of US 2 and US11 gen es whose products caus e deg radation of the
accumulated class I heavy Chains (Sect ion 1.7.6.3). HCMV also encodes a
protein . UL 18, thai is homolo gous to the MHC class I heavy chain and is capable
of bind ing to 13~m and forming an inactive comp le x (Fahnestock et af., 1995). On
the othe r hand . it was rece ntly shown tha t HCM V infected ce lls can esca pe lys is
by NK cell s , Thi s presumab ly IS mediated by o te ract cn between the UL 18
protem and NK cell killer inhibitory rece pto rs (Reyburn et al.. 1997 )
1.7.6.5 Intem41l iza ti on o f MHC c lass I su rfa ce mol ecules
EViden ce suggests thai vi rus-specific CTL are an impo rtant compon ent of
the protective Immune response to HIV Infection . However , des pite a vigoro us
CTL respon se , the CTl are not successfu l in elim inating virus infection
(McKinney e t af.. 199 9). One poten tia l mechamsrn is that the HIV Nef protem
reduces the expression of MH C class I antigens and trus decrease is dependent
on c ncs cn cmoenoe kina se activ ity (Swann et et.. 2001 ). The tra nscription and
translat ion of MHC class I molecules is not affe cted , rather Nef b lock s transport
of MH C-I mole cules to the ce ll su rface and thei r interna lization in endos omal
vesic les where they are subse q uentl y degr aded . This MHC class '
downregulation has been co nfirmed in pri ma ry T ceus . where Nef ind uced a 300-
fold reduction of su rface class I molecu le expre ss io n and pro tected the cells from
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HIV·specmc cn cytotysis (Collins et al.. 1998 ). Therefore. persistence of HIV In
penph eral CQ4. T cell s may be due to a red uced MHC class I display on these
cel ls make them poo r cn targets .
1.8 IMMUNOPATHOGENESIS OF HEPAONAVIRAL INFECTION
As outlined abo ve . a truly effective imm une respon se ut ilize s a
combination of humo ra l. cellul ar and innate im mun ity . Althou gh the cellul ar
imm une response appears to be the main cont ribu tor in the path ogenesis of
dise ases caus ed by non-cytolyti c viruses. othe r im m une responses. such as
cvtckm es . specific antibodies and possibly virus-in duce d autoi mmune reactions
may also playa role (Ctnsan. 2000) . The mech an isms respons ible for t issue
rnJury in acu te and chronic neceonavnar infect ion are not completely understood
Accu mul ating evidence Implie s tha t hepatoce llular injUry is caused by the hos t
Imm une respon ses. presumably by T cells specifically directed aga inst viral
ecncces exposed on the surface of infected liver cell s (Chisan and Ferra ri. 1995:
Curry and K OZiel. 2000 ). Read ily de tectable HB V -specmc po lyclonal C'Tl, in the
pe nphe ral blood has bee n iden tified as a dis tinctive fea ture of acut e infection
(Renermann et aL 1995 ). In contrast. CH is acc o mpanied by a wea k or
und etect able HBV-specmc CTl res ponse in the blood (Fe rrari et a/.. 1990 .
Reherm ann et et.. 1996 ). Recently, a new metho d of CD8 + T ce ll detection (via
MH C class I tetramers com plexed to viral pep tide s) has sugge sted that the
number of HBV specific T ce lls in CH is far grea te r than initi ally suspected (Maini
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et s t.. 1999, Bani et al., 2001 ). The followi ng sections will briefly summarize the
major con tnbutions of investigations perf ormed using ma teria ls from HBV-
infected patients . as well as the tran sgenic mouse and woodchuck models. to our
current unders tanding of the molecular mechani sms of hepatitis B
immunopathology
1.8 .1 Hum oral im muni ty aga inst HBV infe ction
The antibod y respo ns e to HB V enve lope glyeo pro teins is thOu9 ht to be
impo rtant in HBV neu tra liza tion and clearance . The los s of HB sAg and the rise
in an ti·HBs is the ha llma rk of disease reso lut ion in pa t ients acutel y in fect ed wit h
HB V, yet It is not observed in indi vidua ls with CH ty pe B un less spe cific assay s
that dete ct antibodies complex ed to viral ant igens are used (Maruyama et et.,
1993)_ The importance of these neut raliz ing ant ibodies in HBV infection has
bee n demonstrated by the universal success of the HBsAg-based HB V vacci ne
(Beasley et et.. 198 3). The ann-Hgs ma y limit viral spread by removing virions
from the Circulation and/ or by preven ting virus attachm en t and uptake by
susceptible cells . How ever. the antibody response to the en velope proteins
coul d also be a contributo r to liver injury _ Immunocompl ex dep osits conta ining
HBsA g . Immunoglobulin (Ig ) an d complemen t were de tected in infe cted hepatic
tissue from various stages of hepatitis B (Nowoslawski et al., 1972 ). Ther efore .
not on ly does the humoral response to HBsAg remain operational in chronic
infec tion . it may also promote undes irable pa lhologica l effects ca used by intra
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and extr a-hep atic deposition of immune com plex es , In fact. it has bee n shown
that about 10-20% of patients with HBV infect ion have extra-nepatc
immunoco mplex -assoc iated disorders (Gocke. '975 ), including
g lome rulone phntis. mos t frequently found in children (Combes et et.. 1971 ;
Nowoslawski et et.. 1975; Slusarczyk et al.. 1980 ). polyarterit is nodosa (Gock e et
s t.. 1970 : Micha lak . 1978). and arth ritis (Csepreg i et al., 200 0 ). One of the
umque fe atures of HBV infect ion is accumulation of an exce ss of large envelope
pro teins In the ER caU Sing a dram at ic expansion of the he patocyte . Th is ch ange
IS a cnaracteosuc of ' g round~ lass ' neca tccvtes and is found in the livers of
cer omceuv Infected pa tients (H adzryann is e t st.. 1973).
The biOlogical roles of the antibod y responses to HBcAg and HBe Ag are
less clear . Ant.-HBc and antib od ies to HBeAg (anti -HBel do not appear to be
neutr alizing antibod ies . becau se they Co-eXISt w ith the virus during both AH and
C H type B It is Interesting. however. that pass ive adm inistrat ion of anti-HBe
protects ch imp anzee s aqamst HBV intectr c n (Stephan et et., 1984 ). Also .
sercccevers.c n to anti-HBe cc smve state has bee n ass ocia ted with less infect ive
and perhaps mor e be nign state of hepatitis (Schm ilovitZ-We.ss et al.. 1993 ).
Addl1JOnally . it ha s been suggested tha t the decl ine of viru s titer , wh ICh IS usu ally
observed afte r se rocc nvers lon from HBeAg to ant i-H Be . m igh t be the result of
the ehrrunanon of infected cells via an antibody recognition of membr ane bound
HBe protein (Schlicht et et.. 1991). The humoral response ag ainst HBeA g and
HBcAg may also promote undesirable effects because the extrahepatic
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depo siti on of these immunocomplexes have been obse rved in glome n.llone ph ntis
(Slusarczyk et af.. 1980: Ohba et al.•1997). In regard to the anti-HB c response,
the occurr ence of these antibod ies in ch ronically infected patients might be
beca use HBcAg can elicit a T ceu-toc epe noe nt antibody respon se (Milich and
McLachlan, 1986 ). This is in cont rast to HBeAg wh ich is excl usively a T cell-
depe nde nt anti gen. It has also been pos tula ted that compleme nt dependent
cvtctc xrctv of neoatocvtes expressing HBcAg . HBsAg Of asialoglycoprotein
rece pto r (ASGPR) ma y also contribute to the injury of HBV· infeeted hep atocyte,
partlcularty In patients WIth severe CH (MiChalak et aL. 1995).
The antibod y resp ons e to the Ha V polymerase and X proteins are not
rou tinely monrtored in curnca t srtuanon s . altho ug h the y have bee n dete cted . It
has bee n repone d tha t an tibod y to the carboxy termi nus of virus polymerase may
be an ea rly marke r of infec tion and reflects acti ve HBV replication (We ime r et et..
1990). Annecces to HBxAg ha ve been repo rte d to show qu antanve and
qu antnanve heterogen eity . They have bee n fo und at the high est leve ls and mos t
freQuentl y In patients WIth CH and usua lly at low er levels in acutely infected
patients and asy mptomat ic ca rners of HBV (Ste mler et al.. 1990 ).
1.8.2 T c ell-med iated im m uni ty in HBV-infected pa tients
Due to the restri cted host range of HBV infect ion and the lack of cell
cultu res that efficientl y support viral rep lication . studies on T cell involve ment in
the imm unopathogenesis of HB V- ind uced hepatoce llular injury have focu sed on
36
the in vitro ana lys Is of CTL and Th ce lls de rived from pat ients with clinica lly
evident he patitis . In ge ne ral , the T ce ll specifi c response to HBV eortocee 1$
vigo ro us . po lyd on al. and multispecific in paue nts with AH. but wea k and ec rtcpe
res tncted in patien ts with cnrcrnc infection (rev iewed by Ctesan. 2000 ). A rece nt
de velo pmen t in the study of VIral pathoge nes is is th e establishment of techniq ue s
sensit ive enoug h to detect virus -specifi c CTL wrtnc ut in vitro clonal expan sion
One of th ese tec hn iques invol ves the use of a fluorochr ome-labeled peptide-
MH C class I tetrarne nc com plex th at d irectly bind s to the Te R of pept ide-specifi c
CTL (review ed by Ogg and Mc Micha el. 1998) . Us ing this assay, the frequency of
viru s-spec ific CTL in HB V infect ion w as found to be 30 to 45-fo ld greater than
that estimated by conv entional limrting dilut ion ana lysis (Maml er al.. 1999 ). It
has been sugg ested th at beca use this assa y unuz es In vrtre clonal expa nsion of
CTL It ma y unc er -esurnate CTL that expa nd poo r1y or undergo eocc tcnc death
dunng the intense antigenICstimu lation 10cultu re (A lexander-M iller et al.. 1996 ).
Ho wev er. It IS also poSSIble that subset s of pep tide-specific CD8+ T ce lls do not
kill infected ce lls . but rathe r secr ete antiviral cyt ok ines that d irectly inhibrt viral
replica tion without da mag ing the infe cted cell .
1.8.2.1 MH C Class II-restricte d T c ell resp o ns e in acute hepatitis type B
The HBV antigen-specific prolife rative responses of C[)4+ T cell s are
usually me asured by st imulating PBM C from patients with eit her AH or CH type 8
using punfied viru s antigens . reco mbi nant prote ins or synthetic peptides, and
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subseq uently assess ing their proliferation via )H-lhy midine inco rporation. These
assa ys have demonstrated that a vigorous class II-restricted T cel l respo nse is
prod uced against several HBcAg epitopes in virtually all patients with AH (Ferrari
et al., 1990 ; Jung et al., 1991 . Ferra ri et al ., 1991). Although some HBV co re
peptide's are recognized by CD4+ T cells in the context of a part icu lar MHC
back ground . the immunod ominant peptides appear to be recog nized by C04+ T·
cells from patients with mult ip le MHC backgr ounds (Ferrari et a/.,1990). Amo ng
the epitope s identified . the HBcleAg amino acids at pos itions 5Q.69 are the most
co mmo nly recogn ized by CD4+ T cells from patie nts with acute infectio n.
irrespecti ve of the ir MHC hap k>type (Ferrari er al., 1990 . Ferrari et al., 1991 ).
An increas ed HBcAg -specific CD4+ T cell response in acute ly Infected
patients was found to be associated wit h cleara nce of HBsAg from the se rum
and decreases in viral DNA to levels undetectable by slo t-blot hybridization
assays, sugges ting that these cells coul d pla y an important role in virus
elimination (Ferra ri et al.,1 986 , Jung et et.. 199 1). The antiviral effe ct of CD4+ T
cells appears to be prima rily through their ability to help initiate and susta in the
CTL respon se to HBV. This is med iated by the secre tion of pro liferative
cyto kines (e.g .. IL-2) and anti viral cyt okines (e.g., IFNy), as described in Sect ion
1.6 . A funct ional study of HBcA g-specific T cells deriv ed from per iphe ral blood of
patients with AH type B sugg es ted that a prevalen t Th 1 cytokine pattern and high
leve ls of IFNy may contri bute to the succe ssful co ntrol of HBV infection (Penna
et al., 1997)
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The C04 + T cells may also contribute to long term control of trace levels
of HB V replication persIsting after recc ....ery from neoautie. as demonstrated by
the oetecton of HBcAg ·sp eclfic prol iferat ive "l-ceu responses ye ars aft er
reso lut ion of AH (Penna et al.. 1996 , Reherm ann et a/., 1995 ). Along this line .
identification of HBV DNA by hig hly sensit ive neste d pe R in the se ra and in
PBMC many years after self . limiting AH suggests that the HBV -spe cific CD4+ T-
ce ll response is maintai ned ind efinitely by minute amounts of pers istently
repli cat ing VIrUS l Midlalak er a l.. 1994 : Reherma nn et st.. 1996 : Penna et a l..
1996 ; Yotsuyanagl et al. . 1998)
The C04 + t-eenproliferative response to HBVenvelope anbgens IS
relatively weak compared to HB cleAg in patients wIth self-limited AH o r CH
(Ferr ari et al.. 1990J_ The molecular basis for this observation is not unde rstood .
In particular due to the observation th at HB sA g is Immunog enic in healthy
volun teer s (Ferrari et al .. 198 9 : Ce lis et al.. 1988) . It is poss ible that high levels
of CIrculating HBsAg present ea rty in the course of infect ion coul d exhaust or
anerqize the specrfic CD4 + T ce lls respo nses to II .TUS enve lope prote ins
1.8.2_2MHC cl ass II-re stricted T-c ell resp onses in chronic hepatiti s type B
In general. the HBV -specific periphera l blood C D4+ T-cell response in
patients with CH type B are mu ch weaker than in those with AH (Fe rrari et a/.,
1990 : Jung et al.. 199 1; Ma nnos etal.. 1995 ). However. the stre ngth of the core-
SpecifICCD4+ r-een responses m ay be acce ntuated during reactivation phase s
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etCH (Marinos et al.. 1995 . Tsa i et al., 1992). II is pos sibl e that the increased
MHC class II restricted cc re-specfic CD4+ T-ce ll response and the assoc iated
disease flare are de pende nt on the viral replica tion rate. In con trast to HBcAg.
the prolife rative T cell response to HBsAg dunn g these tran sient episodes remain
unaltered . It is postula ted that HBsA g.s pecific T-ceus might be suppressed by
the cer erstennv elev ated level s of circulating HBsAg that typi ca lly occ ur in CH
ty pe B whe reas CD4+ T cells specific for HBcAg co ntinue to playa key
imm unor eguls lory role . In kee ping with th is theory. 12 ch ronica lly infect ed
patien ts tak ing Iam ivudln e (3TC ) to suppress HaV repl ica tion (Oien5139 et af.,
1995), had a rapid resto ration of the ir circulatJOg Ha V nuc leocapsid-specific T
cells after ' ·2 weeks of trea tme nt leading 10a mar1o:.ed reduction of viremia. but
not In the serum levels of HBsAg and HBeAg (Boni et et.. 1998). After cessation
of lamiv udi ne treatment. HBV replication returned 10 pretrea tment levels
Although dat a have indicated tha t in crvcmc HBV infect ion a Th 1-like
response IS strongly represe nted 10the intrahepatic infi ltrate (Bamaba e t al.•
1994: l ohr et al.. 199 5: Penna e r aJ.• 1997). It has bee n repo rted thaI these cells
should be d assified as ThO phenotype because they secr ete IL-4 and IL-S. in
add ition 10 IFNy (Bertc letti et al.. 1997) . Additiona lly. neither cells from HBeAg-
cos mve canents with CH type B or pat ients with high leve ls (>300 pg/m l) of HBV
DNA we re capa ble of prod ucing IFNy afte r in vitro stimulation with recombinant
Il-12 and HBV pe ptides (Schlaak et al.. 1999) . This cou ld be one of the
explanations for the poo r response to immunostimulato ry the rapy in patie nts with
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a high HBV load.
1.8.2.3 MHC class l-restrict ed 'r -cett response i n acute hep ati ti s type B
CTL are thought to be prim ary media tors in virus elimination due to their
ability to recogn ize and kill the infected cells that expre ss vira l epitopes in the
con text of class I MHC mo lecules (Sect ion 1.6 .2.2; Fig 1. 1). However. because
seria l liver biopsies from panents with AH are not obta inable due to eth ical
con s.ceraucns . HBV-specific CTL are rare in CH type 8 and biops ies from
Individu als with AH that prog ress to CH are not rout inely availab le. It ISdifficu lt to
recon struct the complete profile of intrahepatic CTl responses during the course
of HBV infect ion. To ci rcumvent these difficulti es . CTL from the penpne ra l blood
are clcn aUy expanded in Vitro m the presence of HBV-derived synthet ic peptide s
rNayersm a et al.. 1993). Ttus tec hnique involves stimul ation of PBMC wi th
synthetic Immunogenic viral ecrtc ces and recombinant IL·2 . resu lting In CTL
clon al expans ton and Increased kIlling of ta rge t cells . as ce rerrmnec by s'Cr
rele ase assa ys , This stra tegy has been valid ated by «rentrncaton of numer ous
cn ecnooe s In sequences of drffer ent VIral pathog ens (e.g . Ben oni et st.. 1997 ~
Sidne y et af.. 1996; Threlkeld et af.. 1997) .
Several novel obse rvat ions have been made in patients acutely infected
with HBV by using the strategy menti oned above. It is now known that patients
with AH ty pe B display a vigoro us. po!yclonal. MH C class t-restnctec CTL
resp onse against mult iple HBV envelope. nuceocaossr and poly merase
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epnc ces. Many of the infected pa tients recog nize the same spectrum of
epuopes (e.g .• HBV core amino acids 18-27 . env e lope amino acid s 183- 19 1.
250-2 58 and 335--343. and polymerase amino acids 455-463). whereas other
eprtopes we re seen in a minonty of patie nts (Bertoni et al.. 1997; Nayersina et
et.. 1993: Rehermann et a!., 1995). This suggests the presence of a hiera rchy in
HBV-speCific CTL respo nse which may be Infl uenced by the MHC class lIvi rus
ec ncce bind ing affin ity and the heterogen eity of viral seq uences present (Sette er
al.. 1994). So me Ha v -specrt c CTL epitope s lie in protein sequences that are
cntica ! fo r virus speci fic fun ction s. For examp le. the nucleocap sid nuc lea r
loca lization and encapsula tion sign als co ntai n a CT L epito pe (co re 14 1·1 5 1) that
IS recog nized by at le ast tw o MHC haplotypes. A3 1 and Aw6 8 (Missale et al ..
19931. Simdarty . the MHC·A2 ·re stricted HBsA g ec nc ce . that spans residues
250-269 . cvertecs an Importan t tcpoqemc seque nce In the HBsAg
trans mem brane dom a in (NayerslOa et al.. 1993).
The polydonahty and mumsceenety of the e l l response . toge ther with
potential sequen ce constraints . mit igate aga inst the emergence of CTL virus
escape mut ants. cesc ne the high muta tion rate of HBV. It is evident that a
strong polyd onal HBV- spec lfic CTl res ponse is ma inta ined for deca des after the
loss of conventional virus infec tion markers (e.q.. HB sAg . HBeAg) (Rehermann
et a/. . 1996). This respon se could be a cons eq uence of an ongoing st imulat ion
with prote ins deri ved from trace amou nts of transcncnc nauy activ e HBV DNA that
remam years after an app arent com p lete clinical. serological and biochemical
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recovery from hepatit is (MiChalak et al.. 1994 : Rehenna nn et af.. 1995: Pe nna et
al.• 1996: Rehe rma nn et et., 1996 )
The vig orous and pclycrcnat C'I'l, response appears to be a good
pred icto r of recov ery from AH type B. Exper iments in the tran sge nic mous e of
HBV (Section 1.8 .5) and. more rece ntly , in a Chimpanzee model of hepatit is B
suggest that the ncn-cvtccetr ncclearance of the vm rsfrom infected hepatocytes
may be principally med iated by the antiviral cytok.ines re leased from CTL
(Guidotti et af.. 1996; GuidottI et et .. 1999) . Indeed. the num ber of HBV-infected
hepa tccvtes can vastly exceed the number of HBV-specific eT l in the body, so
that antigen-specific des tru ction of all the infected liver cells by the CTl w ould
not on ly to be phYSica lly impoSS ib le . but a lso very detri me nta l to the host (Gu o et
al. .2ooo )
1.8 .2.4 Stud ies on the antiv ir al MHC cla s s I-re stricted COB 'r-eef! response
in chronic hep ati ti s B
In cont rast to the CTl res pons e detect ed in patients wit h self-l imited HBV
Infection. CH type B is usua lly associa ted with weak or undetectable CTl
responses aga inst the virus . In contrast to neon atal infect ion . where
Immunological toleran ce can explain the wea k T~II responses and viral
pe rsistence . the mecha nism s lea ding to weak CDB. T-cetl rea ctivity in adult
onset of CH type 8 are not well understood . This weak , but co ntinual, anti-viral
cell cytotoxicrty probab ly indu ces the injuries that are cha racteristic of chronic
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liver inflammation (Micha lak. 2000 ). Beca use HBV -specmc eTLcan still be
de tected In Chron ica lly infect ed patients . it is unlikely that their decreased activ ity
is due 10 clonal dele tion (Bertcte tt i et et.. 1994 . Bam ab a er st.. 1989 )
Additiona lly . the CTl occasion ally become reactivated caus ing an exacerb ation
in the seve rity Of liver disease . It has als o been shown that patients wit h chron ic
HBV infe ctio n . who expe rien ce d a sp ont ane ous or IFN a -ind uced HB eAg
cle arance display a viqorcu s an d muttiapecrficHBV.specifi.:; CTl respo nse
sim ilar to that observ ed In patien ts w ith se lf limiting AH (Reherm ann er a f.. 1996 )
The dramatic difference in the strength of the antiv iral eTLreact wrty seen
between patien ts with AH and CH type B sugges ts thai th is response is of
pri mary Importance in the determina t ion of vira l clearance
1.8 .2.5 Hepadnavirus infectio n and NKJNKT cell s
Currently , the role of NK and NKT ce lls in hec ec naveat elim ination is not
we ll recog nized . It has bee n repo rted that AH ty pe B is ass oci ated with
enha nced NK cell cvt ctc octy (Cheme Jlo et al.. 1986) and that HBsAg can inhibit
the NK ceu-rnecnetec cytot o xll:rty in VItro (de Ma rtino et et.. 198 5), but fu rther
stu dies are required to fu ily understand the impo rtance of the NK cell med iated
resp on se , Suggestions have been mad e that it is the innate immune respo nse
that is respo nsi ble fo r the irutia l control of HBV infect ion in ch impanzees (G uidotti
et al.. 1999). Rece ntly. the re has been com pelling evidence that NKT and NK
cell s contro l hepadn av irus replication in H BV transgenic mice via IFNa/(3 and
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IFNy release (Kakirni e t al.. 2000 ). However, whether these resp onses are
impo rtan t in natural hepadnavira l infectIOn must still be detennined
1.8.3 HBV im mu ne evasio n
Induction of immunolog ica l tolerance may be one of the key reas ons why
exp os ure to HBV during ea rty de ....elopment (ie.. neonatal) most often results in a
life- long pe rsistent vira l infecti on (reviewed by Ch isari an d Ferran. 199 5). It is
also possib le that during ad uh ons et of HB V infection some of the viru s-speafic T
ce lls may be deleted or anerglZed th rough overs timulation by hig h doses of vrra t
antigen . Evidence for this hypothes is come s from observ ation s of cnrcrnc
hea lthy H8V earners . who demonstra te large am ounts of HBs Ag In hepatocytes
and in the CIrculation. without apparent evroe nce of liver injury (de Franchis et al.,
19931. Thus . the virus may successfully pers ist by eva ding the Immu ne
responses through thei r cversnmurencn with an excess of vira l antigens
Although ther e ISno direct evidence that HBV can influence the
expressio n of Important molecules . Including MHC or other ce ll surfa ce
acce ssory molecules con tnbutlng to the TCR.MHC-peptide Interaction , stud ies
have shown that HBcAg can Inhibit IFN(3gene transcnp tion (VVhrtten et aJ..
1991 ), In add ition . it has been reported that HBV can inhi bit cell ular Immu ne
responses induced by IFNa and IFNy, although the mechan ism responsible for
this has not bee n ident ified (Foster et st . 1991 ), Th us. HBV may hypothet ically
be able to indirectly block a cytokine- induced upregu latio n of MHC class I and its
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accessory molecu les
Beca use HBV uses a revers e transcnption step in its replicatio n cycle
numerou s vir al mutants emerg e dunn g rep lica t ion. Th is may allow th e ....uvs to
have an increased ability 10 evad e both T and B cell based immunity . For
example . HBV variants with one or two amino acid su bst itutions were shown to
an tag onize CTL recog nitio n of the wild-type viru s e cit cc e in chronicall y infect ed
patients (Bertote tt i er st..1994 ). Addit ionally . variant T cell epitopes in the HB cA g
imm unod ominant pept ide (amino acids 18-2 7) which inhibit CTl response
against wi ld type epncce ha ve been derived from pat ients with CH type B
(Bertc le tt i et aI.. 1994 ). The co nco mi ta nt ex pre ssion of vi rus w ild type an d
antag onist ic pe ptide s on the surface of infect ed he patocytes could co ntr ibu te to
viral pers istence
Ano ther mecnamsm HB V may use to avoid im mune recognition is the
mvasscn of Imm uno log Ically pnv lleged sites . HBV DNA seq uence s have been
detected in ma ny ext rahe pat ic SItes th at are pot en tia lly inacce ssib le to CTL d ue
to rmcrovascutar ba mers (Mason et a1..1993 : Og ston et a/.. 1989 : Yoffe et
al..1990 ). as well as in lymphOId cells (Secti ons 1.3.2 and 1.5 .2). These ma y
serve as a reservoir of co nnn uou s viru s rep lication and re lease infect iou s virions
1.8.4 Cytokin e-induced hepadnaviral clearance
As mentioned in Sec t ion 1.6 , it w as pre viously tho ugh t that the elimination
of virus-i nfect ed cells relied excl usiv ely on thei r des tru ction by the effector ce lls of
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the immune system. However. it is now recogniz ed that cytokine-depend ent.
non-cytolyt ic curative mecha nisms ma y also con tribute to controlling infections.
Th is was init ially demons trated in a transg enic mouse rncdet of HBV infect ion
(SeCIIOn 1.8.5). At thISstage . the int race llular events causing the dow nreg ulation
of vrrat expression fOllowing eytok ineJreceptor inte raction are not well
characterized , although sugg ested mechanism s include induction of a host
encc nbc nu creese tha t cleav es HBV RNA. as well as the 2'5'~OAS system wh ich
induces RNase L (Guidott i and ct nsan. 1999 ). Rec ently , data obtained from a
chimpanzee exper imentall y infected wit h inoculum der ived from transgen ic mi ce
that replica te infectious Ha V demonstrated tha t dec reases in markers of HB V
in fectio n pre cede the onset of T-cett mfilt rat ion and hepatitis. This ma y suggest
tha t a non-inflammatory mecnamsm of hepadnavira l Clearance is po ss ible
(GUidotti et a/.• 1999 )
1.8.5 The tr ans genic mo u se mod e l of HBV infection
Transgenic tec flno logy nas allow ed th e cre ation of mice. wtlich are not
natura l hosts for nepacna veuses. to recbce te the HBV genome and produce
com plete virions (review ed by cmsan. 1996) . Studies in tne vario us type s of
HB V transgen ic mice have significa ntly contribu ted to the current understanding
of HBV pamoqenests and mechanisms of hepatocellular injury . Interestingly ,
HBV cccD NA has not been det ected in any mouse lineage generated. incl ud ing
strains wh ich produce infect ious HBV virions. However, wnen inocula from the se
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mice was used to infect Chimpanzees. HBV ccc ONA beca me de tectable This
suggested that speces-specfc diffe ren ce s at the level of generation of cccO NA
may be importa nt in de te rmining the host range of the virus (G uidotti et st..
1999 ). It is now apparent that the process of neoac navuus re pl ication and
synt hesis of virus proteins are not cytop ath ic. The recog niZed excep tion is
transg enic mice wh ich cv erexpress and retain the large enve lope (preS1) prote in
of HB V . These mice can dev elo p sev ere C H and HCC (ChisaMet al., 1987 .
Cnisan et 81..1989) . In othe r HBV transgenic mouse lineages, which do not
spo ntaneously generate liver cell injury. the retent ion of the large pr ote in in the
ER sensitizes the hecatccvtes to cytok ine s. such as IFNy and TNF a . lead ing to
enhan ced hepatocellular InJury (Gi lles et a l.. 1992: Ando et et., 1993)
Since transqeruc rmce can support HB V replication WIthout any ev idence
of a speofic Immune respo nse (G UidOtti e t al .. 199 5). the components of th e
ececnve enmune system that med iate liver damag e cannot be studied directly .
However. investigato rs were ab le to Induce tra nsient AH. as we ll as fu lm inant
eecantrs when HBV.s pe Clfic CD8 + T ce ll clones were adop tive ly trans fe rred into
these mice tMoriy ama et al .. 199 0: Ando et a l.. 1993) . An aly zing m ice which
de ve loped fulminant hepa titis de mons trated that li....er dise ase is an orderly.
mult istep process that inv olves both viru s-eoecrnc e Tl and antigen ncn -speefic
inflam matory resp onse s which ca n am plify the loca l cyto pathic effect s of th e
Cl L. It was concluded tha t when virus-specific e l l encounter HBV antige n they
secr ete IFNy. whi ch activates in tra hepatic macrophages and induce s a de lay ed
48
type hypersensitivity resp onse . This reaction is able to destroy the liver and kilts
the animal. Interesting ly, the pathog enic effect of the HBV·spe cific en and the
mortality rate can be dramatically reduced (" 97%) by prior adm inistration of ant i-
IFNy antibodies lAndo et al., 1993 ).
In add ition to causing hepatocyte cytolysis in transgenic mice which
rep licate HBV. specific e l l adoptive ly transferred into thes e mice can tran sient ly
abolish HBV gene expression and repl icat ion wit h minimal liver ce ll dama ge
This coincides with the indu ction of intrahepatic an tiviral cytok ines (e.q.. IFNV,
TN Fa . IL-2 . Il-12) (Guidott i et al.. 1994 : G uidotti et al. . 1996 ; Cavanaugh st af.,
1997). The existence of this non -cyt olytic clearance mech anism sugges ls tha t
hepatocyte injury may be an un fortunate consequence of a primarily non-
cvtccetmc virus clea rance mecha nism. This may represent an important host
strategy to contro l HBV infect ion in the liver whe re almost 100 % of hepatocy1es
are frequently infected (KaJino et al .. 1994 ).
Althoug h the transqemc mouse mode l of HBV has meaningfulty
contnb uted to our understanding of the immunopathogenesis of HBV infection.
this mod el is art ificia l and . therefore . the data obtain ed need to be interpreted
wrth caution. The proce sses iden tified in the HBV transgenic mo use system will
have to be re-ev aluated in a natura l model of HBV infectio n to confirm the
results
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1.8.6 The woodch uc k model of HBV infection
Sim ilar to HBV infection of humans, woodchucks pers isten tly infected with
VVHV develop chronic liver inflammation with different deg rees of hepatocellular
injury and Iymphomo no nucle ar cell infi ltrations (reviewed by Micha lak, 1998 ).
Add ition ally . as in HBV infection . most of the infected neonates dev elop
sero logi call y evident ch rome infection and almost inva nab ly HCC (Tenn ant and
Germ. 2001 ). The fact tha t animal age. virus stra in and its dose may influence
the rate of chronicity In experimental VVHV infection has recen tly bee n shown
(Cote et et.. 2000). In adu lt animals. VVHV infectio n usually leads to acute self-
limited he pat itis and clea rance of VIruS sero logical ma rkers (Korba et aI., 1989),
but molec ular indica tors of residu al VVHV Infect io n rema in (Mich alak et st .. 1999)
How ever. suppressmg the inrtial immune resp onse aga inst Vl/HV in
expe nment ally infected adu lt wood chuck s with cyclo spo rin A dramatica lly
Increases the rate of cnec mc outcome depend ing on the time of drug
ac munstranon (Cote et al.. 1991: Cote er et.. 1992 )_ Add itiona lly. these amrnats
had reduced seventy of liver d isease. increased VIremi a. and only a transient
nepanns once the dnJg was discon tinued . Thes e data streng then the concep t
that the immunolog ica l status of the host is critica l in the path ogenesis of
beoacn avnar cnrorucrtv and clearance
At the current stage . the ma in constrains associated with the wide
utilizatio n of the wood ch uck mode l for research on th e pathog enesis of
hep adnaviral infecti on are the cctnree natu re of the an imals and the lack of
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reagents recognizing woodchuck immune ceu marxers . However , the
woodchuck mod el of hepatit is B is more acce ssible and substanti ally less
expe ns ive than study ing HBV infected chimpa nzees . Hecednavirat clearance
without ma ssive immune mediated destruction of infected necatocvtee has been
suggested to occur in WHV infection (Kajino et al. . 1994) . Hec atccvtes labeled
during the peak of acute infection , whe n nea rly anuv er cells are infected, we re
stili present after the e limination ofVVHV from the liver (Ka jino et al., 1994 ). This
sug ges ts that non-cytopathic Viral d earance . pe rhap s v ia loca l cyt c»<ine release.
also occu rs In woodchucks Infected WIth WH V . The corr elation of hepatic IFNy
and TNFa expression and virar clearance has been recen tly estab lished in
eeonarauv acquired V\lHV infe ction (Guo et al .. 2000 : Nak am ura et al., 2001)
The estab lishment of assays measuring the prolifera tive 't -een respo nse in
woodchucks has furthe r demons trated that CD4+ cells may play a role in
preven tmq development of chrome infect ion. Similar to HBcAg . VVHcAg and
some of Its synthetic pecne es effectively stimu late prol iferation of T cells derived
from acutely Infected wood chucks. but not those obtained from anima ls with CH
(Menne et al.. 1997). AddItio nally . ervnuruzencn WIth e ither recom binant VVHcAg
or the m munodo minant core pep tide (amino acid 97.1 10) can protect na ive
wood chucks again st VVHV infect ion (Menne et al.. 199 8) .
It has been docu mented that Chronic WHV infect ion . but not acute VVHV
hepatiti s. ISassoci ated with the incorporation of large r (saturable) qua ntities of
virus envelope proteins in heap tocyte plasma membranes (HPM) (Micha lak and
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Churchill , 1988 : Micha lak and Lin. 1994 ). It was po stul ated that this , together
with th e abundant amoun ts of these proteins in the circulation. could provide a
type of immunological bamer. In add ition to VVHsAg , bo th VVHcAg and IN'rlV e
antigen (VVHeAg) we re also found tc be ass oc iated with the outer mem branes of
infected heoatocvtes (Michalak et et.. 1990: Michalak and Churchill . 1988;
M ichala k and lin. 1994 ). Interestingly, while anti·l/v'l-ic reactivity was read ily
de tectable on he patocyte surface membranes. anti · \foJHe antibodie s could only
be de tect ed on the membr anes from an ima ls that had recovered from AH
(Mich a lak et et.. 1990 ). ThIS ma y suggest th at. similar to HBV infecti on in
humans. a humoral res pon se ag ainst eAg may contribute to the resolution of
acute infectio n presumably by the el imina tion of infected hepatocytes thro ugh
annocc v-mecnateo cvtcrvsrs. as In chimp anz ees vacc inated With HBeAg (Sect ion
1.8.1; Schlich t et al ,.1991) .
Furthermore . it has been doc umented that \!VHV infecti on commonly
tnggers the production of both org an ncn -specrnc and liver scecnc u.e..ASG PR)
ectoanneccnes (Ozw onkows ki and Michalak. 1990 ; Drac and Michalak. 1997).
Ant l-ASGPR ant ibodies. rn carncurar . could be cap able of inducing hepatocyt e
cytofysrs in the presence of comp lement. as demonstrated by an in vitro assay
(Olao et al.. 1998 ). If the se autoantibod y med iated cyto pathic effects exist in
vivo. they may co ntribute to the pathogenesis . aggravate severity and prolong
recovery from liver injury In \Mal hepatitis (Oia o et al.. 1998 )
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1.9 THERAPY OF VIRAL HEPA TlllS
Although safe and effect ive prophylactic vaccines for hepat itis Bare
ava ilable . vaccination does not treat established HBV infecti ons and there are no
effective therapies for patients with CH type B (l emon and Thom as . 1997)
A ttempts at treat ing chronic HBV infections hav e met with limited success. Until
recently , IFNa remained the only agent with any beneficial effect for some
grou ps of ceuemswith CH type B (Alt er and Ma st. 1994 )_ Retrospective
mo tnvenae'e ana lysis has shOwn that several features of HBV Infect ion a re
ass ocia ted w ith a higher like lihood of a response to IFNa treatment. The y
Include : adult acquired infection . short duration of disease (longer than 6 mon ths .
but shorter tha n 2 years ). e levated trans am inases (e .q.. 2-5 fold normal AlT
reven . slgnmcant ir rtlernmencn on histological exam ination of liver biopsy , HBeAg
po sitivity , low serum DNA levels. immunocompetence. female, and the absen ce
of hepatit is delta virus infectIon (l au et a l.. 1998). Unfo rtun ately . IFNo therapy
has ma ny other snort commgs. Inclu d ing the fact that It is administered
parenterally , is poorty toler ated . is co stly . and the fact that it results 10sustained
viral clearance In only ooe-rture of pa tients. wrth pnmarily unsuccessful
nonresponders retreatme nt (Hoofn agle . 1998 ). Therefore . new enuwat age nts
and immu nomo dulatory agent s are being active ly pursued . including nucleos ide
analogs and therapeutic vacc ines. One of the mos t success fu l is lamivud ine
(3TC). an ora lly admi nistered seco nd genera tion nucleo side analogue which
inhibits virus reverse transcri ptase act ivity . Init ia lly develo ped as a treatmen t for
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HIV infec tion. this drug also tnh ibits hepad navirus rep lica tion . includ ing "NH\I
(Mason et al .. 1998 : 000n9 et al.. 1991 ; Dien stag et a/., 199 9: Micha lak et a/..
unpubli Shed data ). For exa mple . a tz-week course of lamivudine de cre ased
se rum HBV DNA levels to levels not detectable by hybridization ass ay in patients
that received 100-30 0 mg dail y (Die nstag et al., 1995). Howe ver , on ly 6 of 32
treated patie nts remained serum HBV DNA-negative and only 4 of them beca me
HBe Ag -negatIVe during po st-t reatment followup _ It was also reponed that
lamivud ine ISable to res tore the initially dep ressed prcuteranve T-ce ll respo nses
to HBcA g. HBeAg and Interestlngly to tetanus to xoid and nonspecdic mitog ens
te g .. PHA . anl l-CD3), wit h in 1 10 2 .....eexs of therapy (Bani et al.. 1998 ).
Howeve r, tarrsvueme becomes les s effe ctive due to a muta tion in the high ly
conserved YMDD locus of the HBV polymerase gene in 20·25% of peopl e afte r 1
year of treatment and in up to 60% of peop le after 3 years of treatme nt (Tippl es
e t a l.. 1996 ) The per cent age of the !amivud ine nonrespo nde rs mcreeees.c unnq
long term the rapy.
Thera dtgmce> is an expe rime ntal lipope ptide vaccm e deSigned to stim ulate
Inducti on of HBV·s pecdi c cn respo nses In ind ividuals with the MHC Class 1-A2
subtype by mcfusion of the highly an tigen ic HBcAg 18-27 ec ncoe. a un iversa l Th
motif oenved from the tetanus tOXOId (peptide 83 0-843 ) and tw o pa lmitic acid
mo lecules as the lipids (Vitiello et al .. 1995). Cli nica l trials have demonstrated
tha t although The radi gm is safe and ab le to ind uce a prim ary HBV·specific CTL
response in healthy volunteers. comparativel y weak CTL respo nse s were seen in
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chr onica lly infected HBV patients (Living ston et al.. 1999 ). Add itiona lly , alth oug h
the 'r-ceu proliferative respon ses to th e univers al Th motif in the construct
appea red norm al. the cytok ine profi le observed sug gested the inducti on of a
ThOfTh2 response rather than a Th1 (Livingston et al., 1999). This observation
may support the importance a Th1 response in elim inahon of HB V infection.
The importance of in vivo testin g of the new antiv iral drugs in a suitable
model, such as the wood chu ck· 'NI-lV sys tem . was dem onstrated by the tragic
fa ilure of the anti-viral agen t FIAU (Fialurid ine). Th is seco nd gener ation
nucleoside ana log showed prom ise ag ainst HBV DNA po lymerase act ivity in vitro
and in the duck hepat itis 8 rnocet however clinica l tria ls resulted in the deat hs of
6 of 24 pati en ts chron ically Infected w ith HBY due 10 hepatic failu re and lact ic
acido sis (McKenZIe et al.. 1995 ). Dru g testing conducted In wood Chucks after
the fact show ed that these anima ls dev e lop similar toxicity and dea th rates to
those obse rved In humans (Tennant e t af. . 1998). The abo ve example
demonstrates the Importance of using approp nate an ima l mod els in anti-HB V
drug testIng Interes tmgly . a derivativ e of FIAU. l ·FMAU dram atically decreased
IN t"N WIth no appa rent toxicrty In Chro nicall y infect ed wood chucks . In addit io n.
there was no significant virus reb ound after ces sat ion of the drug treatment (C hu
et al.. 1998 ).
55
1.10 PURPOSE OF THE STUD Y
Chronic infection with HBV is an important cause of mortality w ithin the
human pocufancn due to the development of severe liver diseases, including
chronic active hepati tis . cirrhosis and HCC. The pathogenesis of neoac navuus-
ind uced liv er disease and the establishment of viral persistence are complex
pro ce sses that involve both virus and hos l dep end ent factors . These pro cesses
rema in only part ially eluci dated . VVHV induced hepatitis in eastern North
Americ an woodchucks (Marmot a monax) reflects . w ith a high degree of
accurac y. virolo gical. imm unological and pathological eve nts occurring in HBV
infected patients. The woodc huck model of HBV infection was used in the
present series of stu dies to investigate select ed aspects of hos t immunity against
WHV infectio n, molecu lar mechanisms by which the virus ma y per sist. and
factors of the immune response whose eva luat ion may allow pred iction of the
outcome after adult onset of WH V infection (i.e.. recovery or prog ress ion to
ch ron ic infection and hepati tis) . Fo r this purp ose , novel assays and mole cula r
markers app licable for investigations in the woo dchuck·WH V model were
devel oped and used over the course of the prese nted stud ies
The specific objectives of the current stud ies were as follows :
To develop speci es specific molecular biology reagents and assays to aid
in determining how the sta tus of the immunological response, including
intrahepatic cyt okine express ion , influences the outco me of hepadnavirus
infection and virus-induce d liver disease in the woodchuck mode l of
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hepatit is B
2. To inv estigate the rereuve contributions of Fa sIFa s ligand and pe rform-
based mech anisms of cytotoxicity med iated by woodchuck lymphoid
effe ctor cells dunng acute . ch ronic and conv alescent phases of
experimental bececnevear infection .
To elucida te the relationship be tw een acute and chron ic stages of
expenmentaJhepadna viral hepatitis and the ce ll surface expression of
MHC class I molecule s and related genes in hepatocytes and lymphoid
cells w hich are known to be natural site s of WHV replication .
To determ ine w he ther differ ent stages of expe rime nta lly ind uced
nepac navira r Infection are charact erized by specific Inflammatory and
annvirat cytoklne profi les In organs naturally targeted by the viru s (ie.. liver
and spleen ) and wheth er the evafuet on of these profiles can pred ict the
long-term outcome of nep ecn aveus Infect ion in the woodChucK-VlHV
expenme nta l system
57
CHAPTER TWO :
GENERA L MA TERIA LS AND METHODS
2.1 AN IMALS
2.1.1 Woodchu cks
All wood chucks used in ttus stu dy were mainta ined by the Molecu lar
V irOlogy and Hepatolog y Resea rch laboratory at the Health Sciences Centre .
Me mona l University of Newfoundland. SI. John 's. Newfound land under
environmental and biosafety conditions specifically established for this specie s .
Animals were fed a he rb ivo re diet supp lemented w ith fresh ve getab les and give n
water ad libit um (Michalak an d Churchi ll. 1988: Micha lak and Bolger. 1989:
Michalak et al .. 199 0: Mict'la lak a nd L n. 1994 : Micha lak . 199B).
Anlmals mfect ed wi th \NH.V were housed separate ly from healthy
w oodchucks , Hea lthy w ood chucks had no se rolog ica l ma rkers of curre nt or pas t
WHV infection . i e . they were neg ative for WHs Ag. anti -WH c and anti·VVHs
antibodies (Sections 2.3 .2 and 2.3.3). In add ition . DNA extracted from sera.
penp heral blood mononuclea r ce lls (PBMC). and liver biops ies from these
anima ls were \IVHVDNA non-reacnv e by nested PCR (Sect ion 2.8.2 ) and
subsequent Southern blot analys is of the resulting PCR products (Seeto n 2.9.3).
The beg inning of VllHV infect ion was considered to be after the first
appearance of detectable V\lHV DNA in the circulat ior: (i.e .. seru m and /or PBMC)
when assayed by p e RiSo uth em blot hybridization . The initiat ion of the acute
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phas e of Vv'HV infectio n was diagn osed when IM-t sAg was detect ed for the first
time in serum . The presence of AH was verified by histologi cal exam ination of
liver bio psies obtai ned by laparotomy after VVHsAg appearance (Section 2.5).
Reco very from AH was diagnosed when serum WHsAg permanently cleared and
anti-VlJHs appea red .
C hron ica lly infe cted an ima ls were defined as havi ng the co ntinuous
presence of circulating IJVHsAg . anti -IJIII-Ic. and WHV DNA for at least 6 months
before the ir ut ilizat ion in experiments . Diagnosis of CH wa s confinn ed by
histo logical exa minati on of liver biopsi es that demon strated typica l feat ures of
pro tracted necrcmnammetcry liver injury (Sect ion 2.5)
2.1.2 Oth er anim... s pec ies
Tiss ues and seru m from sev er al other animal speci es were used as
controls in ttus study . These species Includ ed rat. rabbit . mo use and frog
(X enopus afncanus). All arum ets w ere housed in the Animal Care faCility at
Me monal Unlvers rty of Newfoundland.
2.2 SAMPLE COL LECTI O N
2.2.1 Blood s am p l ing
Blood was obtained from the dig ital is ve in of woo dchucks under
isofluorane induced anae sthesia (C DMV Inc .. 51. Hyacinthe . Qu ebec ) into tube s
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with no additives (red top Vecuta inef'«l; Becto n Dickinson, Rutherford, New
Jersey) for serum isolation (Section 2.2 .2) or into tubes conta ining sodi um
ethy lened iamine tetra-acetic acid (EDTA; lavender top Vacutainel'®; Becton
Dickinso n ) for plasma and PBMC isolation (Section 2.2.3),
2.2.2 Serum isolation
Untreated blood was allowed to clot at room temperature (R'T) for
approxim ately 1 hou r (h) . The tube was then centrifuge d at 720 x 9 for 10
minutes (min). The isolated se rum was aseptically al iquol ed to small volu mes
and stored at _70Ge fo r future use.
2.2.3 Isolation of peripheral blood mononuclear cells
Approx imately 5 ml of EDTA-treated blood was overlaid on 3 ml of Ficoll-
Paque® (Pharmacia Biotech . Baie o'urte. Quebec) and centri fuged at 330 x g for
30 min . The plasma layer was collected and stored at ·70 GC . The interlace
containing PBMC was removed and diluted wit h 10 ml of sterile phosphate
buffered saline with EDTA (pBS·EDTA : Appe ndix A) , and cent rifuged at 330 x g
for 10 min . Red blood cells remain ing in the resul tant pelle t wer e lysed with 3 ml
of buffered ammonium chlori de solutio n (AC K: Appendix A) for 10 min, then
was hed with PBS· EOTA under the same conditions as ind ica ted abov e.
Viable cells were cou nted with a hematocytomete r using a trypan blue
exc lusion assay . Approximately 10r cells were pelleted by centrifugati on using
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the con ditions described above and frozen in liquid r ntrcqen. Frozen cells served
as a source for nucleic acid e ciatcn (Section 2.6 ).
2.2.4 Liver b iop s ies
Liver biopsies were obtained by surgica l laparotomy unde r sterile
condit ions Ea ch anim al was sedat ed by an intram uscular inject ion of ketamine
(23 mg!kg : Ketase t COMV Inc .) and xytaz ine (10 mglkg; lloyd Laboratories.
She nand oah . Iowa ) and the n anaesth etized with 2-4% iso fluorane (C DMV Inc.).
Each bIOpsy wa s divid ed aseptically into several fragme nts_ Some of these
pie ces (1· 2 mrn -eecn ) were Immed iately frozen In liquid nit rog en for future
nucleic acid analys es. Other portions (about 5 mm ' each ) were fixed In 10%
buff ered form alin (Fisher) for histo log ical exam ina tion or embedded in
HistoPrep ~ (Fisner Scien tifi c, Canada) and then frozen in isopentane alcoho l
coole d m liquid nitrogen for immunofluorescent (IFL) exerrnnanc n.
2.2.5 Co llection of spec imens at autopsy.
For autopsy . animals were injected with an overdo se ofketam lne:xylazine
Blood was collect ed by carcliac punctu re and used for isolation of serum (Section
2.2.2). plasma. and PBMC (Sect ion 2.2.3). The liver. spleen . kidneys. pancreas.
lymph nodes . bone marr ow . and portions of the small intesti ne and skeletal
muscle were removed asept ically. TIssue samp les were preserved for furthe r
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investigations as descnbed in Section 2.2.5.
2.3 ASSAVS FOR SEROLOGICAL MARKERS OF WHV INFECTION
2.3.1 Detection of woodchuck hepatitis s u rf ace an tigen (WHsAg)
Vv"HsAg was dete cted by a ·sandwl ch " radioimmunoa ssay (RIA ) usi ng a
cross-rea ctive AUSRIA·II kit for detection of HBsAg (Abbott Laboratories. N.
Chicago. ILl . Serum or plasma samples were tested directly for IJIIHsAg
follow ing a procedure reco mmended by the manufacturer. Briefly , 200 ~ ! of ea ch
test and control sample were incubated for 16 h at RT w ith bead s co ated with
anti·HBs . Aft er wash ing the beads 10 remov e exce ss anti-HBs . they were
Incub ated for 1 h at 4S· C with 200 ul ·2'!I·[abe led anti-HB s . The rad ioactivity w as
count ed in a gamma counter. Spec imens gIVIng counts pe r rrwurte(cpm) equal
to or g reater than the cuto ff value were conside red VVHsAg react ive (Michalak.er
af.. 1989 . Based on detect ion of punfJed VlJHsAg. the assa y sens itivity was
estimat ed to be 3.25 n9 proteinlml (M ichalak.er a/ .• 1989 )
2.3.2 Detecti on o f an tibod ies to WHsAg (anti .WHs)
Anti-WHs antibod ies were measured usin g a cros s-reactive enzyme-linked
Immunoassay (ELISA : AUSAS- EIA . Abbott Laborato ries) des igned for the
detection of anti -HS s. The cros s react iv ity with anti-VVHs was established
previousl y (Michalak.er st .. 1989 and 1990), Briefl y. polystyrene beads coated
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with human HBsAg were incubated overnight at RT with 200 1.11of either test or
contrOl woodchuck serum or plasm a or the appropriate pos itive (n = 2) and
neg ativ e (n = 3) contr ols supplied by th e m anufacturer. Unbo und mat eri al was
removed by wash ing with w ater and th e be ads were incubated with 200 1.1' of a
mixture of HBsAg tagged with biot in and then with rabbit anti-biotin conjug ated
with horseradish peroxidase (HRPO) for 2 h at 40· C . Next. the bead s were
washed to remove unbou nd conj ugates and inc ubated with 300 IJI of freshly
prepared o-ph enylenediam ine soluti on co ntaining hydroge n per oxide . After
inc ubation at ambient temperatur e fo r 30 min , the be ads were transferred to
provi de d tube s and the enzym e reaction was stopped by add ition of 1 ml of 1N
H:SO~ . The co lour intens ity in proportion 10 the amo unt of bound HRP O-Iabeled
antibody w as evaluated at 492 nm using a Quantum II du al-wavelength ana lyser
(Abbo tt Labo ratories ). The presence or absence of anti-\NHs reactivity was
ca lcu lated automatica lly by com paring the absorbance va lues of the sample
tes ted to the cutoff value (NC. " 0.05). Sam ples w ith absorbance values grea ter
tha n or equ al to the cutoff value were con sidered positi ve
2.3.3 Detec ti on of anti bodi es to WHcAg (anti·WHcl
Anti -VVHc was detected usi ng a spe cifi c competit ion ELI SA dev eloped in
this laboratory (Michalak et et. 1999 ). This assay is based on a principle that
ant i-VVHc pre sen t in the lest sample competes w ith HRPO-Iabe led ant i·VVHc fo r
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binding to immob ilized VVHcAg . For thi s pu rpo se, a 96-we ll. f1at-bottom plate
(LinbrofT itertek; le N Biomed ica ls. Aurora . O H) was coat ed with w ocd cnu cx anti-
VVHc ant ibod ies at 1 ~g protein in 50 1-11 of P BS (pH 7.4) pe r we ll . inc ubated at
4 · C overmqnt . and washed th ree times. Nonspec ific bindin g wa s blocked by
addi ng 30 0 IJI of 0.25% Tween-20 (Sig ma Chem ical Comp.• St. l ouis Mo) in
PBS (bloc king buffe r) and incubating at RT for 2 h. After washing . the plate wa s
directl y used or stored at ·20 · C. Bef ore the a ssay. the plate was thawed and
the wells washed briefly with PB S. To ea ch well. 0.5 1-19 of WHcAg in 50 IJI of
bloc.k ing buffer was added and the plate was incubated at ambient temperatur e
fo r 2 h In a humid chamber . The n . the plate was washed 4 time s with PB S.
blott ed dry . and 20 IJI of blocklOg buffe r. 5 ul of the lest serum sam ple or th e
approp riate cont rols and 25 ~I of anti·\fIIHc labeled WIth HRPO (diluted 1:2 .500 in
blocking buffe r) was added to each w ell . After a 2 h incubation, the we lls were
wash ed 3 times wrth PBS . and 50 ~ t of fres hly prepared 3.3',5 .5'·
tetramethylbenzidine (TMBI substrate (BioRad Laboratories. Richmond . CA l was
added to each well . The reaction was sto pped after 30 min by add ition of 50 IJI
of 1N H:SO~. Absorb ance was read at 450 nm using a micropla te reader
(BioRad Lab oratories). Sera from he alth y anima ls we re used as nega tive
contro ls. Posit ive con trols incl uded sera from INHsAg -posit ive wood chucks
chronically infe cted with INHV. The degree to wh ich the test sample inhibit ed the
binding of HRP O· labeled anti·lNHc was calculated as fo llows: pe rcent inhibition =
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100 - (test sample 0 0 ...negative control 00" 100). The assa y results were
accepted whe n the positive con tro ls mtubrtec 2:95% of the HRPO·anti·VVHc
bin di ng to \NHcAg and th e neqauv e controls gave no int.ib ltio n. Samples tha t
produced ~ 50% inhibitio n were cons idered positive for anti-VVHc .
2.3.4 Asuy for se rum y -g lu ta m y ltra nsferas e (GGT)
Eleva ted seru m levels of y -gl utamyltransferase (GGT) in wood chu cks is
cons idered a hig hly spec ific ind ica to r of the develop ing H CC (Hornbuckle et et..
1985). GGT was tested using the Vettest assay syste m av ailable in this
labo ra tory (Ve ttest S .A. Neuchate l, Sw itz erland). Sera from anim als examined
In this study showed norma l GG T values (no rm al range 0-2 IU). unless otherwise
Indica ted (reviewed by M icha lak . 1998)
2.4 DETECnON OF SERUM WHV DNA BY DOT ·BLOT HY BRIOIZA noN
A 10 ~I altquot of se rum wa s vacu um filtered bloned onto a nylon
membran e (Hybon d.N : Am ersnam. Ar1ingtoll Heights . ll ) using the Bio-Dot
appa ratus (Bio-Rad t.e borat cnes ). The membrane was denatu red with 1.5 M
Nae llO.5 M NaOH for 10 rmn, the n neutr alized w ith 1.5 M Na CI in 1 M Tris·H CI
buffer, pH B.Ofor 5 m in . The blot was air-dri ed . bak ed for 2 h at BO·C under
vacuu m . and hybrid ized to a raoj otabeled recombinant WH V DNA (rWH V DNA )
probe as des cribed in Section 2 .9 .3. The rVIIHV DNA w as exci sed from a pSP65
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vect or kindly pro vided in the past by Dr. J . Summers from the University of New
Mexico . Albuquerque. NM (Pardoe and Michalak. 1995 ).
Each hybrid ization ass ay used serum from a chro nic VVHV carrier and
rVv'HV DNA as pos itive contro ls and serum from a healt hy anima l as a negative
control. The assa y sensit ivity for WHV DNA detec tion was assessed us ing two-
fold sene ! dilutions of rWH V DNA followed by dens itom et ric analys is using the
Cyc lone phospho image system {Canberra Packard . Meriden. en. The lowest
ce tecncn limrt was 30 pg of WHV DNA wtucn corres ponded to approximately 2 x
1()4VIrUS genome equ rvaien te (vge)/ m l (Lew and Michalak, 2001 ).
2.5 HISTOLOGICAL EXAM INATION OF LI VER TISSUE
Pa raffin embedded live r fragm en ts wer e sectioned to 5 urn and routi nely
stained with hem atoxylin and eosin. Ma son-trichrome , per iodi c acid shift or
Impreg nated WIth silver . Live r examin ation included assessme nt and numeric
sconng Of three categones of histologica l lesions: hepatoce llular,
mtraioeurerrext rahec etcceuuter and port al. as previously des cnbed by Micha lak
e t al.. 1990. Brie fly . lrver tissue exam ination Inc!;Jded assessme nt and numera l
sco nng of three categones of histo logic lesions: hep atocellular , intra lobular
extr enepatcceuur ar . and port al. In hepatocellular lesions , particular emphasis
was placed on the determin at ion of the loca lization of necrosis (l.e .. necrosis
affecting interlobul ar necatccvt es-io butar nec ros is , assigned score 3:
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centr eccutar necetocytes. score 4 ; pe ripo rtal nece tccstee-cecerrea t necros is.
score 8 . and bndging necrosi s. score 10) and its exte nt in each location through
the examined sect ion (score rang ing from 0 to 3). In add ition, evaluation of the
se ....enty of hepatocyte ba lloo ning pleomorp hism , swe lling, eo sinophilic and
acrdc ptuhc dege neration . hyaliniza tion. and the presence of acido ph ilic bod ies
were taken under consideration in the assessment of trus category of liver tissue
lesion (score of each alteration ranging from 0 to 3). In tms scoring system. the
maximal possible score assessing hepatocellular damag e was 55. When
mitoses an d/or multi nu clea r ce lls we re present. the sco re was d imin ished in
ran ge from 1 to 5 Ove rall . a hepatoce llu lar lesio n was graded acco rding to the
total sco re pomts uSing the follo wing sca le. 0 to 3 po ints. g rade 0: 4 to 20 POints.
grade 1; 21 to 40 points . grade 2: and above 41 POlOtS. grade 3. The degree of
the Intralobu lar extranecetccenutar iesrons was determined on the baSIS of the
cnsmeunonof inflammatory Infi ltrations WIthin lobules u.e..Infi ltrations lOCated
mainly In one zone mtenoccrar. assIQned sco re 3: cen trilobul ar. score 4 :
cemomnar. score 6 : or spilled over into all zones . score 10) and the ir ext ent
through the examined sect ion (sco re rang ing from 0 to 3). As sessment of
Kupffe r and endothelia l ce ll prolifer ation . bile canal icular proliferation. and
disorgan ization of reticula r netw ork was also inc luded (score rang ing from 0 to 3)
On the basis of this scori ng . the grade of an e xtranepatccenutar lobular les ion
was determined according to the following scale ; 0 to 3 points. grade 0 ; 4 to 15
poin ts. grade 1: 16 to 30 poi nts. grade 2: and abo ....e 31 points, grade 3
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Ass ess me nt of the portal les ions induded evaluation of the porta l tract
enlarge men t owing to ed ema and inflammatory cell infiltrations (sco re ranging
from 0 to 5), proliferation of bile duets . and fibrosis (sco re of each altera tion
rang ing from 0 to 3. dependent on its presence, frequency and/or exten t). The
grade of portal lesions was judge d using the sca le : 0 to 1, grade 0; 2-5. g rade 1:
6-9 . grade 2: and abo ve topoints. grade 3. An overall grade of disease severity ,
taking into consideratio n a glob al impression of the path olog ica l picture of liver
inju ry as a whOle. rated in a sca le from 0 to III and defined as "Histolog ica l
Degree of Hepatiti s~ . was assigned for each uver speceren exemmed . All
histo log ical evaluations were performed on COded sample s on tw o different
occasions. each time testing at least lJ lobules and 10 portal area s and was
perform ed without the knowledg e of sero log ic data
2.6 ISOLA TION OF NUCLEIC ACIDS
2.6 .1 Is ola ti on of cellular DNA
For DNA isolat ion . 100 mg tissue fragmen ts we re homogenized in 1.2 ml
of lYSIS buffe r cont aining prote inase K (Appe ndix A). The samp les were
Incubated ovem rght in a 50· C shaking incubator . then ext racted with an equ al
volume of Tris·HC1-buffered pheno llchloroformlis oam yt alcoho l (25:24 :1)
following a standard procedure (Strauss, 1997). DNA was precipitated from the
aqu eous phase with one- ha lf volu me of 7.5 M amm oniu m acetate and two
volumes of absolute etha nol (Sigma) . Afte r cen trifugation, the resultant pe llet
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was wa shed with 70% etha no l. The DNA w as then air dried a nd resuspe nded in
TE buffer (Appendix A) to an approxim ate fina l concentration of 0 .5 mg/ml.
If the tissue w as in limited suppfy . DNA was recovered from the non -
aqueous phase of TR lzo~ follo w ing RNA extra ction using the manufa ct ure r's
protocc r (Gibco BR l . Grand Island . NY). Brie fly . the DNA was precipitated from
the interp hase and phenol phase w ith 0.3 ml of ab solute ethanol per ml of
original TRlzol. Samp les we re kep t at 30 · C fo r 5 m in and th en. DNA was
petleted by centnfug ation at 2.000 x 9 for 5 m in at 4 · C. The DNA pellet was
was hed th ree times for 30 m in each . at 30·C in 1 ml of 0 .1 M sod ium CItrate in
10% etha nol. Aft er ea ch wash . the DNA was peuet ed at 2 .000 x 9 for 5 min at
4"C . The final DNA pell et was suspended and wa she d by ro tation in 2 ml of 7 5%
eth ano l fo r 20 min at 30"C and then pe uetec at 2.000 x g for 5 min at 4"C
Subseque ntly . the DNA was air dried and resuspended in 8 mM NaOH to bring
the final DNA concentratio n to appro ximale ly 0 .5 mg /m l. To remove any
remalmng RNA . the DNA wa s trea ted with 2 ~g of DN ase·free -RNase
(Boe hnngel Maii~helm . laval. Quebec) for 30 min at 37 "C an d then extr acted
with phen ol/ch loroform. as des cnbed abo ve . DNA was Quant itated as described
In Secnon 2 .6.3. Any DNA not used fo r slot- blot hybndizatio n or PCR ana lysis
was stored at ·20 "C
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2.6.2 RNA iso latio n
Total RNA was isolated from tissue samples . as we ll as na ive and
rmtcqe n-snmutatec PBMC using TRlzol® reagent (Gibco BRL). according to the
man ufactur er's instruct io n. Briefly . tissues or cells we re pulverized in liquid
nitrogen , hom ogenized in 1 ml of TRlzol® reagent and m ixed fo r 30 min . After
the addit ion of 200 1.11 chloroform , the tube s we re shake n vigo ro usly for 15 sec
and the samples centri fuged at 12,000 x 9 for 15 min at 4 °C . RN A w as
pr ecip itat ed from the aqueous upper phase with 500 IJI of isopropa nol (Sigma)
fo r 10 min at ambien t tempe ratu re and collected by centrifugat ion at 12.000 x 9
for 10 min at 4"C . The RNA pe llet was washed in 1 ml of RNas e· free 75%
etha nol , The final RNA pel let was briefly air-erre d and resuspe nded in RNase-
free water. RNA was qua ntitated as described in Sect ion 2 .6.3 and used
immed iately for Northe rn blot hybridization an alysis or reverse tra nscrip tion
rea ction or stored at ·70· C.
2.6 .3 Quantitati on of nucleic acids
DNA . RNA and synthe tic oligon uc leotide primers or probes used in this
stud y were qua ntitated ba sed on the ultraviolet (UV) absorbance at 260 nm using
a DU 530 spect rophotometer (Beckman Instrum ent s. Inc .• Fuuert cn . CA l . DNA
and oligonucleotides wer e rea d afte r suspe nsion in TE buffe r. whe reas RNA was
diluted in alkaline wa ter to enhance accurate conce ntr atio n readings (Wi lfinger et
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al ., 1997). The concentration of RNA was determined assuming an optical
density of 1 corres ponded to 40 mg RNAlmJ (Maniat is et st., 1989). The actual
calculat ion used was as follows: RNA (mg/rnl) = (00 @ 260 nm - 0 0 @ 320 nm)
x dilutio n factor x 40 mg/rnl. DNA concentrations were determined as above
except that an optica l density of 1 corresponded to 50 mg DNAl ml (Maniatis et
al.. 1989 ). The concentratio n of oligo nuc leotides w as determi ned us ing the
spec ific w eight per 0 0 obtained in the ce rtificate of anal ysis from the
manufa ctu rer (Gibeo BRL ). The ev aluation of the purity of the nucleic ac id
preparations were based on the 260:280 nm abs orba nce ratio . Only RNA with a
260 :280 nm ratio of greater th an 1.8 and DNA grea ter tha n 1.6 we re used .
2.7 REVERSE TRANS CRIPT ION REACTION
The reverse transcrip tion (RD react ion was used to conve rt Iota I RNA to
single stranded eDNA. To help eliminate RNA secondary structures, 1 ~g of total
RNA in 5.5 IJIof RNase-free water was denatured at 70~C for 10 min and then
ice chilled. Final assay conditio ns consisted of 1 1-19 of denatured RNA , 20 U
RNasin® (promega Biosc.ences Inc ., Madison , VII), 1X reaction buffe r (50 mM
Tns-Hc t buffe r [pH 8.3). with 75 mM KCI and 3 mM MgCI.). 10 mM dithiothreitol.
1 mM of each deoxyn ucleotide triphos phate (dNTP, Gibco BRL), and 200 U of
Moloney murine leukemia virus reverse transcnpt ase (M MLV-RT; Gibco BRL) in
20 IJI. The reaction proceeded at ambient tempe rature for 10 min and then at
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42"C for 1 hr. After completion of the reaction. the sample was heated to 1OO"C
for 5 min to inactivate remain ing enzy mes and then ice ch illed . The eD NA
samples were used for peR amplifica tion as outlined in Section 2.8.
2.8 POLYMERASE CHAIN REACTION (pe R)
In trus study. ncc iec acid amplification s by p eR were used for thr ee
di ffere nt purpos es , First. 10 test fo r the expression of 'MiV gene sequences in
serum, PBMC, liver and spleen of infected animals, seco ndly , to amp lify and
cl one woodchuck gene s which were not identified prior to this work and . las tly , 10
qu ant ita te the expression of woodch uck cyt okine gene tra nscripts prese nt at
lev els undet ectab le by Nort he rn blot hybridization
2.8.1 General cri teri a for primer design
Since many of the woodchuck gene sequences required in this stud y w ere
undetermi ned poo r to rts mrneno n, the p eR pnme rs initi ally used were ba sed o n
the con sen sus of hu man, rat. mouse and rab bit sequ ence s . At thi s in itia l stage.
most of the oligo nucleotide primers con tained at leas t one deg ene rate base
(referred to as de ge nerate pri mers). A s the st udy prog ressed . the woodchuck
specific sequences we re estab lished in our lab orat ory . or by other groups
( l ohrengel er et.. 1998 : Nakamura et st ., 1997) and the primer seq uences were
mod ified according ly .
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In order to ensure effi cient amp lificat ion of the target sequences. each
primer pair was matched according to GC content (approximately 50%). length
(18-2 5 bases) and melting temperature (+1- S·C ). Matching was done with
PC/Gene software (Intelligenetics. Gene va, Switzerland) and the BLAS T search
eng ine software (http://www .ncbi.nlm.nih.gov/BLAST; National Centre for
Biotechnology Information, National Libra ry of Med icIne. National Institute of
Health . Bett' esda . MO). All oligonucleotide s were synthesized and desalted by
Gibco BRL. Pnmers used for the Initial amplification and doning of particular
wood chuck genes are outlined in the respectiv e chapters .
2.8.2 Standard peR cond itions for WHY DNA det ec tion
Three sets of prime rs spe cific for non-over lapp ing genomic regions of
W'rN DNA, i e., core (C) , surfac e (5) and X genes were used for the detection of
viru s genome by direct PCR. In addi tion . 3 other primer pa irs , internal to tho se
mentioned above. were used tor nested PCR when (he results of the direct PCR
were neqanve_ Sequences of these prime rs and the ir locati on in the WHV
genome have been outl ined in previous studies from our laboratory (Coffin and
Michalak. 1999; Micha lak et al., 1999).
In general . direct PCR detect ion of WH V utilized 2 IJg of total DNA as
templ ate , The final reaction conditions consisted of 200 IJM of each dNTP , 10
pmo l of each oligon ucleo tide primer, l X react ion buffe r comprising 1.5 mM MgCl 2
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with 50 m M KCI in 20 mM Tris -Hel buffer (pH 8.4) and 2.5 un its of Taq DNA
polymerase (all Gibco BRL) in a 100 1-1' total volume . The react ion mixture was
layered w ith 100 1-11 of mineral oil (Sigma) to inhibrt eva pora tion. DNA
amp lificat ion proceeded in a program mab le therm al cycier (Twi nBlocX Syst em :
Ericom p Inc.. San Dieg o. CA ) using the followi ng prog ram : 94 °C for 5 min as the
first step . then 94°C for 30 sec . 52°C for 30 sec . and 72°e for 30 sec for 30
cycle s. A final extension step was perf ormed at 72°C for 10 min . For each
thermocycl ing reactio n . rVVHV DNA and liver DNA from a VVHsAg-posit ive
cnrc mcauv infected an imal we re used as positive controls . In add ition . both a
water and a mock sample . containing all reagen ts used du ring the DNA
extraction and peR . were included as negative controls . For nest ed PCR. 10 ~ I
of the direct PCR rruxture was reamplified unde r the same condrtio ns as the
direct reaction . PCR amplifICations were perfonned und er con d itions limiting the
poss ibility of contaminatio n. as outlined in detail in previous studies (Coffin and
MIChalak . 1999: Mich alak et al.. 1999)
2.8 .3 Amplification of woodc huck cDNA fo r cl on in g us in g deg enerate
prim ers
All PCR using degenerate primers uti lized len ien t PC R co nditions and 5 ~ I
of eDNA (Sectio n 2.7) as the amplifica tion template. The 100 ~I fina l reaction
mixtu re was the same as for WH V DNA amplification (Section 2.8 .2) except 20
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pmo l of each synthet ic oligonucleotide primer and high fidelity Taq polyme rase
(Boehringer Mannheim) W ith exonuclease act ivity wer e used . The follow ing
program was emp loyed for all peR using degenerate primer pairs: 94· C for 5
min for the first cycle and then 94-C for 1 min, 52-C for 2 min , and n -c for 3 min
for 35 cycles . The products were analyzed by ge l electrophoresis as per Section
2.9.2. and product identity confirmed by Southern blot hybridization us ing
specifi cally designed oligonuCleotide probe s or pu rchased cross-react ive
heterologo us DNA probe s .
If the peR produ ct produ ced a single band after agar ose gel
elect rophoresis and Southern blot hybridization, it was cloned witho ut furt her
man ipulation (Sect ion 2.11 .2). However , if multiple band s were observed the
p e R products we re electrophores ed on a 0.8% low me lting tem perature aga rose
gel. the band cc rreeocn emq to the expect ed mo lecular size was exci sed and
then punfted USing the Wizard PCR purification kit (Sect ion 2.11 .1). The purified
PCR produ ct was ClOned as descri bed in Sect ion 2.11.2.
2.9 DETECTI ON OF DNA
2.9.1 Slot..tJlot hybridization ass ay
To determin e the levels of VVHV DNA in tiss ue samples (e.g .• liver .
spleen) or cells (e .g .. PBMC) from the ani mals invest igated. a slot-blot
hybridization assay was used . For this purpcse. B IJQof tota l liver DNA or 10 IJg
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of spleen DNA was heat denatured in 200 1-11 o~ 6X sse (Ap pe ndix A) for 10 min ,
ice chill ed and then vacuum bloned onto nylon (HYbOnd-N : Amersham) using a
rrucrcfittratson appa ratus (BIORad l abo ratories). To aid in the quantification of
VVHV DNA test samples were done in pa rallel with sena l tw o-f old d iluti ons of
rINHV . After loading the DNA . the we lls were washed twi ce with 400 IJI of 6X
s s e The nylon membrane was removed . air -dned and baked for 2 h at 80· C in
a vacuum oven . The ny lon membranes were hybridized to a J2p . random prime-
labeled recomb inant DNA probe , as descri bed in Secti on 2.9 .3. Hybridized blots
were washed and exposed fo r autoradiography according to Sect ion 2 .9.3.3.
2.9 .2 Agarose gel elec:trop ho res is
To detect peR products an 18 IJI reaction aliqu ot (Section 2.8) or 1 \.19 of
the app ropnate £coR I restnction enzyme-diges ted plasmid DNA as po sitive
contro l (Sect son 2 .10 1) was mixed WIth 2 IJI of DNA load ing dye (Ap pe ndix AI
and poured into the well s of a 1_5% aga rose gel {Gibcc BRL). The ge l was made
with 1X TAE buff er (Appe ndi x A) cont aining 0.5 ng/ml ethidium bromide. Afte r
ele ctrop horesis at 80 V for 60 min the DNA bands were docu men ted USIng a low -
tight imagIng system (Chemi lmager 40 00 . Alpha lnnotech Corporation : San
Leandro. CA l
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2.9.3 Southern blo t hyb ridiUi tion .
2.9.3.1 DNA bl otti ng ont o nylon membrane
To co nfirm the authen ticity of DNA products and plasmid preparations or
to estimat e the qua ntity of (he p eR prod ucts Sou them blot hybridiz ation using
loOp _ labeled cloned DNA or synthe tic oligon ucl eo tide pr obes was performed. For
thrs purpose . the agarose gel containing the peR or resmcucn enzyme digestion
prod ucts were den atu red with 1.5 M Na CI with 0.5 M NaOH for 45 min. The D NA
was the n neu tral ized w ith 1.5 M Na CI in 1 M Tris-Hel buffer (pH 8.0) for 45 min.
Blotti ng of DNA from the ge l to the nylon m em brane was perform ed usi ng
downw ard cap illary transfer. After trans fer, the membrane was baked at eo' C in
a vacuum even for 2 n.
2.9.3.2 Southern hy brid ization with: DNA probes
Membrane s to be hybridiz ed with radi o- label ed reco mbinant DNA probes
were sealed in a plastic bag WIth 10 ml of hybridizatio n buffer (Appe ndix A)
con taining 100 ugJml sonicat ed salmon sperm (sss) DNA (Sigma ). The
membrane was prehybridized at 65 °C in a Shak ing oven for 30 min. After
prehyblidizati on . 1S x 10' cpm of a heat-d en at ured rad iolabeled probe was
added and the blot was hybridize d overni ght at 6S"C in a shak ing oven.
For hybridizatio n w ith oligonucleo tide probes the nylon membranes were
prehybridized at 42°C in a shak ing ove n fo r 1 h w ith 10 ml of hy bridization buff er
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(Appe nd ix A). The blot was then incub ated in a rotary Shaker at 42 "C for 18 h
w ith 15 x 10$ cpm of a l<:p end -labe led oligon ucleotide probe (Section 2.10 .3).
After hybridizatIon . all blots we re wash ed eccc rofnq to Section 2.9 .3.3
2.9 .3.3 Blot washing
All blots were washed twi ce in 2X sse with 0.1% SOS for 5 min foll ow ed
by two wash es with O.2X sse wit h 0 .1% 50S for 5 min each at RT . This w as
proceeded wrth tw o I S-min mode rate stringency washes at 42· C using
prewarmed O,2X sse with 0.1% 5 0S. To alle viate problems of high and low
sIgn al mtensrtv when blots are ana lyzed on film the nylon membranes were
expos ed to a multipurpose Phosph o r scree n for 15 min to 2 h and analyzed on
the Cyclone system (Canbe rra Pa ckard). For final c ocume nteno n, membranes
we re expos ed to x -ray fi lm (XRP. 1: Eastma n Kod ak Co .• Rocn este r. NY) at
·70·C in cass ettes equipped with Intensifyi ng screens . Multiple fi lm expo sure
nrnes we re used to com pens ate for th e fact that ther e is a sensitivity lag in fi lms
at low sIgn als an" saturatio n at hig h sIgnal intensities .
2.10 GENERATION OF DNA PROBES
2.10.1 Exc is ing recomb ina nt DNA from plasmid vec to rs
All recombinant DNA fragmen ts used in thi s study we re excised from the
plasmid vectors WIth EcoR I restriction en zyme . For this purpose. 10 IJQ of the
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reco mbin ant plasmid DNA was incu bated with 100 U of EcoR I. lX REAC T 3
buffer (both from Gibco BRL; Appendix A). and 50 U of DNase-tr ee-RNase
(Boe hringer Mannheim. Quebec . Can ada) for 4 h at 37· C. After digest ion . the
DNA insert was separ ated from the plasmid by electrophoresis at 50 V in a 1%
low-me lti ng po int aga rose (Gibco BRl) made with l X r AE containing EtST
(Append ix A). The band contain ing the DNA of intere st was excised fro m the gel
an d purifie d uSing the WIZard"" pe R Prep DNA Purifica tion System (Section
2 .11 .1 ).
2.10 .2 Rand om prim e lab el ing o f rec ombina nt DNA
To prepare a VVHV DNA probe . a rand om primed DNA labeling syst em
(Redlpnme : Pna rmeea Biot ech ) usmg J.:P-dCTP was em ployed . Briefly , 25 n9 of
the recom binant DNA of interest In 45 IJI of TE was bOiled for 5 min and then
chil led on ce . The de natured DNA and 5 IJI of :llP-dCTP (3000 Cilmmo l)
(Ame rsham) was added 10 a reactio n tub e conta inIng freeze dned dATP . dGTP.
dTTP. Klenow enzyme . and 9-me r random primers . The labeling reactio n
proceed ed for 1 h at 37-C and was sto pped with the add ition of 2 jJl of 0 .5 M
EDTA.
In later experi ments . the strip- EZ IXI. random primed probe synt hesis
procedure (Ambion Inc .. Austin . TX ) was used to prepare probes for Northern
blot hybridization. Briefly . 25 ng DNA template wa s suspended in g jJl of water.
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boiled fo r 5 mm. and then snap frozen in liquid nitroge n . Aft er thaw ing . 2 .5 l..l l of
a l OX random decamer pnme r solution, 5.0 1-11 ofdATP/dCTP-free 5X bu ffer. 2.5
IJImod ified l OXdCTP, and 5 1J1 :l:P-dATP (3000 CiJmmol) (Amersham) were
added . The labeling rea ction proceeded at 37"C for 30 min afte r the addition of
2 U of exonucleese-rree Kle now fragment
2.10.3 End labeling of ol ig onucl eotide probes
Sy nthe tic oligonucleotides were labe led wrth J2p _ATP (3000 Cilmmo l)
uSing T4 _kinase (Gibco BRL) fOllow ing manuf acturer's ins tructions . The final
reecto n m ixture ccn srsrec of 5 pmol of tem plate . 2.5 IJI of l:/P_ATP (3000
Cilmmol) (Amershaml . t x fOl"Nard react ion buffer (Appe nd ix Al . and 10 U of T4
kinase In a total volume of 25 1.11. The tube contents we re mixed gentl y and
incub ated for 1 h at 37°C . The react io n was sto pped with the addit ion of 2 ul of
0 .5 M EDTA
2.10.' Pu ri fi cati on ofrad io labeled DNA probes
The ~P.labeled reco m bina nt DNA and oligonucl eo tide probes were
sepa rated from unincorp or ated :t:p by fract ionation on Sephadex G·5Q NICKTM
columns (Pbarrnaera Biot ech ). as pe r the man ufactu rer's instructions , Briefly , the
co lumn was equi librate d with TE buffer. the pr cce mixtu re wa s applied onto the
column and the n washed th rou gh with 400 IJI of TE buff er. The firs t was h was
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discarded and 450 1-11of fresh TE buffer was applied to the column. The
recovered eiu tent. con tainin g the labeled probe . was saved. The radioactivity of
the probe (cpmllJt) w as determined us ing a scintilla tion cou nte r. Probes not
immediate ly used were stored at ·20· C.
2.11 DNA CLONING
2.11.1 Pur i fic ation of peR products
peR products de stined for cloning were purified using the Wi zard ~ peR
preps DNA punficat ion syste m (Promeg a). Afte r electrophoresis on a 1% low
me lting comt agar ose ge l. the ban d containi ng th e peR prod uct of interest was
excised . placed in a 1.5 ml m icr otube and me lted at 65 "C . One ml of purification
resin was added to the tube, mixed briefly . and filte red under vacuu m throug h a
Wiza rd $ minicolumn. The co lumn was washed tw ice with 70 % isopropanol,
dried unde r vacuum for 30 sec . and then ce ntrifuged at 12.000 x g for 2 min.
The collected isopropanol was d isca rded . TE buffer (50 \.II) prewarmed to 65 ·C
was added to the column and left for 5 min. The minico lumn was centrifuged at
12.000 x 9 for 20 secon ds and the erutant containing the DNA sav ed . The DNA
con centration was determined by spe ctr oph otometric ana lysis as described in
Sect ion 2.6 .3.
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2.11 .2 TA cloning reaction
DNA fragments amp lified by peR using dege nerative primers we re daned
using a dual promoter TA CloningCl Kit (Invitrogen. Car1sbad. CA). The final
cloning mixture cons isted of 25 ng of pe R product, 1X ligation buffer (Ap pe ndix
A). 50 n9 of linearized peRil ~ plasmid. and 4 U of T4 DNA ligase in a tota l
volume of 10 ~l. The reaction proceeded at 14-C for 18 h. After incubation, 2IJ I
of the react ion mixture was added to 50 ut of lNVa F' bacteria l celts (Invitrogen)
in the presence of 20 mM 13·mercaptoethanoL The mixtu re was chilled for 30
min on ice. heal shocked for 30 sec at 42-C, and placed on ice for 2 min.
Subsequently, 250 1-11 of SOC medium (Appendix A) was added and the cells
were incubated at 37-C fOf 1 h in a rotary shake r (250 rpm)
2.11.3 Growth of pl asmid.transfected ba cteria
A 100 IJI aliquot of each transformation reaction mixture (see abo ve :
Section 2.11 .2) was spread onto 1.5 % Baeta-Agar (Difco laboratories . Detro it
MI) coat ed with 40 ~ I of X.Gal (Sigma: Append ix A) in 10 em petri dishes . Petri
dishes were incuba ted at 37· C for 16 h. Sing le bacterial colo nies we re collect ed
and inoculated into 5 ml of sterile LB mediu m supplemented with 50 ~gfml
kanamycin (Sigma) Bacteria were grow n overmqnt at 250 rpm in a rotary shaker
a137"C
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2.11.4 Small sca le (M ini) pr epar ations of plasmid DNA
For prepa ration of sma ll amounts of plasmid DNA . a 1.5-m1aliQuot of
transfo rmed ba cteria l ce lls were pe lleted at 20 .000 x 9 for 20 sec . The cells were
res uspended in 100 1-11of Gluco se Tris-EDT A (GTE; Ap pe ndix A) and left for 5
min at ambient tempe rature. The bacte ria we re lysed with 200 IJI of fresh ly
prepared 0.2 N NaOH/l % 5 0 S solution and ice chilled for 5 min. To neutra lize
the solution and aid in the removal of chromosomal DNA and prot eins. 250 IJIof
3 M potassium . 5 M acetate (pH 5.5) was added to the tube . vortexeo for 10 sec.
and the mixture ice chilled for 5 min . The mixtur e was centrifug ed at 20 ,000 x 9
fo r 3 min to pe llet ce ll deb ris and Chrom osom al DNA . The supernatant was
transferr ed to an ec ce n oo rt tube and the nucle ic aees were preopitated w ith 1
ml of 95% ethanol for 2 mm at RT. Plasmid DNA was pe l1eted by centnfugat ion
at 15.000 x 9 for 1 min. The pellet was wa shed with 1 ml of 70% ethan ol. air
dned and resuspend ed In 3D-50 IJI of TE buffe r. Plasmid mini-prepara tions were
ana lyzed for the pre sen ce of the proper DNA inserts as ce scnbec in Section
2.12.1.
2.11.5 u rge -sca le (Max i) plasmid DNA prepar ation
A 50 ~I bacterial aliquot containing the prope r plasmid insert. as judged by
mrr nprep analysis (Section 2.11 .4) , was grown to saturat ion in 500 ml of LB
medium supp lemented with 50 IJg/ml of the app rop riate antibiotic (kanamyci n or
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ampici llin ). The bacteri a we re collected by ce ntr ifug atio n at 6.000 x 9 for tomin
at 4"C. The pellet was resuspended in 4 ml of GTE so lut ion.
Bact eria we re lysed with 25 mg of hen egg white lysozyme (Sigma) and
0.2 N NaOH with 1% 5 0S alkaline solution, followi ng a stand ard proced ure
(Heilig et et.. 1998 ). The visco us mixture was supple mented with 7.5 M
potassium acetate. stirred un til a white precipitate formed and then cen trifuged at
20 .000 x 9 for tomin at 4°C. The resulting supe matant was filtered through
steri le surg ical gauze into 50 ml tubes. Nucleic acid was precip itated by the
addition of isopropan ol and recovered by centrifugation at 15,000 x 9 for t o min.
The pellet was washed in 70% ethan ol and resuspended in TE buffe r.
Remaining RNA was removed by incubation with 20 ug of DNase- free-R Nase
(Boe hnnger Mannhe im) for 30 nun at 37"C. Then, freshly prepar ed 0 .2 M
NaOHJ1% SOS sc luuo n was added to the ep penccrt tube and mixed for 10 min
at RT. In the next step. 3 M potass ium aceta te wa s added to the DNA solution
and mixed by mversicn for 10 min at RT. After cen tnfugation for 10 min at
20 .000 x g. the plasmid DNA was extr acted uSing a standard phenol extra ction
proced ure (Sect ion 2.6 .1). Plasmid DNA wa s reco vered by cen trifugat ion at
10 .000 x g for 10 min at 4 "C, and the resu lting pe llet was hed with 70 % ethan ol
and then dried briefl y und er vacuum. The DNA pell et was resuspended in 1 ml
TE buffe r. then 1.5 ml of 30% eterue filtered polyethylene glyco l was added and
the mixture left overnight at 4"C . The plasmid DNA wa s recove red by
centrifugation at 10,000 x 9 for 20 min at 4"C and resuspended in 1 ml TE buffer .
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The DNA was precipitated usi ng absolu te ethan ol cont aining 3 M sodium acetate
(pH 5.5), a s outl ined in Sect ion 2.6.1. The fragment of interest was removed
from the plasmid by E'coR I restrict ion enzyme dig est ion . as pe r Section 2.10.1.
2.12 DNA SEQUENCI NG
2.12.1 p eR amplification
Final confirmation of the identity of the cloned wood chuck eDNA
fragments was done by nucleotide seque nce analysis using the fm o11)DNA cycle
sequencing system (Promega Corp.). Briefl y , a coc ktail containing approximat ely
40 fmol of recombinant plasm id DNA, 1.5 pm ol of a universa l sequenc ing primer
(n or M13 reverse ) end-labe led with n p_ATP (3000 CiJmma l) (Am ersham)
(Section 2.10.3), 2 mM of MgCI~ in 50 mM Tris·HCI buffer. pH 9.0 , (supplied as a
5X buffer ). and 5 units of sequencing grade Taq DNA polymerase (promega
Co rp.) were prepared. The cocJctail was divided eq ually into each of 4 tubes
containing 2 1-11 of either the G (guanine ), A (adenine) . T (thym ine) or C (cytosIne)
term inating nucleotide mixtu re . Cycl e sequ encing was conduct ed using the
followin g program: 9S· C for 2 min. then 30 cycles co nsisting of 9S· C for 30 sec.
42· C for 30 sec. and 70·C for 1 min . Upon completio n. 3 IJI of formamide stop
solution (Appendix A) was added to each tube and the lube was stored on ice
until electroph oresis in a sequencing po lyacrylamide gel (PAGE) (Sec tion
2.122).
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2.12 .2 Sequ enc ing PAGE
Pnor to loading on the sequencing gel each sample was hea t-dena tured
for 2 min aI 70~C . tnen chilled on ice . The DNA samples were separated at 50 V
on an 8% denaturing polyacrylamide ge l containi ng 7 M urea (Gibeo BRl). After
erectrcc ncre srs at sO'e (mo nitored by a thermal probe ), the gel wa s fixed with a
10% metha nol. 10% acetic acid solution and dri ed at eo"c in a slab gel dryer .
Subseq uent ly, the ge l was exposed briefly to a mu hipurpose storage Phosphor$
screen and the image analyZed usi ng the Cyc lon e system (Canbe rra PaCkard ).
Fina l docu men tation was done by ov emlQht exp osure of the ge l to X~ay film
(KOd ak)
The Identity of the nucleo tide sequences was confirmed by companso n
With published sequences in GeneBank library (National Cen tre for
Biote chnology Information. National Lib rary of Med icine , National Insti tute of
Hea lth. Bethesda. MD) uSIng the BLAS T searc h so ftware
(http.JIwwvv.ncbi.nlm.Olh,govI8 LA Sn. Once confirmed . the com plet e seque nces
of the clOned wooocbucx DNA we re obta ined by employing a commercial
fluorescence-b ased automa ted DNA sequence a na lyze r (ll-COR: l iCor Inc .•
lincoln. NB)(Department of Genetics. Hosp ita l fo r Sick Children. Toronto,
Orrtanc) . All wood chuck seq uen ces obtained throug h the cou rse of this stud y
were submitted to Genbank at the Natio nal Institutes of Health. They can be
viewed In the order suermtt ec in Appendix 8 o r at 'NWW.ncb i.nlm .nih .goy.
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2.13 DETECTION OF RNA
2.13 .1 Dena tu ring gel electrophor es is
Pno r to Northern blot hybridiz ation , RNA was eie ctrcpnc renceay
fract ionated on a dena turing agarose gel foll owing a standard protocol (Brown
and Macke y. '997). Briefly , 10-20 1J9 of Iota1RNA (Section 2.6.2) was
su pplemented with 3 volu mes of RNA den aturing solution (Ap pendix A) and
Incu bated for 15 min at 6S-C . Sam ples we re then chi lled on ice and 1/10 volume
of formaldehyde ge l load ing buffer w as added , and RN A electrophoresed at 5
V/cm on a 1% den atu nng form aldehyde aga rose ge l. Aft er e lectr op hore sis . the
to rmao env ce w as removed by wa Shing the ge l in RN ase-tree wa ter (5 min ) and
tw ice In RNase-tree lOX sse solut ion (25 m in each). The qu ality of the iso lated
RNA was assess ed by visualiza tion of ribos omal RNA on a UV transillumi nato r
(Fotcc yne Inc .. Sio/C an Scientific . Miss issauga. Onta no)
2.13 .2 Northern blo t analysis
After electroph ores is. the RNA was blotted onto positive ly charged ny lon
memb rane (HybOnd-XL l!>: Amersham) by downward capillary transfer using
Rrease-free 10X SSC . as per Section 2.9 .3.1 . After a 4 hr transfe r. the
membrane was air-dried and then baked for 2 h at Boac prior to hybridization
with radiolab eled probe
Nylon memb rane s co ntaining RNA were pre-hybridized in 10 ml of
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form aldehy de hyb ridiZa tion solution (Appe ndi x A) at 42 ·C . After 30 m in. 15 x 10-
cpm of a heat-denatured 12P-tadio labeled probe was added. The bl ots were
hyb rid ized overnight at 42· C and th en the membranes were washe d and signa ls
were quantified the following day , as descri bed in Sect ion 2.9.3.3.
2.13.3 Rem o val o f hyb rid ized probes fr om Northern blots
To hybrid ize the same Northern blots with d ifferent probes. radi oa ctive
sIQna ls wer e remo ....ed fro m the blots using a deg radation sol ution ereveee in the
EZ- stnp DN A la beling kit (Ambia n Inc.). foll owin g the mao cracturer's proced ure
Ttus tecnnc ce p rovides mild slOpp ing co ndit ions whi ch gre atly enhance the
lifespan of Northe rn blots compared to stand ard probe remov al protocols.
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CHAPTER 3:
PERFORIN AND FA$ /FAS LIGAND·MEDIATED CYTOTO XICITY IN ACUTE
AND CHRONIC WOOD CHUC K VIRAL HEPATITIS·
• n ilS study was published ,1'1Clinica l and Expenmental lmm unology In OCtober 1999 (vOI_l 1a
pp 63-7 0) The cloning and seQuenCing Of the woodchuck perfonn gene was done after the
pul:/llCatJon of the rnanuscnpt, A ll the research repo rted ,n thiS study . With the exceptio n of
«n rncn cmstoioqrcar anal ysIs of liver sections. was perfolTl1edby the candid ate
3.0 SUMM ARY
The Fasi FasL and the perforin -granzyme cyto tox ic pathwa ys presumably
playa central role in the development of hepat oce llula r injury in vira l hepat itis .
To recogn ize the potential contribution of FasL and perfor in-based cell killing in
hepadnav iral infection . we adop ted a cytotoxic assa y using murine Fee-ccsrnv e
P815 and human Pes-neqe nve K562 cells as targets. Fresh ly iso lated PBMC
from wo odch ucks with newl y acquired INHV infection (n=6), chr onic VVHV
hepatit is (n=9 ) and from health y animals (n= 11) were used as effect or cells . We
have found that woodch uck lymphoid cells kill cell targe ts via both the FasU Fas
and the perfc nn death pathways . The contribution of the Fas-dependent
cvtorysis was ascerta ined in blocking expe rime nts with anti-Faa antibody and by
incubation of PBMC with cycloheximide to prevent de novo synthesis of FasL.
The invo lvement of the pert cnn pathway was confirmed by treatment of effector
ce lls with colch icine to inhib it the microtubule-dependent pertcnn release
Comparative ana lys is showed that peri phe ral lymphoid cells from acute IJVHV
hepatitis, but not those from chro nic \NHV infect ion . are more cytotoxic and that
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th is increase seems to be entirely due to activation of perforin-mediated killing
The data indicate that acute infection in woodchucks is ass ociated with the
augmented capa city of lymphoid cells to ehcrt cert cnn-deoencent killing . but in
chr onic infection. Independent of the severity of live r disease and duration of
chronicity . these cells have the same or lower cytotoxic potential as PB MC from
healthy con trols . These findings sugg est a role for nons cecrnc cell ular immunity ,
pres umably NK cells . in the control of earty WHV infection and in the progression
etCH
3.1 INTRODUCTION
Al though the rnecna msms of the action are not com pletely unde rstood
injury In nepa trns 8 1$ pres umably caused by e l l which are readi ly detectable in
the penpheral blood of patients with acute infect ion (Reh erm ann et at.• 1995 ). but
are apparently laCking or at low levels in CH {Ferrari et et.. 1990 , Rehermann et
at . 1996 1. Acti vated Immune effector cells use at least two Independent
mecnanrsrns to k ill targeted cells . These cvtotocc pathways are media ted by a
FasiFasL interaction and by pertorin.granzyme re lease . In add it ion , it is
assumed that cy1okines . such as IFNV and TNFo , secreted by activated
lymphoId cells cause cell damage and death (Ando et at , 1993).
Hecatcc ytes are Fas bearing cells and are highly se ns itive to Fast,-
induced injury, Cross linking of Fas mole cules with an anti- Faa antibod y has
been shown to cause fatal hepatic fail ure in mice du e to he patocyte ac optc se
9Q
(Og asawara et et. 1993) . In viral hepa titis. the involvement of the Fasl. -Fas
system was postulated based on the presence of act ivated T ce lls , which display
Fasl . in the intrahepatic inflammatory infiltrates and on the unregulated
expression of Fas on nepatccvtes during ongoing necroinflammation (Galle et
al.. 199 5). Demons trat ion that soluble Fas can preve nt CTL-induced hepatitis in
transqemc mice retaining HBsAg in hepa tocytes suppo rted a notio n about a
principa l role of the Fas L·Fas interaction in the development of vira l hepatitis
(Kondo et at . 1997). Howe ver . other experiments in HBV transgenic mice in the
absence of hepatic HB sA g retention showed thaI both Fas L and perlorin-b ased
cyto tOXICity contribut e 10 hepatocyte injury and thaI both the se pa thw ays must be
ope rat ive to krllla rgeted cells (Nakamoto et aI., 1997). The importance of the
perform pathway in T ce ll-med iated liver inJury was also subs tant iated in pertorin
knock out mice which fail to eliminate virus and are resist ant to LCMV ·induced
necautrs IKagi et aI., 1994 ). Unt il now . the cont ribution of th is FasL and perform-
depend ent killing had not been comp arativ ely evaluated in acute and chronic
phases of natural nececnavnu s infectio n.
In this study. we measured the cytolytic capacity of PBM C from
woodchucks WIthacute and chro ntc VVHVhep atitis and from health y anima ls to
investigate differe nces in the effecto r cell kill ing durin g hepadnavira l infection. To
drscnrmnate betw een FasL and pertonn-e ased cytoto xicity and to assess the
relative contributio n of eac h of the mech an isms In acute and chronic Vl/HV
infections. we adopted an assay with hete rologous FasL-sensit ive and Fast -
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insensitiv e cell s as targets and man iou latecl the testing condi tions using agents
that sele ctive ly block ind ividual reactant molecules of each pathway. Our results
show that the circulating wood chuck Iympho mononuclear cells kill cells by both
Fasl and pertcnn-dependent mecha nisms. Furtherm ore . comparative ana lysis
show ed tnet AH, but not chronic VVHV infec tion , is un iform ly associated with an
enhanced ability of the circulating lympho id ce lls to induce cell deat h and that
this increase is a consequence of activ ation of perl orin but not the Fasl -
med iated pathway. These data ind ica te that an increased acti .... lty in the perfa rin
effector syst em could be impo rtant in defence aga inst earty hepadnavirus
infectio n and that its de crea sed efficie ncy ma y contribute to the establishment
and /o r perp etua tion of ch ron ic infection.
3.2 MATERIALS AND METHODS
3.2.1 Animals and categ o rie s ofWHV infectio n
The stud y gr oup comprised in total 20 adult wo od chuc ks (6 males and 14
fema les) randomly sele cted from anim als housed in our co lo ny . Eleven of the
anima ls were hea lthy and we re investigated as cont rol s (Table 3· 1). Six of the
inltl ally healthy animals we re subsequently inocu lated wit h a WHV infect ious
pool (Mich alak and Lin . 1994 ; Michalak et aI., 1999 ) and analyzed for se rological
ind icat ors of VVHV infect ion (Section 2.3) at weekly intervals during the pre-a cute
and acute ph ases of he patitis. The rem ai ning 9 woodchucks were chronically
infected with WHV and their sera typically tested mont hly fo r WHV infect ion
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Table 3·1. Details on 'vVHV infect ion in adult wood chucks at the time of
acquisit ion of circul atin g Iymphotd cell s analyzed in tne cyto tox icity assa ys .
Newly
Acqu ired Chronic
c naractensncs Hea lthy Infect ion rnrecnon
Anima ls (n j 11' 6 9
Male:Female 3 8 2 :4 3:6
No. of PBMC samples tested 33 15 30
Se rum I/vHV DNA p OSItiVity (o j
Slot- blot hyb ridiz ation D 9
p e R/ So uth ern b ioi hybridization C nt '
Seru m WH sA g POSitIVity (n)
Dura tio n of \lVHs annqenerma (wee ks)
Range ' -4 34-1 92
Mean 2 83
Seru m anti-lJIIHs positiv,ty (nJ
"
0
Serum anti-lfoIHc pos Itivity (nJ 6 9
Serum GGT pc srtivity (nJ 0 0
Liver histo log y (n)
No rmal 11
"Acu te hepatitis 0 5
Chrome neceune 0 0
a lnd udes 6 anim a ls th a i wer e subsequently inocul a ted wit h WHV and deve loped
preacute or acute WHY infe ction .
~ Ap prox imate sensitiv ity 106 . 10r vgel rnl.
~ AmpliflE!'dby nes ted p e R wrth VVHV core gene spe Cific pnmers and detected by
Sou thern blot hybrid ization; appr ox imate se ns itiv ity l D-l~ vge/m l.
: nt. not tested
• One animal became ant i-VV'Hs react ive 5 weeks afte r inocu lation with 'NHV
followlOg a 3·week pe nod of Vv'HsAg po sitivity (see Fig . 3-4A: 838JAH an imal).
• After 'WHY inoculation. one anima l rema ined VVI-lsAg non-reactiv e and had
norma! live r histolog y at the time of cyt otoxic assay des pite the presence of'v'IHV
DNA and an ti-WHc in the serum (see Fig. 3-4A; 821 'preAH animal).
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mark ers . Of these. 5 had CH which had developed after experimenta l injecti on
.....ith WHV and 4 others were broug ht to the colo ny as juve niles with serologicall y
and histo logi ca lty evident chron ic infectio n acqu ired in the wi ld. The stage of
\lVHV in fect ion and status of liver disease in the anima ls investig ated was
d assified acco rding to serological and histological criteria outl ined in Sect ions 2.3
and 2.5. All animals in thi s study had normal levels of GGT excluding the
likelihood of HCC
Onset of preacute WHV infection in experimentally inoculated animals
wa s rec og nized wh en WHV DNA and an ti-WH c first appeared in the circu lation
but seru m remained WHsAg nega tive
3.2 .2 Preparation of u rget cells
Munn e mastocytom a pe lS ceus (ATCC #T IB-64 ). whICh ccnsntuav ety express
Fas (De l eon et ar.. 1998) and are sus ceptible to crc ss-sceces Fas L and
perfo nn.mediated killing (TakahaShi et at.. 1994 ). and human chronic
myeloge nous leukemia K562 cells (ATCC #CCl-243). which are Fas-negative
(Montel et at . 1995) and are mode l ce lts for deterrmnat ion of perfortn-induced
cvtotcxicrtv . were purchased from the Am erica n Type Culture Co llect ion (ATCC ;
Rockville . MOJ. The cells were maintained in growth medium consist ing of RPMI
1640 supplemented with 10% (vI V) feta l calf se rum (FCS) , 10 mM HEPES. 2 mM
l .g lutamine. 2% (v/v) penicillin/strepto my cin (a ll G ibco BRL) and 2 IJM t>
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me rca ptoeth anol (Sigma). The cell s were subcufturec 24 h prior to cyt otoxiCIty
assa y to allow for log-phase ce ll growth . To radiola bel the cell s. appr oximately 5
x 106 ce lls we re penetec by centrifugatio n at 32 8 x g for 10 min and incu bated in
minimal vo lume WIth 200 IJCi Nat CrO. (Amershaml at 37 °C for 90 min .
Labe led cens we re washed four times in phospha te buffered saline . pH 7 .4
(PBS ) su pplemented with 1% (vlv) FCS and resus pe nded in grolNth medi um at a
fina l concentrat ion of 2 x 10' ceuszmr. Labeled cell s were used immediately for
cytotoxicity assays.
3.2.3 Preparation of effect o r cells
Woodchuck PBMC we re isolated by density grad ie nt separation as
de scnbed In Section 2.2 .3 . The viab ility o f isolated PBMC was consistently
greater than 90%. as ev aluated by try pan blue exc lusion . After iso lation ce lls
we re washed WIth stenle PBS con ta ining 1% FCS and resuspended at a final
concentr ation of 10 ' viab le ce llsl ml in reacti on med ium wh ich consisted of gr owth
med ium (Seet o n 3.2 2) supplemented with 5\Jg /m l phytohemagglut inin (PHA ;
Murex Biotech Ltd . Dartford . U .K .). The ce lls were used immed iately in
cytotoxicity assays
3.2.4 Cy tot oxic ity as say
The standard cyt otox icity assay wa s pert ormed in ge·wel1 round bottom
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plates ( le N Phannace Lrticals. Montrea l, Ouebec. Canada) w ith 200 IJI of reaction
med ium (descnbed above) per we ll. Effe ctor (E) cell s were added to d uplicat e
wens to achieve three differen t E:T rat ios . equ ivalen t to 50 :1. 25 :1 and 12.5:1.
Subsequent ly, 1 )( 10' "Cr-labefed target (T) pa lS or K562 cells in 50 1.11 and an
appropr iate volume of growth medium we re added to the wells to reach a final
volume of 300 IJI. The plates were incubated at 37 "<; in a humid ified 5% CO J
incubator for 5 h . Following the incubation. 125 IJI eucucts of ce ll free
supe ma tan t were trans ferred Into l -m l glas s culture tube s and the rad ioactivity
measured In a gamma count er. As a cont rol . cells incubated in the absence of
PHA were Included in ee cb assa y. The maximum and spontaneous relea se
we re de te rmined by mcubanen of 10" labeled target cell s in 50 IJI with 250 IJI of 1
N HCI or 250 IJI of reaction medi um . respect ivel y. The pe rcent eoecrttc lys is w as
ca lculated from means of duplica te eva luation s as follows : 100 x (experimental
re leas e - spontaneous reieasept ma xnn um release - spontan eous release). In all
assay s. the spo ntaneo us ~'Cr rele ase w as less than 20% of the max imum
release
3.2 .5 Detennination of the effects of an ti-Fas antibody an d regulatory
ag ents on cytotox icity
To dls cnmmate between Fasl and perf o rin-med iated killing of P81 5 cells cau sed
by wood chuck PBM C. the hamster anti-mo use Fas Jo2 mon oclon al antibody
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(Jo2 mA b: punfied IgG. PharM ingen . Mississauga . Canada) was used . It has
been pre viously established tha t some cells . ind uding PB15. resist direct lysis by
Jo2 mAb despite the fact that the antibody specffica lly recogniZ es Fas on these
cells and blocks FasL Int e raction with Fas (data not show n; Kuw ano and Arai.
1996 ). T hus. prior to the cytotoxic assa y. app roximately 3 x l et of ~ 'Cr-labeled
P8 1S cells in a minima l volume were incuba ted with 5 1.J9 of Jo2 mA b or an
unre lated hamster ant ibod y (co ntrol) at 3r'C In a humidifi ed atmosphere of 5%
CO:: for 30 min. The cells were resus pende d in growth med ium at a fin al
concentration of 2 x 10$ ceuszrm. and the n the standard cyto tox ic assay was
performed as cescnoeo above .
To determine the effect of Inhibition of de novo FasL synthes is on the
PBMC cvtctcxc act lvrty . 0 .177 mM cyClOhexIm ide (CHX: CalBioch em-
NovaBiochem . La Jolla . CA l was added to test we lls with E;T rat io of 50:1 at the
stan of the stand ard 5-h cyto to xic assa y. In para llel expenme nts . the effect of a
microt ubule polymenz atiOn mtubrtor. coicncire (Sigma). on the oert cnn-rrecratec
kill ing of Fas-cenc ent K56 2 cell s was tested . In these assays. reectcn mixtures
conta ining effector and target cells at 50;1 ratio were supp lemented with
ccrcmcme at a final cc ncentranon of 1 mM and incubat ed for 5-h at 37 "C. In all
assay s. the results were compared to the data from assays done under iden tical
cond itions in the absence of the test agents.
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3.3 RESULTS
3.3.1 Woodchuck lymphoid cell s kill both Fas ·positive and Fas-negative
target cell s
Initial experimen ts were aimed at determining whethe r heterolog ou s cells
which either express Fas or were Fas-negative could serve as wocccnuck
lymphoid cell targets and whether they could pro vide a means to differentiate
between FasL and pert c nn-ce eec ce ll kill ing caused by the woodchu ck cells . For
thi s purpose . murine pelS cell s susceptible to cross-specie s FasL and perf orin-
med iated killing were used as the principal ta rge t ce lls . In add ition. to asce rta in
the accura cy in discnm ina ting perf or mfrom FasL-med iated cytOlysis . Fas-
defic ient huma n K562 ce lls. model cells for dete rmining pertc nn-cepe ncent
toxicity . were used . EmploYi ng this two-t arget celt sys tem. PBM C from healthy
woodchucks lysed both pa l S and K562 ce lls in the presence of PHA in a manner
strict ly dependent on the effe ctor ce ll concentr ation. Thus . a line ar decrease in
the level of killing of bot h target cell s was obse rved as the effect or cell numbe r
decreased in the assa y (Fig . 3-1). The above cytolysis did not occur in the
abse nce of PHA (data not shown ). This ma y suggest that in an in vivo situatio n
d irect contact between effe cto r and target cens is req uired to faci litat e both Fas
and perf orin-medi ated cell k illing
At all three E:T ratios exa mined . Fas-deficien t K562 cell s were killed with
an efficiency of abo ut 25% of th at observed wit h an eq uivalent number of pa l S
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Figure 3·1 . Cy to tox ic ity o f normal woo dchu ck PBM C toward s Fas ·
co mpetent and Fas-de fic ient ta rget cell s . PBM C from 11 healthy , WHV -
negative woodchucks were incubated with "Or-labe led Fas express ing P81S
cells (solid line ) or Fas deficient K562 cells (dashed line) at indica ted E:T ratios
Data from evaluat ion s with 30 and 19 individual PBMC samp les were used to
determine PB1S and K562 cell killing . respe ctively . The results are expressed as
% specific lys is :t.SEM
cells (Fig . 3-1), sug ges ting that the woodch uck PBM C lyse targe ted cells more
efficien tly via the Fast-Fa a pathway. Pre incuba tion of pa lS cells with J02 mA.b
reduced p a1S cell lysis by an average 0161% (see Fig. 3-2A). support ing the
conclusion that the wood chuck ceus eliminated pe 1S cells to a larger extent via
the FasL·m ediated mechanism. A simi lar level of inhibit ion of the pa1S cell lysis
(approximately by 72 %) was seen in the presence of CHX, an inhibitor of de
novo FasL synthesis (see Fig. 3·2A). This last finding prov ided addit iona l
evio ence that the observ ed cytOlySISresulted mainly from activa tion of the FasL ·
Fas pathwa y
3.3 .2 Acute but not c h roni c WHY hepati ti s is associated with increased
pe riph eral ly m phoi d cell killing activi ty
To estab lish whether the cytolytic potentia l of woodc huck effe ctor ceUs
vanes in different stages of WHV infection . Circulating lymphoid cells collected
from animals In the pre or acute phases of VVHV Infection and dunng advanced
en-one Infectio n were analyZed in a 5--h " c r rele ase assay wrt.h pa1 5 cells
Figure 3-3 shows that the PBMC from an imals WIth newty acq uired infect ion
displayed approximately 50% greater cap ability to kill pa1S cells than PBM C
from hea lthy anima ls et all three E:T ratios . In con trast. pe ripheral lymphoid cells
from woodch ucks with CH lysed p a1S targets at substantially lower levels than
those found for animals with the recently acqui red infec tion . In CH, the rates of
PBMC-mediated kill ing were the same or , at 50 :1 and 25 :1 E:T ratios , even lowe r
Colc h ici neUntreatedCHXJ02Untreal ed
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Figure 3-2. Ncn-Fae mediated killing of P8iS and K562 target cells by PBMC fro m wood chucks with newly
acqu ired and chronic WHY Infec l lons and from hea lth y contro ls. PBMC from Wl-IV-negaliIJe, healthy animals
(10 individual PBMC samples; open bars) and from woodchucks with recently induced WHY infection (14 PBMC
samples : grey/do tted bars) or chronic WHV hepatitis (11 PBMC samples : solid bars) were incubated with 5lCr.
labeled P81Sor K562 cells. IA) Fae-pcsinve pa1Scells were used untreated, pre-incubated with anti-Pas Jo2 mAb
or tested in the presenceof the protein synthesis inhibitor cycloheximide (CHX). (8) The Fas-negative K562 cells
were used unheated or les led in the presence of the perforin release inhibitor colchicine. Results are prese nle d at
all E:T ratio of 50:1 from 5 experiments and expressed as a mean percentage of lhe specific lysis of P8 15 or K562
cells t SEM
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th a n those det ected for PBMC fro m healthy uninf eeted an ima ls (Fig. 3-3 ). Of
note is the fact th at all PBMC samp les fro m chro nica lly infect ed wOOdchu cks.
indepe nd ent of the severi ty of he patitis and the duratio n of chronicity . uniform ly
displaye d a low cyto lyt ic activity comparable to that of PBMC from Vv1-iV-naive
anima ls. Although the majority of PBMC samples from woo dch ucks wit h rece ntly
acquired pre-acute or acute INHV infectio n di sp layed mar1<edly ele vate d ki lling of
P81 S targets . there wer e also some which induced ce ll death at lev els simil ar to
those typically fou nd for PBMC from hea lthy woodchuc ks (see Fig . 3-4 )
3.3.3 The inc reased PB MC cyt oto xic ity in acute WHV infection is perfa"n
b ut no t Fasl~ediated
To unco ver the mechani sm of the augmented ce ll killin g by lymphoid cells
from acutel y infected animals, P8 15 cells pre incubated wrth anti-Faa J02 mAb
wer e used as targets . In a para llel experime nt . the de novo expression of FasL
on woodctwcx PBM C was inh ibited by CHX be fore and during the cytotoxicity
assa y uSIng P8 15 cell s. As illustra ted in Fig 3·2A . a nu-ses an tibod y decreased
ki lling of P815 target s by 52%. wher eas CHX treatm en t of the same effect or
PB MC red uced killing of una ltered PB15 ce lls by 68 % . Thus. nerthe r of these
entaq c msnc treatments blocked th e enh an ced cytolysIS caused by PBMC from
acutely Infected animals. ind icating that the Fast.-Fas in teract ion unl ikely
cont ribu ted to the inc reased killing . This w as supported by the da ta obtained
afte r subtracting values of the ki lling of P815 ce lls preincub etec with Jo2 mAb
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Fig ure 3-3. P81 5 cell ki ll ing by PBMC from woodchucks with newty
ac qu ired and chronic WHY infec ti on s . Circul atmg lymphom ononuclear cells
isolated from anima ls with newly Induced prea eute or acute WHV infectio n (14
PBMC sam ples; grey /dotted bars ) or with chr onic hepatitis (11 PBMC samples;
ccen bars) and from health y woodch ucks (10 individual PBMC samples: solid
bars) we re incubated with "Cr-tabejed PB1S cells at indica ted E:T ratios. Results
for each E:T ratio are expres sed as a percentage of the specific lysis induced by
PBMC cenvec from healthy anima ls and tested at the sam e E:T ratio (taken as
100%)
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(Fig . 3·2A: columns depicted as Jo2 ) from the value s of the killing of untreated
palS ce lls (Fig. 3-2A; columns mark ed as untreated) by PBMC from differe nt
groups of the ammals stud ied
The final values we re almost identical both for healt hy anima ls (20.3%)
and for wood chucks with rece ntly acq uired (22 .6%) and Chronic (19.8%) WHV
Infections . This suggested that Faa-media ted cyto toKicity participated to the
same extent in the cytolys is cau sed by PBMC from eithe r VVtiV-naive or infecte d
anima ls and , therefo re . that the enhanced cell killing in newly acqui red infection
was a co nsequence ct tne non-Fas -mediated pat hway.
Circulating lymp hoid cells from woodchucks w ith newly acqui red VVHV
mfection killed Fas-negative K562 cells with ap proximately twice the erncencv of
PBMC trom healthy or chronically infected an ima ls (Fig . 3.28). Only the perf orm.
release Inhibrtor co lchicine blocked the increased cyt otox icity seen from PBM C
from acu tely Infect ed anima ls . This finding provided stro ng evidence that the
Increased killing by PBMC fro m an ima ls with rece ntly acquired infect ion was non .
Fas-med iated but most likely perfo rin related
3.3.4 Profi les of Fas an d pe rforin.m edi ated ki lli ng in newly acquired and
ch ronic WHY infeetions
To investigate dynamics of the PBMC -media ted cell killing and the
contribution of Fas and pert cnn-baseo cytoto xicity during newly induced and
advanced chronic WHV infections . se rial PBM C samples collected from 3
104
recently infected animals and 2 Chronic VVHV carriers wer e assa yed usin g pa l S
and K562 ceus as targets. Two of the acutely infected an imals (838/AH and
851/A H; Fig . 34 A). wh ich were VVHsAg reactive at 4 weeks pos t 'WHV
inoc ulation (wpi). sho wed high and cont inuous increase in the cyto to xicity tow ard
P815 cells at all three E:T ratios when se qu ential PBM C samples were
investigated . One of thes e woodchucks (838/AH) cleared VVHsA g and
eer occnvertec to anti-VVHs at 5 wpi, where as the second (851/AH) rem ained
Vv'HsAg reeewe du ring toncw-cc. Bo th anima ls showed histOklg ical fea tures of
AH In liver tissue samples obtained im med iately after completion of the cyto tox ic
assays . In contr ast. the ki lling exh ib ited by PBMC from 821/preA H animal, wh ich
was WH sAg neg ative unti l 8 wp i. fluctu ated at levels com parable to thos e
exhibited by P8M C from heathy contro ls teste d in parallel (Fig . 3-4A). Th is
emme t showed normal liver mo rpho logy at the time of the cytoto xic as says
desp ite the presence of INHV DN A and anti-V'VHc in the se rum and was
class ified as be ing in the preacute pha se of V'VHVhepatit is (Table 3-1). PB MC
from wood cnucxs With CH (274JCH and 1237JCH) killed P815 cells at levels
grea tly be lOWtho se found fo r woodchucks with acu te infect ion and these lev els
were close to or slig ht ly below those for healthy an ima ls (Fig . 3-4 8 ).
The level of non -Fas-med iated killing wa s de term ined in the same se rial
PBM C samples using K562 ce ll targets . In 838JAH an imal, the lysis of these
targe t cells decreased as the time from the VVHV inoculat ion prog ressed and the
anti-lNH s de ve loped . Neverthe less. despite the decrease in no n-Fa s-dependent
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Fig ur e 3-4. Profi les of PBMC -induc ed cyt otoxi c ity toward P815 or K562
target cells determined in individ ual woodchucks du ring newly acqui red
and ad vanced chronic WHV infec ti o ns . Sequent ial PBMC samp les collected
from 3 wOOdchucks between wee k 4 and 8 after VVHVinocul ation (A) and serial
PBM C samples from 2 IJVHsAg-positive anima ls with chronic VlHV hepa titis (B)
we re tested in parallel at grven time points for cytot oxicity aga inst Fas-positive
PB1S or Pes-neqenve K562 cells at E:T ratios of 50:1 (circles). 25:1 (squares)
and 12.5:1 (triangles). Points represent the means of dupl icate e va luat ion s and
are shown as a percent age of the cytotoxicity exhibited by PBM C from hea lthy
an ima ls against a given cell target and tested in the same ass ay. The res ults on
serum VlHsAg and anti-VVHs react ivities and WH V DNA detectio n are presented
for animals With newly acquired WH V infectio n in panel A. All anima ls chronica lly
infected With \'VHV (shown in panel B) were \lVHsAg and INHV DNA
pc s.trve at all time points tested .
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kill ing ov er time . the level of cytolysis was evidently elev ated (3 to 8.5-fOId) over
the cytotoxicity displ ayed by PBMC from hea lthy and chronically infect ed an ima ls
at all ti me points and E:T ratio s tested (Fig . 3-48). Killing exhib ited by PB MC
from 851 /AH woodc huck was approximately two-fold greate r at all E:T ratios than
that for he althy controls and animals w ith CH. except 5 wpi (Fig . 3-4A ). In
contra st to 838JAH and 851/AH, 82 1/preAH anima l demonstrated a slig htly
elevated (up to 1.S-fold) K562 cell k illing and th is level rem ained relatively stab le
over the 5-w eek te st pen od .
The Fas-oc eceneern cytOlysis exhibited by se rial PBM C samp les
co llected dunng th e 5-week invest igation penod fro m chronica lly infected amma ts
was at the same level or m oderate ly augmented in com pans on to PBMC from
heal thy woodchu cks (Fig . 3-4 8 ), In con trast to acutely infected emm ars. the leve l
of the K562 cell ki lling in C H showed no or rrummat fluctuatio ns
3.4 DISCUSSION
The present study de monstra tes that CirCUlating wood Chuck lymphoid cells are
capa ble of ceect lySISof heterolog ous ta rget cells throug h acnvenc n of both
FasUFas and pertorin dea th pathways . that tms cyt opath ic effect requ ires PHA
and . therefore . effe ctor and target cell contact. and that AH is seecnvefv
assoc iated With the enha nced capac ity of lymphoid cells to induce cell de ath via
the pert onn-ee ce nc ent mechanism. The emplo yed two-cen ta rget cytotoxicity
assay system. wh ich is based on the cross-species produ ctive interacti on
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betw een woodchuck lymphoid cell FasL and Fas on murine pal S target cells and
on the cross spec ies perfonn-mec.atec cell killing. showed that Fas-d epe ndent
cytotOXICity could be the main path way by which wOOdchuck PBMC induce cell
death. The accuracy of th is determination wa s ascertamed us ing Jo2 mAb wh ich
blocks cell surface Fas antigen and by treatm ents with CHX and colchicine to
inhibit Fas L expression and microtubule-d epe ndent perf orin relea se ,
respect ive ly. In addition , the obtained res ults demonstrate that close cross-
spec ies compatibility exists in the FasUFas and cert c rm-c ren zvme systems
betwe en woodch uck . mouse and human, as has bee n pre vious ly shown between
huma n and mouse (Takahashi et er. . 1994 ; Tana ka et at.. 1995 : Smyt h et ar..
1996) . In the case of FasL. ttus was furth er supported by sequence analysIs of a
SOBbp- fragmen t that mciucec complete sequences of exc ns 2 and 3 and
flan king fragments of exc ns 1 and 4 of the wood Chuck FasL (Hodgson and
Michalak: GeneBa nk accession num ber AF15236B ). This ana lysis showed 89%
and 86% nucleotid e homology wrth the human and mouse Fas L sequ ences .
respective ly (data not shown ). Additiona lly , a 700 bp fragm ent of wood chuck
perf orin (Hcdqscn and MIchalak; Gen eBank accession numb er AF298158)
demonstrated 85% Slmi lanty to hum an perforin and 74% homology to mou se
pore form ing protein. The se sequence s are available in Appendi x B
Although wood chu ck peripheral lymphoid cells killed virus unin fect ed ce lls
main ly through the FasUFas pathway. the increased cytoto xicity found for
animals with recently acq uired WHV infect ion wa s entire ly media ted by perforin
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release This ind icates that the perforin-dependent killing is select ively activ ated
in the early phase of VoIHV infect ion . In th is respect . considerable evidence has
been accumu lated to cenctcce that the perf orin-dependent cytotoxicity is the
princi ple mech anism by which NK cells el im inate targeted cell s (Kagi et at.. 1994 :
Sayers et at . 1998 ), that the peak of NK cell cytolytic act ivity and prol iferation
usu ally occurs shortly after vira l invasion (rev iewed by See et aI., 1997 ), and that
NK ce lls are an impo rtant e lement of the natural resistance to m any viruses
(reviewed by See et et.. 1997 and Smyth and Trapani, 1998). Considering ou r
find ing in the context of the data "revious ly reported !';Iy others , it is like ly that the
increased perf onn-mediated kill ing in the early stage of VVHV infecti on was a
consequence of NK cell ecnv encn. altho ugh. at this stag e. we do not hav e
reliable tools to separate woo dc huck NK cells from other circulatin g effector cells
Nevertheless, the augmented kil ling of K562 cells by PBMC from acutely infected
anima ls corroborat es the previous obs erv ations on the increased cytot ox icity
toward K562 cells by PBM C from patients WIth AH type B. which has bee n
interpreted as Ind icative of enhanced NK cell cytotoxicity (Cberneuc et at.. 1986;
Ecne vama et at . 199 1). The ab iJrtyof the hos t to mount a strong cyt otoxic NK
cell response very ea rty in the course of bepacnavnu s infection co uld playa
dec isive role in controlling virus spread and limiting progression of the dise ase.
The observed co-occ urrence of the initially very strong PBMC cyto toxic act ivity
follo wed by a swift seroccnversicn to anti-\lVHs and recove ry in one of the
woodcnucks with AH in our study (83BJAH: Fig. ~a) cou ld be inte rpret ed in
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suppo rt of this poss ibility .
The ma in adv antage of our experim enta l app roa ch is the ab ility to dissect
the cont ribut ion of the FasUFas system from the perforin-dependent killing
ind uce d by the same eff ector cells and to asses s sim ultaneously the cyto pathic
effe ct cau se d by PBM C derived trom different stages of viral hepatitis and from
healthy an imals . By pa rallel exa minatio n of the effector cell s fro m acute and
chronic infect ions using me two-cell cytotoxicity assa y sys tem sup plemented with
selective Inhibit ion of reactant mo lec ules of both the Fa sUFas and perf ann
pathw ays . we neve circumvented concerns raised by other auth ors ui et the ta rget
cell itse lf ma y hav e the last word in sel ect ing its mode of exec unc n (Nakamo to et
al .. 1997). This allow ed for an un biased demon strat ion th at chronic VV'HV
hep atitis is accompan ied by cytotoxic acti vity in the per iphera l blood equa l to or
lower than in healthy co ntrols and that there is no relation between the level of
the PBM C· ind uced cell killing and the seve rity of hepatit is or th e duration of
chr on ic WHV Infect ion. This find ing appea rs to be co mparable to the repo rted
reduced cytoto xicity of circulating NK cel ls in patients with chronic active and
persis ten t hepatitis B (Actis et al.. 1991 : Ono er et ., 1996 ), alth oug h elevated
levels of this cell activ ity ha s also been obs erved in an aggressive form of CH
type B (O no et et., 1996 ). Our stu dy also impl ies tha t. in contra st to acute
infection. the levels of non specrrlc cell killing rem ain relat ive ly stable in chronic
infect ion. as was shown by an alysis of serial PBMC samples colle cted during the
s-week exami natio n period of 2 of the chro nically in fected animals.
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Of note. in the above context . is the earner observ ation tha t HBsAg
decreases . In a dos e-depende nt man ner. NK cell cytotoxicity in vitro by
interfenng WIth their binding to target ce lls (De Martino et a/.. 1985 ; Azzan et al..
1992). If the contin uo us persistence of larg e qua nt it ies of c irc ulating HBsAg and
WHsAg (which IStypical for chronically infected humans and woodchu cks,
respectively) in fact suppresses NK cells . it would be reason able 10expect
re latively no rmal or decrea sed function of these cells reflect ed in the suppressed
PBM C cvtctcxc actIVity . The same co uld also be tru e for intrahepatic NK ce lls
It has been we ll document ed tha t chronic 'WHV necetms is accompanied by an
extens ive . Irrev ersi b le accumula tiOn of Vw'HsAg in the out er membranes of
Infected ne catccvtes . as opposed to A H (rev iewed by Michalak. 1998 ). It IS
poss ib le tha t the mcorporancn of the saturable quan ti ties of .....«us envelope
materra! mtc hep atocyte surfa ce . coe xist ing with the large am oun ts of virus
en ....elope ant ige n In se rum . ac ts as a neg ati....e mod ula tor fo r in sifu NK cell
cytOtOXICity In chro n ic VVHV mfecncn. Th is mig ht be an impo rtant element of
vnu s strateg y de ....eeo to prote ct in fect ed ce lls ag ains t ammunocytolYSls and cou ld
be In agreement wrth our recent obse rvation of the im paired exp ress ion of the
woodch uck MHC class I molecules on hep atocytes in chronic VlJHV infection
(Mich alak et al.. 2000). whose deple tio n is known to upregula te loca l NK cell
act ivity trev iewed by Bru tkiewfcz and Wels h. 1995). Our pre sen t dat a suggest
that vi rus nonspecific lmmur nty ma y contri bute to the ind uct ion and perpetuat ion
of chron ic liver dis ease in hepadnavi ra l infection . The de tected d iffe rence in the
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efficiency of the perfo nn-med iated cell killing between acute and chronic 'NHV
infections provides bas is for further investigations on the pat hogenic role of th is
form of cytotoxicity in HBV· infeeted humans and in animal model s of hep atitis B.
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4.0 SUMMARY
WH V , srrr urar to human HBV. causes acute live r mflamm aticn that can
progress to CH and HCC . WHV also invades cells of the host lymphatic system
wh ere it pe rsists for ute. We report her e th at acute and chronic hepadnav ira l
hep at rtis is cnaract enze c by a profound difference In the expres sion of MH C
class I molecules on the surface of infected hepatocytes and. notab ly .lymphord
cells. While acute VVHV mrecnc n is accomcenec by the enh anced hepatocyte
surf ace prese nta tion of MHC Class I and up regulated transcnptio n uf the re levant
nepanc gen es. lOhibltlon of c rass I antige n d isplay on liver ce lls IS a unifo rm
hallm ark. of cnrcnc VI/HV mtectco. Thi s inh ibitlon In CH occurs despite
augmented (as in acute mrecuon j express ion of hepatic genes for MHC class I
heavy cha in . 132-mrcrogl obu lin and transport ers associated with antige n
process ing (TAP 1 and TAP2). Further. the class I antigen inhibition is not related
to histological severity of hepatocell ular inJUry, the extent of lymphocytic
infi ltration s. the level of intrahepatic IFNy induct ion or hepatic INHV load.
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Importantly , the antigen expression is also inhibited on organ lympho id cells of
chron ica lly infected hosts. The resu lts obta ined in this study demonstrate that
the defective prese ntation of MHC class I molecules on cells supporting
persistent \NHV rep lication is due to viral pos ttranscri ptional interference.
mec han isms of whiChare described in Sect ion 1.7.6. This event may diminish
the susc epti bility of infected hepatocytes to wu s-sceefic T cell-med iated
eliminat ion . hinder virus clea rance . and deregu late the MHC class l-depend ent
functions of the host's immune system. This multifarious effect could be critica l
for perpetuation of liver dam age and evas ion of the anti-viral immunolog ica l
surveill ance in chronic infection and. therefo re , supportive of hepadnavirus
persisten ce .
4.1 INTRO DUCTIO N
The host's ce llular enmune respo nses directed aga Inst HBV pep tides
displayed on infected hepat ocytes are considered to be crucial in the ind uctio n of
hepa tic dam age and likely contnbute to both cyt opathic and noncyto path ic
elimin ation of virus from infected live rs (Sect ion 1.8; ChisaM and Ferrari. 1995;
Guidotti et al .. 1999), AlthOugh a diminished ann-virus CTL respo nse is thought
to be the main contributor to the pathog enesis of CH type B, the basi s of this
hindrance remain s uncertain. Since trigger ing and strength of anti -viral CT L
responsiveness de pend s to a significa nt deg ree on the efficient cell surfa ce
presen tation of viral peptides by MHC da ss I. delin eation of the changes and the
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me chanisms modu lating their expression in the course of viral hep atiti s might be
decisive for understand ing the pathogenes is of protracted liver d isease and virus
persistence in hepadnavira l infect ion. The above reaso ning has proven to be
corr ect for other virus infect ions , These investigatio ns have shown that virus-
Inouc ec alterat ions in the MHC class I surfa ce d isplay play an importan t ro le in
viral pathogene sis and pers istence (Fruh et et.. 1999 : Miller and Sedm ak, 1999:
Olds tone , 1997 ; Rina ldo. 1994 ).
l ymph otropism is a common featur e of man y viruses, includi ng
nec acna wuses. capable of induct ion of long -term infection in the hos t.
However, the dire ct link between HBV Iymphotro pism and Chronic in fectio n is not
yet establish ed . It is concerv atne that. like in othe r viral infections . inv asion of the
lym phatic system ma y have a detrimental effe ct on a variety of the host' s
immune responses . Am ong oth e rs, the virus may alter the display of MHC class
I molecules on lymp hoid cells and , in cons equence , Impair a vanetv of cell
immune tuncncns
In trus Study, we investigated tne VVHV·wOOdchuck mode l to elucidate the
relatIonship between acute and chronic phases of hepadnavirus infection and the
MHC class I presentation on cells naturally supporti ng WHY repl ica tion . We
have also searched for a mole cu lar bas is of the disco vered dis parit ies in the
MHC class I expression. In co ntrast to the past eva luat ion s, whi ch brough t
conflict ing conclusions based on immunohistoc hemical staining of liver tissue
from HBV·infected patients (Chu et ai, 1988 : Lau et et.. 1993: Pigna tell i et al.,
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1986). punfied cell plasma membranes. quan titative and highly sensitive
immunoblotting tecnncues and molecu lar methods measuring MHC class I
affi liated gene activ ity were used in thi s study . We report that acute and chronic
Vl/HV mtecnc ns are cneractenzec by a profound d ifference in presentation of
class I antigen on hepa tocytes and org an lymphoid cells . Hence , while AH is
accompamed by an augmented express ion of class I mole cules on live r celts . but
an unaltered display on lympho id cells . inhib ition of the anti gen pres entati on on
both cell types is a uniform cha racteristic of chronic I/IIHV infection. Interestingly ,
this Inhib ition in CH occurs despite upreg ulated transcription of the he pat ic genes
encoding MHC class I heavy (a) and light (132·microglobulin) chains , and
transporters assocated With antigen presentation (TAP1 and TA P2). implYing
that the defect in c rass I mo lecule presentation occurs oos ttranscri ptionally
4.2 MATERIALS AND METHODS
4.2.1 Anim~ls and ca te gories of WHV infecti on
Fou rteen wooc cnu ccs co nstrtuted the ma in study group (Study Group 1)
Eight anima ls (Vv'M 2070 .1NF 21 12. WF 2114 . WF 2 131 , vvtJI2121.1NF 2160 .
'vVM 2167 and 'vVM 2171 ) were infect ed intravenously with VVHV (Michalak and
Lin. 1994 . Micha lak et a/., 1999). Four others (WF 202 0. INF 2030 . INM 204 0
and INM 2150) had nat urally acq uired , VJHsAg -positive CH wh ich was monitored
for up to 21 months prior to the start of the expe riment. In this study group , two
healthy animals ('v'\'M 2075 and WF 2078) were examined as control s (Table 4-
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1). A ll the woodchucks . exce pt WF 2112 and WM 212 1. were a part of ou r
prev ious study aimed at identification of molecula r species of 'N'r--lVstructural
prot eins an d the nature of meir interactions with hep ato cyt e plasma m embrane s
(HPM) (M ichalak and Lin . 1994) ,
The serological statu s of VVHV infection was determined by tes ting
seq uential sera for IJVHsAg, anti-VVHs and anti.vv'Hc by immunoassays descnbed
In Sect ion 2 .3. Seru m WHV DN A was determmed by slot-blot hybrid ization
(Sect ion 2 .4) and . when nega tive . by po lymerase ch a in re actio n (pe R) using
WH V co re gene specific pnmers. as desc ribed In SectJon 2.82.
HistOlogical ex armne non of liver samples . ob ta ined by lapa rotom y 3 to 4
we eks prior to the ex periment or at the time of liver pe rfusion , was done afte r
conven tio nal processing to par affin . Par affi n sec tions (4 IJrn) we re stai ned with
hematoxyli n and eosin . Masscn-tncnrc me . cenccnc acid-S chiff or impreg nated
with silver (Michalak and l in. 1994 ). Morph olog iC assessment of live r damage .
referr ed to as histo logi C deg ree of necanns. was based on cntena cescn eec in
our orevecs worxe (Mich alak an d Lin. 1994 . Mich alak e t al.. 1990 ).
Based on sero logica l and histological assessments. woodchucks in Study
Group 1 were cla ssified to th ree cat egories : (1) he althy or recov ered fro m AH (n
:: 41: (2) with AH (n :: 4). and (3 ) pers istently infected wit h serol ogically and
his tolog ica lly evident CH (n = 6) (Table 4· 1). Histolog ica l exa mination showed a
highly vari able deg ree of infla mmato ry live r inJUry in the an imals examined (Table
4- 1). The chang es ra nged from mino r lesion s (grade I) seen in 2 WOOdchuck s
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(Vv'M2070 and INF 2114), throug h mild acu te or CH (grade II; INF 2030, W'M
2040 and WM 2167 ) to severe liver injury w ith heavy lymphocyti c infi lt rations and
prominent necrosis of parenchyma (grade III; INF 2020, WF 2112, WM 2121,
WM 2150 and VVM2171). Liver biopsies from healt hy anima ls (Vv'M 2075 and
WF 2078) did not show morpho logical alter atio ns. whereas hepatic ch anges in
woodchucks which resolved AH (WF 2131 and VVF2160 ) we re min imal and
consisted ma inly of mino r lymp homcnonucJear infil tratio ns in som e po rtal areas
and scanty intra lobula r infi ltrations surrou nd ing singula r degenerating
hecatocvtes. as reported prev io usly (Michalak et al .. 199 9)
Liver and spleen specimens from 7 oth er woodchucks with detai led
characterization of serological and histologica l profi les of AH (n =3) or CH (n =4)
and from 2 healthy anim als (Study Group 2) were also investigated (Table 4-1 ).
Hepatic hist ological lesions in th is group varied from no ne in healthy anima ls
(WM 306 9 and INF 3299 ). through minor (grade I: INF 3392 and INF 4832) and
mode rate (g rade II : WF 3349 . WF 3838 . and INF 4980 ) to se vere (gra de III ; WM
3158 a nd VVF4751 ) in ani ma ls wit h eit he r AH or CH . In addition. several other
woodchucks with well defined status of VVHV infection were used as a source of
PB MC to test the MHC class I display on the surface of circ ulating lymphoid ce lls.
For this purpose . freshly Isolated PBM C from 2 animals with AH , 2 animals
conv alescent from AH. 4 with CH. and 4 he althy an ima ls were examined by
fluores cence activa ted cell so rtin g (FACS : see bel ow). In a parallel expe rime nt.
PBMC collected from 2 woo dch uc ks prior to WHV infecti on and then during AH,
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and from 2 other an ima ls be fo re 'NHV edmtrasneton. during AH and then in
advanced CH were used for iSolation of PBMC plasma membr anes and
eva lua tion of MHC d ass I hea vy chain presentation by imm unoblotti ng .
4 .2.2 Ce ll and pl Oilsma membrane iso la tion .
Hep atocytes were iso lated by two-step co llage nase pe rfus ion of livers
from an im als In Study Gr oup 1 usi ng methods reported prev iously (Mich alak and
Ch urchill . 1988 . Michala k et al ., 1989 . Micha lak. and Lin. 1994) . HPM were
purified from the isola ted bep etccvtes by diffe renti al fracti onation in suc rose
grad ients (Michalak an d Churchill. 1988 ). Purity of HPM was determ ined by
measunng actrvrte s of marker enzymes for plasma membranes (S'.nucJeotidasel .
rmcrc sornes (glucose-6-pho sph atase ). and mitocho ndria (cytOChrome C
oxidaSe )(MiChalak and Ch urchill . 1988: Mich alak.and Lin . 1994 ). These
eva lua tions showed th at the HP M wer e essentially free from subcellular
contam inatio n and of com parable punty. Kidne y plasma membranes (KPM)
we re Iso lated from the wOOdchuck. kidn ey ho mog enates fo llow ing the HPM
Isol ation procedure
Splen ic Iymphomon onuclea r ce lls (splenocyt es) , contai nin g mainly
lymphocytes, were prepa red by two sequential density gradient centnfu gations in
Histopaque 1119 (Sigma ) as described pre vrcusfy (Michalak et al., 1995 ). After
dep letion of residua l eryt hrocyte s, spleen pla sma membranes (S PM ) were
punfied by hyp oto nic tre atme nt and su crose gradie nt centrifugation (Mich alak.et
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af.. 1995).
PBM C were isolated from freshly drawn EDT A treated blood by grad ient
centnfugation in Histopaque (Jin et al.. 1996 ; MlChalak et al., 1995). Plasma
me mbranes were prepared by hypotonic shQClo; and bnef sonicati on. and
subsequen t remov al of nuclei and ce llular deb ris by centrifu gation (Jin et al ..
1994 ). Protein cont ent w as ce terrmnec by a blcmc ncmmc acid assay (Sigma).
4.2.3 Monoclon~1 anti body to woodchuck MHC c lass I heavy cha in.
Mou se mo nocl onal ant ibody (Bl b.8 S mAb ) aga inst a nonp oly mo rphic epitope of
the wood chuck MHC clas s I heavy chai n was gene rated and cha racterized in our
previous study (Mich alak et al .. 1995 ). Ftus antibod y reco gnizes tw o poly pept ide
speces of woodch uck class I heavy ch ams with mo lecular masses of 43· and 39·
kDa
4.2.4 Western and dot imunoblotti n g
Plasma membra nes . succeaurer fractions or tiss ue ho mog en ates were
Immob ilized at the c eseec protein con centr atio n onto nitroce llulose (NC ; 0 4S.~m
pore size : BioRad labora tories). exposed to a blocking sol ution containing 3%
bovine seru m albumin. 1% normal goa t serum. 0.05% Tween-2 0 and 0.001%
sodium azide in PBS , and Inc ubated with B1b ,B9 mAb und er conditions
de sc ribed before (Michalak et st.. 1995). After incubation and was hing . the blot s
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were exposed to goat ann-mouse conjugated with alkal ine phosphatase (Jackson
ImmunoRes earch Labor atories Inc ., West Grove, PAl . washed . and reacti ons
developed (Diao and Michalak. 1997),
For W este rn immun oblott ing. purified memb ran e preparations were
subjected to 50 S-polyacrylamide gel electrop horesis (5 0 S·PAGE) at 20 1..19
protein/ lane an d separated proteins electrotransf err ed onto NC. and
immunoblOtted as described before (Diao and Micha lak. 1997 . Micha lak and lin.
1994 ). EffiCIency of prote in transfer and moleCul ar ma sses of the detect ed
polypeptide spec ies were determi ned usin g presta ined molecular weig ht markers
(BioRad Labo ratories ]. The relativ e exp ressio n of MHC d ass I he avy and light
chams was determ ined by den sit ometry using a computerized Cneml-rm aqer
4000 Sys tem (Canberra-Pack ard Canada Ltd .)
4.2.5 Im m unohis toc hemical s tai ni ng.
Cryos tat sect ion s 4 101m thick we re cut from frozen liver and spleen tissue
blOcks. ae-c rec . and fixed in co ld acetone-c hloroform ( 1:1) mixture for 5 min at
amb ient tempe rat ure (Mich alak et aL 1995). Secncns were hydrated in
phosphate·b uffered saline . pH 7 .4 (PBS). incu bated for 45 min w ith B1b .B9 mAb
or PBS (contro l). and wash ed fo r 30 min in 3 changes of PBS . Subsequently.
sections were incubated with FITC -conJugated ant i-mouse IgG (H+L) antibody
(Jackson Immun oResea rch Laboratories Inc .) for 30 min . washed 3 times for 10
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min in PB S, mounted in 20% glycer ol buffe red in PBS , and examined using an
epifluorescent Leitz-Oiaplan microscope.
4.2.6 Fluorescence activated cell sorti ng
Freshly isolated PBMC . approx imately 5 x 10$ce lls/sample with 'liability
greater than 95% by trypan blue exclusion , were incubated wIth B lb.B9 mAb or
PB S (control) and then with ant i-mouse ant ibody labe led with FITC (Jackson
lmmunoResearch Laboratones Inc .) by a procedure describe d prev ious ly
(Michalak er al .. 1995). Ce ll analysis was done using a FACS Star-Plus flow
cytom eter (Becto n-Dick inson. Miss issauga, Ontario . Canada)
4.2.7 Nucle ic ac id extractions .
DNA and RNA we re iso lated using standa rd procedures des cribed in
Section 2 .6 . Nucle ic acid s wer e quantit ated by standard spe ctr oscop ic analysis
and stored in small aliqu ots at -80· C prior to use .
4.2.8 Dot-b lo t detection of tissue WHV DNA.
For IIVHV DNA hybridiZation . 5 IJg of liver or 10 JJg of splee n DNA was
denatured by boiling for 10 min in 200 lJl of 6X sse. chilled on ice , and
immobilized on a nylon mem brane (Hybond-N; Amersham) using a SioDot SF
appa ratus (BioRad l abo ratories). The memb rane was hybridiZed for 16 h at
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6S·C to a full-length. linearized. cloned WHY DNA (Pardoe and Michalak. 1995 )
label ed WIth IJ2 PJ-dCTP (300 0 Cilm mol) by a random prim er method (Rediprime :
Amer sham ). The blot was washed to final stringency ofO.2X sse . 0.1% SOS for
30 min at 65 · C, and exposed to X·ray film (XRP· ' or XAR-5; Eastman Kodak
co.j with an intensifying screen or to a phosphor screen (Canberra-Packard
Canada ltd.). For estimation of the levels of Vl/HV DNA exp ression .
autoradiog raph ic or phosphor images of hybrid ization signals were quantitated
for equ ivalence with 1D-fold senal dilutions of reco mbinant, complete WHV DNA
using a chem i-image ana lyzer or a Cyclo ne Phosphor Imag ing Syst em
(Canberra-Packard Canada Ltd .), respective ly.
4.2.9 Clon ing of woodchuck gene s .
r etat RNA Isolated from sple en of a healthy woodchuck was reverse
tran scribed to cDNA then amplified by PCR uSing deg ene rate oligonucleotide
prime rs . For amp lification of woodchuck MHC c rass I heavy cha in sequence. the
sense pnm er MHC -W (S··AGTCTTICCGA GTGAA CCTG CGGAC) and the
ant isense pnme r W-C HM (S··TCCTTTCCCATC TGAGCTGTGCTIC) were used
The wood Chuck 132-microglobufin was amplified with the sense and antisense
degenerat ive primers p2 M.p lus (S'-ATGKCTCGC TCSGTG RCC) and 132M-minus
(5'·TIACATGTCTCGRTCCCAS) , respect ively . The wood chuck TAPl seq uence
was amplified wit h the sense pnmer APT· l (5'·
n CTIYACRGGCCGCMT CACTGA C) and the ant isen se primer l ·PAT (5'-
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AGGGCACTGGTGGCA TCRTC). whereas TAP2 sequence with the sense
primer AP T·2 (S'·TI CGGGTCGTGTRATTGACATCC) and antisense primer 2-
PAT (S'-C ITSACAGAACCSGAGAACAGCAC). For identifica tion of the
woodchuck CD3 gene . whose transcripts are speofic fo r T lymphocyt es. prim ers
CD3P (S'-CTGGGACTCTGCCTCTTATC) and CD3M (5'·
GCTGGCC TTTCCGGA TGGGCTC) with sequences essent ially identi cal as
thos e reported by others (Nakamura et st.. 199 7), were used . W ood chuck IFNy
was amplified with primers designed in th is laboratory W-IFNG (5'·
GGCC TAACTCTCTCTGAAACG) and W-G NFI (5'·
GAGGACTGTIATTTGGATGC ). In addit ion , an appr oximately 315-bp fragment
of woodchuck ll- aClIn and a 57D-bp fragment of glyceraldehyde.3 -phos phate
dehydrogenase IGADPH) were generated by pe R uSing woodchuc k liver eD NA
and olig onucleotide pnmers publi Shed prev iously fo r hum an ~actm (Fuqua et et..
1990 ) and mouse GAOPH (Ju et al .. 1995 ). For PCR amp lificat ion of cDNA to be
ccoec . samples were denatured at 94 -C for 5 min . the n 35 cyeses of 94-C for 1
min. 52°e for 2 min and 72°C fo r 3 min at ea ch step wer e carried out . The last
cvce w as followed by an elong ation step at 72°C lastin g 10 min . PCR
amplifica tions were carried out in a TwinB lock Therma l cyc ler (Ericam p Inc.)
using 5 ~I of the rev erse transcript ion react io n produ ct and a standard reagent
rmxture desc ribed previou sly (M ichalak et al.. t 999). The specific ity of the
amplified woodc huck DNA fragments was ve rffied by Sout hem blot analysis
using inte rnal ol igonucleotide probes except for the MHC class I hea vy chain
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wh ich w as probed WIth a [l: P)-labe led fragmen t of rabbit M HC class I texan 4)
exceed from plasmid pUC12·RLA-A (ATCC 77230 ; Marche et al.. 1985). After
confirmation of speCIficity . the DNA ampficons were punfied fro m Iow-melting
po int agarose using the Wzard peR Preps DNA Purification Sy stem (Promeg a
Corp.) and cloned into vect or pe Ril using a TA Cloning Kit (Inv itrog en). Aft er
plasmid amplification. the specificity and orientation of the fragme nts cloned wer e
valida ted by sequencmq eit he r by using the j rnor DNA Se quenci ng Sys tem
(Promeg a Corp .) or a fluo resc ence- based aut oma ted sequence ana lyze r (L1-
CO R).
4.2.10 Ge ne ex pression ana lysis.
Liver and splee n RNA was ana lyzed for MH C class I heavy ch a in . ~2·
rmcroq lcb ulin . TAP 1 and TAP2 . as well as . for C03. WHV. (l..actin and GA POH
expression by Nort he rn b lOt hybndization (Secnc n 2.13). The blOts were
hybridIZed for 18 h at 42-C to probes labeled WIth (1:P) us ing the Stnp-EZ DNA kit
(Am bton Inc .. Ausnn . TX). After hybridization . membrane s wer e washed to a
final stnngency of 0 .2X SSC . 0 .1% 50S at 42-C and exposed for
auto radiography or ph osphoimage ana lysis . Prior to rehybridization . probe s were
stnpp ed from the membranes following Secti on 2.13.3. The signal intensity wa s
qua ntified and equalized to !3-actin expression by densitometry.
Intrahepatic IFNy RNA expression wa s estimated by relativ e p e R using
woodchuck liver cONAs and oligonu cle otide prim ers presen ted above. PCR was
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perf onned in the linear amp lificat ion range under the followi ng conditions: 94 GC
for 5 min , Sl 'e for 2 min and n oe for 1 min in the first cycie. then 94 "C for 1
min. S2°e tor 1.5 min and 72°e for 1.5 min for 32 cycles . followed by the final
extens ion at n "e for 10 min (Fig . 4-1). As loading contro ls. the same eDNA
samp les were amplified with t)·actin prim ers . The resulting peR products were
analyzed by Southem blot hybridi zation with appropriate clo ned probe s and
comp ared to (3-actin express ion with a phosphoimage ana lyze r.
4.2.11 Nucleoti de sequence .accession nu mbers.
The access ion numbers for the woodChuck nuc leotid e seque nces derived
in th is study submitted 10 GenBank we re as follows: MHC class I heavy chain.
AF232723: TAP' , AF2 32724; TAP2 . AF232725: t32-microglobulin , AF232726:
CD3. AF232727; IFNy . AF232728 ; GA DPH, AF232729 , and Bcectm . AF232730 .
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Figure 4-1. Determination of co nd it ions for quantitaticn of w oodchuck IFNy .
A. peR amplification of a constant amount of woodchuck recombinant IFNy (r1FNy) over
increasing cycle number. Woodchuck r1FNy at 1 P9 was amplified for 20 to 40 cyCles under the
following conditions: denaturation. 1 min at 94·C ; annealing, 1.5 min at S2°e : and extension, 1.5
min at n "c. The integrated density values of the amplified products were determined by a chemi-
imager, plotted al"ldthe linear range mar1o:ed with a dashed line
B . Amplification of lD-foId serial dilutions of r1FNy at 32 peR cycles. r1FNy at concentrations
between 1 pg and 1 f9 were amplified for 32 cycles under conditions described in A. The densities
of the amplified signals are presented as integrated density values. The coefficient factor (R1) of
the plotted slope is above 0.99 indicatin g a high degree of correlation.
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4.3 RESULTS
4.3 .1 Upregulated ex p ress ion o f MHC cla ss I on he pa tocyte surfa ce is a
ha llma rk o f acu te bu t not chro nic WHV infecti on .
Liver sect ions from healthy and convalescent animals showed MHC class
I heavy chain immu nofluorescent staining of sinusoid al lining cells and the bile
duet epithe lia. but littl e or no expression on he pat ocyte oute r plasma mem brane s
(Fig. 4-2A ). In the live rs of anima ls w ith AH. a stron g staining of periportal and
intralobular inflammatory infiltrate s and memb ran es of the nepatocytes adjacent
to these infi ltrates w ere seen. The lobular hepatocytes . not as sociated w ith
inflammato ry cells . show ed a membranous stain ing of pa rt or the entire surface .
whi le their cyto plasm essentially remamed negative (Fig . 4. 18 ). Woodc hucks
chroni cally Infected wi th INHV had an enhanced disp lay of the crass I antigen on
hepatocyt es only In the areas of inflam matory infi ltrations . Hepatocyt es distan t
from the in filtrates w ere nonreactive (Fig. 4-2C ). howeve r. some ce lls . usu ally
occu m ng in clusters . had weak staini ng at theIr outer membranes. Ove rall . the
MHC c rass I pattern w as ncnce ebfv differe nt in AH and CH (Fig. 4-28 . 4- 2C) , but
there was no relatio n be twee n th is display and overall h isto log ical severity of liver
injury (assessed by cnteria outlined In Section 2.5) . There also was no
d iffere nce s in th e MHC antige n staining on si nusoida l lining en dothe lium or o n
the bile duet epith eli um in livers fro m infected. hea lthy or reco vered anim als.
Sect ions incu bated using the seco nd laye r antibOdy al on e as a contro l sho wed
the same minimal ba ckground sta ining in all livers ex ami ned .
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All HPM preparat ions isolated from Stu dy Group 1 and probed wit h
B1b.B9 mA b by Western blottin g. demonstra ted the MH C d ass I heavy chain 43-
kOa polypep tide . althou gh the protein was displ ayed at markedly higher dens ity
in HPM from anima ls with AH (Table 4-2 and Fig . 4-3). The HPM from hea lthy
and convalescent wood chucks . as well as those from anima ls WIth CH . showed
ncnceaeiv lower expression of the polypeptide. In addit ion to the 43-kD a
species. the 39-kDa polypep tide was detected on hepatocyte outer membrane s
from AH (Fig 4·3 and Table 4-2 ). This ban d was not ide ntifiabl e on blots of the
mem branes fro m he althy , reco vered or chron ically infected woodchucks . The
de tec tion of the 39-kDa pOlypeptide was consistent w ith our prev ious find ing Ihat
only woodchu ck cells displaying surlace MH C class I molecules at the highe st
densit ies (e.g .. norm al splenic lymphoid cells ) show both 43 and 39-kDa heavy
cham spe cies (Michalak et et.. 1995)
Densitometne cu anutaucn of the class I hea vy chain stgna ls detected by
Western (Fig . 4-3 and Table 4-2) or immuncc ot (Table 4-2) blotting confi rmed a
significant drfference in the hep atocyte su rface pre se ntati on of MH C class I
between acutery infect ed and the hea lthy . recove red or chronica lty infect ed
anima ls. Thus . HPM from e ither healthy or convalesce nt woodc hucks , which had
norma l (VIM 2075 and WF 2078 ) or nearly norma l (VVF21 31 and WF 2160) liver
histology. displayed app roximately the same amounts of class I heavy cha in. In
contrast. the quantity of MHC on HPM from AH was on average 3.5-fold greate r
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Ta ble 4-2 . Hepatocy1e outer plasm a membrane expression of MHC Class I
heavy cha in in woodc hucks with W'r-N hep atit is and in control animals.
HPM~ MHC Class I
Category of Histolog ical heavy-chain expression"
disease and degr ee of
43 kOa prote in 39 kOa proteinan imal' hepa tit is
Healt hy
VoJM 2075 1.1
WF 2078 0 .9
Resolut ion of AH
WF 2131 011 1.4
WF 2160 011 1.1
AH
VoJM 20 70 I 3.1 0.3
WM 2167 II 3.0 0
WM 2121 III 3.5 0 .6
WM21?1 III 4 .0 3.3
CH
WF2114 I 0 .6
WF 2030 II 0.8
WM2040 II 1.0
WF 2020 III 0.7
WF2112 III 1.4
WM 2150 III 0.9
• VVM. woodch uck male; INF . woodchuck fem ale
~ HPM. hepatocyte plasma me mbran es
~ Assessed by Wester n blotting with B 'tb .Bg mA b agai nst woodchuck MH C
class I hea vy ch ain and expressed us ing a sca le from 0 to 4 , comparatively
presenting the densities of the 39- and 42·kD po lypeptide bands based on
integ rated cherm-imeqe den Sity values .
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Figure 4~2. Immunofluorescent ide nti fi catio n of th e MHC c lass I express ion
in liv e rs of healthy and WHV·infeeted woodchu ck s . Cryostat sect ions from
hep atic tissue of a normal wood chuck ('Nrv'I 207 5) (A) and livers of anima ls with
AH (\iVM 212 1) (8 ) and CH (WF 2114) (C) were incubated with are.ss mAb
directed against woodc huck MHC class I heavy chain followed by FITe-labeled
anti-mous e IgG. A plasm a memb rane-associated patte rn of the MHC class I
sta ining of intra lobu lar necetccytee is evide nt in the liver o f the an imal with A H
but not in the livers from health y wood chuck and that with C H. Magn ifica tion , l(
400
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than th at on the membranes from healthy and convales cent woodch uck s (Table
4- 3)_ VVhen HPM from anima ls with AH and CH we re compared . a 3.2-fold lower
cont ent of the he avy cha in was found on the mem branes derived from ch ro nica lly
infected an imals (Table 4-3). Taken together. the hepatocyte surface expression
of MHC class I was evidently eleva ted in AH. but was es sentia lly the same in CH
and In the healthy or convalescent woodchucks
It is of note th at prob ing of the whole liver homogenates with B lb.B9 mAb
by sn muoccc t and Western blOtting d id not show detectable variatio n in the
hep at ic MH C d ass I co ntent between Infected and hea lth y an ima ls . This
observ at ion suppo rted the concl us ion that the identified difference w as
predo mi nantly restr icted to the hepato cyt e su rface . The re was no venation in the
class r hea vy cham displa y on KPM purified fro m the anim als examined (Table 4-
3)
4.3.2 Inh ibiti on of hepatocyte surface MHC cla ss I express ion is associated
with ch ronic WHV infec ti on bu t not with hepa tic virus load. severity of
hepati ti s or intra hep ati c IFNy indu cti on.
The level of the class I heavy cha in exp ression o n HPM was not related to
the am ount of INH.V prese nt in the liver. The average hepa tic content of INHV
DNA was 6 .1 x 10' ': SEM 1.2 x 10- vge/lJ9 live r DN A in acutely infected an ima ls
and 8 .2 x 10' ,: SEM 4.5 x 10' ....geJlJg in animals with CH . Also. the hepatic
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expression of WHY specific mRNA. ceterrr anecby Northern hyblidization and
densitometric an alysis. we re not mea ningfully different between woodchucks with
AH and C H. as illus trated in Fig. 4-7. In animal s which recov ered from A H 0NF
2131 and WF 2160 ). traces of WHV ge nome were identifi able in live rs by nested
p eR followed by Southern hybndization of the amp lified produ cts (sensit iv ity <
10' WHV vge/ml ). This result coll abor ates our previous find ings which
demonstrated that traces of repl icatin g IJVHV persists in th e live r fo r life afte r
res ohrncn of AH (Mich alak et af.. 1999 ). In these se rolog ica lly silently mtect ec
anima ls . hepatocyt e membrane expres sion of d ass I antig en was not apprecia bly
different from th at in healthy wood chucks . CollectIVely . these data showed th at
compa rab le hepatic loads of WHV wer e acco mpa nied by stnklngly dist inct
hepatocyte surface display of MHC clas s I molecules that dep end ed on whether
HPM Orlgmated from acutely or chro nica lly infected anim als .
As illust rated in Fig. 4·3 and Tab le 4-2. there wa s also no correlation
between the be cetocvt e surface pres en tation of class I morecu'es and
hIStolog ica l seventy of liver disease . A lbe rt. HPM from anima ls with the most
severe AH (V'VM 2121 and V'V'.JI 217 1) tended to display grea ter amou nts of d ass
I hea vy Chain than HPM from woodChucks w ith m ild or moderate AH (VVM 2070
and WM 2167) . HPM from an imals wit h chronic infecti on. wh ich had
hist olog icall y very mild CWF2114). mo derate (WF 20 30 an d WM 204 0) or severe
(WF 2020 , WF 2112 and WM 2150 ) hepa tit is , sho wed comparably low
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Table 4-3. Relative expression of ce ll surfac e MHC class I he avy cha in an d its
RNA in woo dch ucks with acute and chro nic he patit is .
MH C heavy chain MHC heavv-cnam
exp ression " in mRN A level b in:
Category
HPM SPM KPM Liver Sp leen
He a lthy and convalescent 100 100 ' 00 100 ' 00
an imals (n = 4 )
An imals with AH (n =4) 350 100 95 33 0 120
Ammats with CH (n ". 6) 110 <5 100 350 95
a: The dot blots of the ind icated plasma membrane prepa rat ions were prob ed
wit h 8 1b.B9 MAb for class I he avy-chain expression and the re sulting signa ls
were quantified by ehemi-image densitom etry . The ave rage integrated dens ity
values were calcula ted for each animal group and mem bra ne type and are
presented as percentages of the avera ge amounted detected in HPM. SP M or
KPM denved from healthy and convalescent woodchucks . which were take n as
100%
b: The MHC class I heavy cha in mR NA levels were norm alized to !3-actin RNA
signa ls in each tissue and are presented as percentages of the average amounts
dete cted in live rs or spleens of healthy and conv alescent animals . which were
taken as 100%.
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leve ls of surf ace crass I heavy chain . The intrahepatic CD3 RNA . an ind ica tor of
T lym phocyte infiltration. w as ba rely detectable in he alt hy animals but elevat ed to
the same level in woodchucks with AH and CH (see Fig , 4.7). Sim ilarly . the
Ieveis of liver IFN y RNA were comparab le in bo th acutely and ch ron ically infect ed
wood chucks. but were on aver age app rox 4 .5-fold greater than th at in hea lthy
ar nmars (F ig _4-4 ). Overall , the se data suggest that the status of the MHC clas s I
display on hepatocyte surf ace in active ly progre ssing hepatit is was not related to
histolog ica l severity of hepa tocellular injury . degree of lymphocyt ic infi ltra tions or
intra hepatic IFNy activ ity . but was clear ly connected with chro nicity of VVHV
infect ion
4.3.3 Chro nic bu t not acute WHV infec tio n is assoc iat ed wjth decreased
MH C cla ss I e_press ion o n tym p hoi d ce ll s
Beca use WHV rep lica tes In both hepatocytes an d lym pho id cells , It was of
interest to establ ish whe the r the class I antigen disp lay differs in the lymphatiC
nssoe In AH and CH. Immunohistochemical staining of spleen se ctio ns from
hea lthy and WHV-in feeted anima ls show ed the sam e Intens ity of the MHC class I
expr ess ion on the ce lls lin ing splenic sinus es and blood vessels . The sta ining of
the pe nartencra r lymphoi d sheaths . which ar e enri ched in lymphoid cells . also
was simila r in healthy (Fig . 4·5A). reco ve red (data not shown) an d acutely
Infect ed wood chuck s (Fig . 4-5B ). However. lymph oid cells in the same
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Figure 4·3 . Express ion of the MHC c las s I heavy chain on HPM in an im als
w ith acute and ch ro nic hepa ti ti s . healthy woodchuck s , and an animal
convalescent from sel f-li mi ti ng acute in fecti o n . Purified he patocyte outer
mem bran es were sepa rated at 20 1.19 proteinll ane on 5 0S-PAG E (12%
polyacrylamide gel ). eiect rctrensterree onto NC and probed by Wes tern blotti ng
with B 1bB9 mAb against woodchuck MH C class I heavy chain , The pc erncns of
the class I 43- and 39-kOa heavy-c hain polypep tides and the pres tained protein
standard s (lane 1) are Indi ca ted on the rig ht and left s ide. respectlve ly . The
relative density values of the ident ified neaw-cnam prote in bands (scale from 0
to 4 ) were ass19ned ba sed on integrated chemi-image sca nning values. The
neavv -cr.am displa y is augme nted in HPM from anima ls wrth AH . whereas HPM
from woodchucks with CH , as well as tho se from healt hy or reco vered animals .
have comparably low contents.
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Figure 4-4 . Expression of IFNy mRNA in l ivers of woodchucks with acute
or ch ron ic he pati ti s . Total liver RNA was rev erse transcribed to eDNA and
amplified WIth wood chuck 1FNV and jl.act in spe cific prim ers . as descnbed in
Mateners and Method s. The amplified p e R prod ucts we re detected by Southem
blot hyb rid izati on . The signa ls showed that the hepatic leve ls of IFNy induct ion
are com parable In an ima ls with AH a nd CH
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Figure 4 -5. Splenic d istributi on of MHC class I in hea lthy and WHV -infeete d
woodch ucks. Sect ions from spleens of a healthy an imal (V\'M 2075 ) (AI and
from a woodchuck WIth AH ('NM 2167) (B) incubated with a lb.B9 MAtIand
FlT e -labe led anti-mouse IgG show immunofluorescent stain ing of tymphocyt es
as well as endothelium lining intratomcutar capill aries (arrow hea ds) and the
ce ntr al arterio le (arrow ). The same sta ining of a splee n section from a
chronically Vv'HV-in fect ed woodchuc k (WM 2150) (C) demonstrates MHC class I
exp ression on endothelium of blood capilla ries (arrow heads ) but not on lymp hoid
ce lls , Magn ifica tion . x 400.
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periarteriol ar regions in animals with CH showed recogni zably less intense and
sometime s almo st absent staining for the class I heavy chain . des pite the
endoth elial cells remamec positive (Fig . 4·5 C) .
West ern blott ing of SPM isolated either from VIJHV-infect ed , recovered or
heahhy wocd chucxs showed both 43- and 39-kOa he avy chain polypeptide
bands. The same protein bands . or only in some cas es the 43-kDa species,
were exhi bited at lower dens ities in SPM from animals with CH (data not sho wn ).
Dete rmination of the class I heavy cha in disp lay by immunodot blott ing and
subsequent den sitometric analysis revealed closely comparable levels of class I
heavy chain in SPM from healthy , convalesce nt and acutely infected anima ls ,
Similar to the results from Western blot analysis (Table 4-3). In contras t, the
MHC class I heavy chain con tent was evidently red uced in SPM from
woodchucks With CH, Ov erall. SPM from chronica lly infect ed animals displ ayed
mo re than a 2D-fold lower level of MHC class I than SPM from woodchucks with
AH or healthy controls (Table 4-3). Interestingly, identical results were obtained
when the whole splee n ncmcqeoatee. inste ad of SPM . wer e probed with B l b .B9
mAb . as illustrated in Fig . 4-6. This finding suggested that MHC class I
expression in chrome infection is not confined to the lymp ho id cell surface . as
seems to be the case In VVHV infected hepatocyt es. but has rather a cenceuure r
character . In co ntrast to splenic tissue. immunod ot -blots of KPM preparations
(Table 4-3). as well as whol e kidney homogen ates from the same animals (data
not shown) did not show any variation in the MHC class I heavy chain conten t.
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Figure 4-6. Expression of MHC class I heavy cha in in spleens of
woodchucks with acute or chroni c hepatitis and from control an imals.
Serial two-fo ld dilut ions of wh ole spleen hom ogenates prepared from
woodch uck s with AH or CH, healthy animals . and a woodchuck conv alescent
from self-ljrmt ed AH (SLAH) we re immo bili ze d onto NC at the ind ica ted prote in
concentrations and probed With woodchuck class I beavy-cnam-scecftc B1b.B9
MAb _ The heavy chain expression is faint in sp lenic tiss ue from an ima ls with CH .
but IS intense and not altered in anima ls WIth A H and in conv alescent or healthy
animals .
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The WHV genome levels in the spleens of aruma's with AH and CH were
com parable with an ave rage VIral DNA cont ent of 8 4 x 1 0~ Z SEM 3.4 x 10~
vge/jJg of splenic DNA for animals with AH and 1.9 x 10E ! SEM 1.1 x 106 vge/ jJ9
for w ood chucks with CH. wh ile WHV mRNA w as not dete ctab le by North ern
blott ing , Renal t iss ue was WHV DNA and mRNA neg ativ e by the same assay s
In the amrnals exam ined . In separate expen ments . den sity of the MHC class I
heavy cham disp lay on Intac t. freshly iso lated PBM C versus punfied P8MC
surface membranes was c eteemn ed Analys is of comparable numbers of PBM C
by flow cy10metry and the same amounts of PBM C membrane pro tein s by
«nmuococt blotting WIth B 1b 89 mAb failed to demonstrate any ccoseten t
difference between hea lthy animals and those wIth AH or CH (data not shown )
PB MC membranes probe d for class I hea vy chain by We stern blottmg displayed
the 43-kDa protem only (data not shown)
4.3 .4 Both acute and ch ro nic WHV infection upregulates MHC clas s I-l inked
gene tra nsc ri pti on in hepa ti c but not in sp lenic ti ss ue
To de te rmine whe the r the de tected vaneton in the cell surface
crese ntanon of MHC class I molecu les between AH and CH reflects a diffe rence
in transcncnonar act ivity of the relev ant gene loc i. RNA from livers and sp leens of
the animals investigate d were probed for MH C class I heavy an d ligh t ch ains.
and TAP1 and TA P2 transcripts , In additio n. to learn ab out possible differences
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In the T lym phocyt e con tents. RNA preparations from livers and splee ns of
an ima ls be long ing to Stud y Group 2 were ana lyzed for expressio n of CD3 gene
rranscn ots. Northern blot hybridization of hepatic RNA showed mar1<edly
elev ated leve ls of hea vy Chain mRN A in bo th acute ly and chronically infected
wood chucks whe n com par ed to hea lthy or convalesce nt an ima ls (Fig. 4.7). as
well as increased ex press ion of t'32-microglobul in. TAP1 and TAP2 mRNA (Fig
4--68). Phospho-im age q uantitation of the hybridization sign als . co rrected to ~
actin gene expression , revealed a greater than 3· fo ld en hanc ed intra hepa tic
transcription of the class I hea vy chain gene in wood chucks with AH and a sim ilar
Increase in animals With C H. when comp ared to normal or recove red
woo dchu cks (Table 4·3 ). In ge neral. the hepatic MHC cla ss l-affili ated genes
wer e upregulated 10 the same exte nt In AH and CH . ind icat ing this augmentation
was not related 10the duration of WHV infection. Al so . the intrahe patic levels of
the CD3 RNA we re tne same in anima ls w ith acute and Chronic liver disease.
rev ealing th at th e mag nit ude of lymph ocyt IC infiltr ations was com parable in these
two phases of VIHV-induce d necrc mnernmaocn In the an ima ls stud ied (Fig . 4-
78) . As pre viously prese nted (Fig , 4-4). the extent of induction of IFNy was the
same In livers from acutely and chro nically infected woodchuc ks . Taken
together. thes e resu lts imply tha t the defect in prese ntation of these mol ecu les in
chronic rnfection was certain ty relat ed to pos ttra nscript iona l suppression .
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Figure 4·7 . Eff ect of acut e and chronic WHV infec tion on hepa ti c
ex pres sion of MHC c lass I affi liOlted genes . Total hepatic RNA was iso lated
from woodchucks with diffe rent histo log ica l se verity of AH or C H. an anim al
convalescent from AH (StAHl and he althy woodchucks in study group 1 (A) or 2
(8) (for de ta ils see Tab le 4· 1)_ The RNA wa s probed by Northe m blott ing with
[:UPHabe led woodchuck MH C class I hea vy ch ain (M HC I h.c.). 132-m lcrog lobulin
(l3:m ). TAP 1, TA? 2, CD 3 eDNA. complete recombina nt WH V DNA or clon ed
w ood chuck GA DPH eDNA and/or hum an l3·actin eDNA as hou sekeepi ng gene s.
Frog live r RNA (Al and human RNA (Hu RNA) (8 ) were used as species spec ific
references . The whi te astenk in panel B dep ict s a signal tha t required inc reased
exposu re . The expr ess ion of MHC class I heavy and light chain s . TAP 1, TAP2
and C0 3 RNA is aug mented to th e same exte nt in livers of both acut ely and
chr onica lly infected a nima ls .
:!E ;;::
::c ::c
""
< o
'"
;0 -
a z :::T5 · » P
Frog Liver RNA
WF 2078 (healthy)
WF 2131 (SLAH)
WM2070 (AH)
WM 2167 (AH)
WM2121 (AH)
WM 2171 (CH)
WF2114(CH)
WF2030 (CH)
WF2112 (CH)
»
WM 3069 (healthy)
WF 3299 (healthy)
WF 3392 (AH)
WF 3838 (AH)
WM 3158 (AH)
WF 3349 (CH)
WF 4980 (CH)
WF 4751 (CH)
WF 4832 (CH)
:T
f>
s::
I
o
~
::iE
o I
"'"
}> < ~ ~
'"
"U ::0 0n- O z 0 "U "U5 · I }>
'"
N ~
, ,
,
Hu RNA
OJ
152
c
o
.~ 200
~
~
'"~ 100
..
0:
Figure 4-8. Relative expression of MHC c lass I heavy c hain and related
gene mRNA in spl eni c ti ssue from woodchucks with acute or chro nic WHV
hepati tis . Total RNA isolated from spleens of animals with AH (n = 3) and CH (n
= 4), and from healthy animals (n =2) (study group 2) were probed with [32pJ_
labeled woodchuck class I heavy chain , ~2-microg lobulin <P2rn), TAP1 , TAP2 ,
CD3 or ~actin by Northern blotti ng, whereas IFNy was assessed by RT-PCR
and Southern blotting as described in Materials and Methods. Hybridization
signals were quantitated by phcsphoimaqe densitometry, norma lized to the f)-
actin. and presented as a percentage of the average amount detected in spleens
of healthy woodchucks, which were taken as 100%.
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Splen ic tissue showed compa rable levels of the class I heavy chain , TAP1
and TAP2 RNA, as we ll as CD3 RNA , both in acutely or chron ica lly infe cted
woodchucks and in the healthy or recove red animals (Fig . 4·8). The ex ception
was (32-microgfobulin RNA that was moderately elevated in WHV-infected in
compa rison to health y animals . In add ition. the splen ic leve l of lFNy RNA wa s
identical in acute and chronic infection but at least twice of that detected in
healthy controls (Fig . 4-8). Overall. the findings showed that. in contrast to the
diseased livers , neither AH or CH infection meaningfully upregulates MHC class I
linked mR NA in splenic tissue. These data imply that the de fective expression of
MHC class I molecules in splen ic lymphocytes in chroni c WHY infect ion does not
result from inhibited trans cription of the relevant cellular genes and . therefore .
has to occur on the posttranscnptionallevel
4 .4 DISCUSSION
Analysis of hepatocyte surface membranes in this study revealed a
significan t difference in hepatocyte presentation of MHC class I molecules in
acute and chronic phases of hepadnavirat hepatitis . VJhile acute V"v'rIV infect ion
is accompanied by increased hepa tocyte surface disp lay of MHC class I. chron ic
disease. independent of seve rity of live r injury and du rat ion of chronicity, is
uniformly associated with a dec rease in the protein level similar to that seen in
healthy anima ls and those convalescent from AH . This defective class I antigen
display in CH occurs despite of the en hanced tra nsc ription of relevant MHC
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class I-affiliated becanc genes . equal to that ocservec in the livers of acute ly
infect ed ho sts. Considenng the abo ve findings . our study demonstrates that
he patocyte presentation of the MH C class I molecu les is evide ntly enhan ced in
acut e d ise ase . bUl dram atical ly suppressed at the pcstrranscnono eatjevet in
chronic stag e of WHV hep atit is. Importantly . this impairment in ch rome infection
also aff ects splen ic lymphoid cell s. another site of virus prop ag ation. Howe ver. in
contrast to the dise ased live rs. transc ript ion of the MHC class I linked genes is
not al te red in the infected splen ic t issue when compared to hea lthy anima ls
Also . th e sp le nic displ ay of the MH C class J mo lecule s is es sentially ident ical in
AH as in the hea lthy or convalescent wood chu cks . In addition . ne ith er acute nor
cruc nrc WH V infec tion affe cts the MH C class I antigen express ion in kidn eys .
whic h were found to be \NHV neg ative . Collect ively . the presen t fi ndings show
than ') the uver-resmctec . augmented tran scnption of the MH C class I affi liated
gen es IS an mvanece ch aracteri st ic of any active liver inflammation induced by
Vl/HV; (2) the severely impaired prese manon of MH C class I molecules IS a
umqu e featu re of ch roni c VIHV infection ; (3) the dec reased ce llul ar presen tat ion
of MHC c rass t In chro nic disease appea rs to be restricted to tiss ues in wtucn
Vl/HV replicates: and (4 ) the cencent hepatocellu lar and lym pho id ce ll disp lay of
MHC class I in CH IS a conseq ue nce of vnus-cepence nt posttranscnononet
Inh ibit ion , Overall. the data from our study reveal a multifari ou s interplay
between ph ases of bececnavirar hep atit is. the sta tu s of MH C class I affili ated
gene transcript ion in viru s infected organs. and the expressi on of the MH C class I
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molecules on cells of these organs.
The MH C class [ antige n processing and presentation pathway involves
formatio n of the tnmenc comp lexes const ituted by class I heavy chain , l32-
microglob ulin and a prote olyt ically generated peptide (Hi ll and Ploegh, 1995 )
The assembly of the stab le MHC class I mol ecu les requ ires tra nslocation of
cvtoscucenv produced peptides into the lu me n of endoplasmic ret iculum . Th is
proce ss is facilitated by transmembrane transporter proteins. referred to as TAP1
and TA P2 . which de live r peptides into the endoplasmic ret iculu m to bind to
empty class I hea vy -light chain heterodimers (Spies et et.. 1990). The created
tnmenc co mplexes are transp orted to the ce ll su rface for interaction with spec ific
CTL. The cu rrent model also includes au xil iary molecules . such as proteasomes.
In the ge neration of oecnoes for load ing on to class I mole cu les and emphasizes
a role for lFNy In the modulation of pep tide processing and in upregulation of
gen es Invo lved in the ant igen MHC class I prese nta tion pathway (reviewed by
Fruh and Yang. 1999 and Van Endert. 1999 ),
As unco vered in this stud y. progressive acute an d chronic WHV hepatitis
is accompanied by increased gene exp ress io n of hepatic class I heavy ch ain .
light cham and TAP ge ne expression. as well as by the inc reased levels of
hepatic T cell (CD3) and IFNy RNA Since Iy mphomononuclear cell infiltrations
are an Invariable feature of active liver inflammation in beoacnew ar infect ion and
acti vated T lymphocytes and NK cells , secreting infl ammato ry cytok ines includ ing
IFNy (Guidott i et et. 1996 : Scharton and Scott 1993 ), are constituents of these
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infiltrates , induction of intrahepatic IFN y coul d be main ly responsible for
act ivat ion of MHC class I affiliated genes in VVHV hepatitis. Th is is supported by
the fact that regulation of MHC class I genes by IFNy occurs primarily at the level
of gene transcription (Wallach et et.. 1982) , In addition to the indi rect
augmentation through IFNy , direct upregulation of the MHC class I genes by viral
prote ins m ight also be poss ible . It has been shown in vitro that the HBV X
prote in can transacnvete the MHC class I heavy chain promo ter in the virus-
trensfecteo HepG2 and related liver ce ll lines. leading to a 3 to 4-fo ld increase in
the heavy chain RNA and protein levels (Z hou et st.. 1990 ). Since this event has
bee n observed in the absence of T cells and indepe ndently of IFNy. this may
suggest that the HBV X prote in can directly modulate MHC class I gene acti vity in
cult ured liver cells . It has also bee n postulated that HBV X. by interfering with
proteasorne func tions. may prevent vi ral peptide interaction and presentation by
clas s I mo lecu les (Huang er et. 1996 ). Deterrmrnnqwhether these hypothetical
mechanisms operate in in vivo infected hepatocytes require s further studies .
In contrast to the livers . act ivity of MHC class [ genes was not alter ed in
the spleens of WHV-infected animals . except for (32-mic roglo buhn RNA. The
divergent effec t of WHV Infectio n on the M HC class I gen e transcriptio n in the
liver and the spleen could be due to an innate difference in the levels of the gene
expression between these two org ans . Quan titative a nalysis pe rformed in this
study showed that class I heavy ch ain mRNA is prese nt at 3 to 4-fold grea ter
levels In the splen ic than in hepatic t issue of he althy woodchucks. It is possible
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that whi le viral infectio n is capable of upregul ating d ass I gen es in hepatocytes.
where their transcriptional activities are naturally low, it ISnot able to exert this
add itive effect in lymphatic organs . like the spleen . where the gene expression is
inherently high . Therefore. VVHV infection may aet as a con dit ional
transcript ional inducer whose indirect or direct mod ulatory effect depend s on the
microenviron men t regulating local acti vity of MH C class I gene s. On the oth er
hand . although perhaps less likely, the lack of class I gene upregulation in the
infected spleens might be a co nsequence of 10 to 100·time s lower VJHV DNA
and RNA conte nt than that observed in the liver s of these animal s. Co nceivab ly ,
virus replica ting less efficie ntly or occurring at low Quantit ies in infected celts
might be unable to induce an identifi able increa se in transcription of the MHC
class I linked genes . This seuancn seems to be true for livers of wood chucks
convalescent from AH. whic h support persisten t INHV replicat ion at low leve ls
(Michalak et a/.. 1999 ). but wh ich do not show any ncnce aole change in class I
heavy chain RNA or prote in e xpress ion. In addit ion . the splenic C03 influx and
IFNV RNA levels we re iden tica l in acute ly and chronical ly infected anima ls .
Therefore . a diminished T cell number or a dec rease in the local activtty of IFNy
can not acco unt for the obs erv ed class I antigen inhib ition in splenocyt es in
chronic VVHVinfection .
The equally augmented expression of ttece uc MH C class j·affi liated gene s
in AH and CH should imply enh anced synthesis of class I heterodimers and the
availability of processed vira l pep tides for thei r load ing . Consequently. this
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sho uld lead to the increased pres entation of class I comp lexes on liver cells
irrespec tiv e of the ph ase of hepatit is. Howe ver , this situ ation exists only in acute
infection. whe re the HPM class I heavy cha in expression was eviden tly highe r
th an that detected on HPM from hea lthy or convale scent animals and appeared
to be prop o rtiona l to the elevated tra nscription from the respective ce llular genes.
In contrast. the reduced he patocyt e display of class I hea vy cha in in Chronic
infect ion was accompan ied by an increased level of RNA compared to that
observed in AH (Table 4 -3). In splee ns of ch ronically infect ed animals, unaltered
expression of the MHC class I affi liated genes was associ ated with a dr amatic
(more than 2G-foldj red uction In class I he avy cn e.n pres enta tion w hen assessed
by immunoblott ing . In ge ner al. the results on these c uantnanve anal yses of class
I disp lay In Isola ted hepat ocyte and splen ocyte oute r plasma memb ranes agr eed
w ith the immuno fluo resc en t stai ning of tissue sections. In summary . the
obtai ned data clearly document th at the d ispa rity betwe en class I·affi liated ge ne
activity and class I antigen display in chron ic infection is not related to
down reg ulation of gene transcnptio n and . therefore. it has to be due to a virus-
depe nde nt posttranscnption al interference that is unique for ce lts support ing
persistent WHV replica tio n. However. they do not ex clu de that the inhibited
presentation of class I molecule s ca n be a conseq uence of their imp aired
traffick ing to the cell surfac e or enhanced recycling (Se ction 1.7 .6). The
obse rved lack of heavy cha in accumulation in the cyto plasm of the chr onically
infected hepalocytes by immunohistochemical stai ning has to be interpreted with
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caut ion considenng the relative ly low sensitivity of th is method
Many veu ses inhibit the class I surtace molecules on invaded cells to
avoid cytopath ic or noncytc cemic elimina tion imtiated by specif.c CTL (reviewed
by FrLih et et.. 1999 : Miller and Sedmak . 1999 : 0 1dstone . 1997 ; Rinaldo. 1994 ).
It IS known that VIral c rotems may induce posttra nscnptiona l inhibition of class I
antige n by mterte nnq w ith generation or transpo rt of pept ides predestined for
Interact ion WIth class r he terodimers in endoplasm ic reticulum. The y may also
disrupt the class 1com ple x assemb ly, trafficking and cell surface prese ntation or
Incr ease tnerr degradatio n (rev iewed by Mi ller and Sedmak, 1999). Freq ue nt ly .
the same 'N US uses a venery o f strategies med iated by mor e than one viral
factor , In the conte xt ofVVI-IV abi lity to suppress MHC class I an tige n display m
diffe ren t cell types . It IS conce watne that the virus may also util ize murtitactonat
mecnamsms actmg on the diffe rent pc srtranscn pnc natievers of the MHC Class I
cresentanon pathway
The data collected so far reveal that the deficient expr ession of ciass I
molecules on hepatocytes comcees with another un ique feature of hepatocyte
surf ace that is metmcnve of chronic \llJHV hepa trtis (Michalak and Churchill . 1988.
Michal ak and Lin. 1994 . Michalak et al .. 1989 ). We have previous ly shown that
HPM from cnrcrncanvInfect ed woodc hucks. Independent of histo log ica l seventy
of hepat itis and dur ation of Chronic ity. contain large quantities of INHV envelope
proteins irrevers ibly incorporated into the membrane lipid bilayer (Michalak and
Churchill . 1988: Michalak et al .. 1989). Ass ess ments of the IIIJHs antigen ic
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content and the bind ing of exogenous WHsAg to HPM fro m d iffer ent form s of
VVHV· induced fiver pathology revealed that HPM from CH have the greatest
amou nts of the integ rated antig en a nd they are char acteriz ed by th e inability to
bind exog enous WHsAg (MIchalak et et.: 1989 ), indica tin g the presence of a
sat urated qu antity of the virus env elope . We have hy pot hesiZed th at this exp licit
fe ature of hepat ocyte su rtace membrane in ch ronic disea se. which natura lly
coexists wi th the abun dant amounts of the same viral proteins in the circulation .
may constitute an im pon ant element of protection of infected hepatocyt es
against rmrnuncelirrun atic n and . therefore . contributes to pro longed liver disease
and virus persi stence (Mic halak and Churchill . 1988 : Michal ak and Lin , 1994 :
review ed by Michalak . 1998 ). Since the same HPM preparations we re anal yzed
to determine exa res sson of MH C class I in this study (Study Group 1) and V'VHV
enve lope po lypep tides in ou r prevsous wo rk (M ichala k and Lin . 1994 ). we can
concl USIVely state that suppression of class I molecule s on necatocvtes occurs
only In the cont ext of the massrve incorpo ration of Vl/HV enve lope prote ins into
HPM . This aSSOCIatIOn. coex lsung with he avy depos its of vuat env ecce maten el
In the encc ptas rmc rencuicrn wh ich are typical for beca tccvtes in chr on ically
Infected livers (MiChalak and Lin. 1994 . Micha lak et et.. 1989) . may exert a
severe cons tra int on intrace llular assembly and transport. as wel l as on
present atio n of clas s I molecules at hepatocyte su rface . This mech anism
provides a reasonab le explanation for the deficiency in class I antigen display on
chrcrucenv infected he cetocvtes. howeve r. it is rather unlikely th at it also
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oper ates in lympho id cell s wh ich . at the bes t. express WHsAg at minute
c uan nnes . Therefore . we speculate that d ass I expression in the lymphatic
system is dow nrequtated by VVHV throug h an alte ma tive pathwa y .
Ind ependent of the mechanism involved , defective expression of MH C
class I co mplexes on hepatccvt es in chro nica lly infected ho sts has to hav e
sigOlfica nt immunopathogenic consequences . As in other viral infection s. the
foremost cou ld be evas ion of immune surve illan ce by virue -epecrtc CTL leading
to suppressio n of cytolytic and non-cyto lytic eliminat ion of virus. This alone can
contnbute to perpetua tion of liver disease and facilita te s virus per sisten ce
Howe ver. there could als o be other implications potentially import ant fo r WHV
pathogenesIs du nng chr onic infection. Since vira lly infected ce lls with red uced
class I antigen exp ression are considered to be inhe ren tly susceptible to attack
from NK ce lls (Brutk lewlCZand Welsh. 199 5: l ju ng gren et et.. 1990). this may
Imply that non-MHC class l-dependent. ceU-mediated cyt otoxicity might play a
role In both contro lling VIru S spread and induction of he patocellular injury in
chr onic nepaone virer in fect ion. W e have recently te sted this intng uing poss ibility
by eva luating perf onn and Fasl·based cytotoxicity of ci rcu lating lymphoid ce lls
from woodchu cks with acute and ch ronic VVHV hepatit is (Hodgson et aI., 1999 :
Section 3). The data from this stu dy showed that the levels of the perfonn-
depend ent kill ing . which is the princi ple mechanism of ce ll e limination by NK cell s
(Kagi er a/.. 1994 : Sayers et af ., 1998 ). are signifi cantly enha nced in AH but
essenti ally the same In chronica lly infected and hea thy animals . Altho ugh
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intrahepatic NK cells were not exam ined in th is study . the abov e finding s sugge st
that NK cell acnvrty could be inhib ited during the Chronic phas e of \NHV he patit is.
desp ite suppr essed hep atocyte MH C d ass I surface expre ssion . In th is co ntext .
of note are th e pas t observations pos tu lating that HBsAg dep res ses NK ce ll
cytotoxicity. presu mab ly bV interferi ng w ith their bind ing to ta rget ce lls (Azz an et
a11992 : De Mart ino et al. 198 5). lf ttus is the cas e . it is conce ivab le that the
large quantities of becac nevnus envelope prote ins inserted into hepatocyte oute r
membrane. coexis ting WIth the la rge amount s of the same antigenic material in
se rum . ma y act as a negati ve modu lator on intrahepatic NK cells in chronic
Infectio n. This mechan ism. tog ethe r With inhibit ion of hepatocyt e surfa ce MH C
class I present ation , mIght constitute a strateg y that the virus emp loys to escap e
elimin ation by bot h CTL and NK ceus
At least on e more Issue req uire s com ment in reg ard to the find ings of the
present study , Identifica tion of severe ly reduced expre ssion of d ass I mo lecule s
In spleruc lymphOIdcell s IS like ly reflecting a sit uation eXisti ng In other lym phatic
organs ," chronic VVHV Infect ion: although , we d id not see rts evidence In
Circulating tymphotd cells , It is known th at class I mo lecules are invo lved in the
el abo rate netw ork of interact ions be tw een ce lls of the immun e system and they
play key roles in regulat ing imm une cell functio ns . Am ong them . it has bee n
show n that interrupti on of the MH C class I presentation on lympho id ce lls is
sufficient to indu ce auto imm une reactions (Fu et et.. 199 3) , which are a very
common consequence of WH V infectio n (Diao and Micha lak , 1997; Diao et at ,
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1998: Dzw onkowski and Micha lak. 1990 ). Therefore, downregulation of MHC
class I presentation on lymphoid cells by nepad navirus infection could deregulate
a variety of host immune react ions whose effects . althou gh not directly apparent,
may profoundly dimin ish ove rall effect iveness of anti-vira l immu ne responses
This important issue awa its futu re studies . The defect in MHC class I
prese ntation on both hepatocyte and lymphoid cells identifie d in this study once
again exem plifies the complexity of the strateg ies utilized by hepadnavi rus to
survive Within the host. Unraveling this defect and its funct ional consequences
w ill be necessary to fUlly understand the mechanisms underly ing perpetuation of
liver disease and virus persistence in hepad navir al infections.
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CHAPTER 5:
AU GMENTED HEPATIC INTERFERON GAMMA EXPRESSION AND T CEL L
INFLUX CH ARA CTERlZE ACUTE HEPATITIS PROGRESSING TO
RECOVERY AND RESIDUAL LIFELONG VIRUS PERSISTENCE IN
EXPERIMENTAL AOUL T WOODCHUCK HEPATITIS VIRUS INFECTION-
"Th,S study was pue~sl'led In HepatolOgy 2001 rver 34 pp 1049- 1059) My SPeCIficcontnbuoons
to n usstlldy ccmsnses all ollhe m()lec:ular tnolOgy data. ,nCludlng ClOnong01woodC huc k genes
NottI\em DI01 nyondlZaoo n and quanblat",e peR ana lyses .and eval uatIOn of I/III-fV DN A by dOl Dlot
l'lybnCliZallon
5.0 SUMMA RY
Woodchucks mtectee WIth 'rNHV demonstra te profi les of liver disease and
age dep endent rate s of progr ession to CH co mpar able to thos e seen In human
hece uns B The mech anism of reco very from acu te bec eco avu er infection or rts
evolution to cnrcrnctv rema ins unkno wn . although the loca l Immune ce ll and
cvto kme respon ses In the hver are expected to play an important role To
determin e the dynam ics of Intrahepatic cvtoone express ion and T cell
Involvement. and to asse ss their value In predictlOg the outcome of AH In the
adult ons et of nec ecn ewus otecncn . we eval uated levels of liver u anscncton of
IFNy . TNFa and IL·2 . -4 and -0. and the T cell Influx in relation to histolog ica l
seventy of disease and virus load In seri al liver biopsies coll ected during the
lifespan of woodc hucks With exper imental acute WH V infection wh o eithe r
ceased to have hepatit is or developed chrome live r disease. Our result s show
that recovery from acute viral hepatitis in adu lt animals is preced ed by a
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significantly greater neceuc expression of IFNy and C03 . an increased level of
TNFo tr anscription, a lOwer hepatic \IVHVload and by a g reat er degree of liver
Inflamma tion than in acute infect ion with CH outcome . Furthe rmore , we have
learn ed that the elevated aver IFNy . TNFa and C03 expr es sion end ures for
years no t only in the anima ls with evident CH but also . although to a lesse r
ext ent. in those which resolved acute infect ion. This is consistent with our
previous find ings tha I res idu al \!VHV replication and remn ant liver inflammation
contin ue fo r life after reco very from AH in adult wo odc hucks . The current study
Indicates that ant ivira l cvtc km es. in part icular IFN y , may playa central role in the
long term control of occu lt necee newus persistence In the liver.
5.1 INTRODUCTION
Ha v Infection In adu lthood is us ually followed by self limit ing AH that is
traced by serolog ica lly concealed pe rsistence of small amounts of viru s in the
reco vered hosts (MICha lak et et., 1994 _Penna et al .. 1996 : Reherma nn et al ..
1996: Yotsuyanagl et a l.. 1998 ). In 5· 10% of adu lt pa tients . the infect io n
ad vances to lifet ime CH which is a freque nt precursor to cirrh osis an d HCC This
is In contrast 10 HBV 'nfecnc n in newborns of wh om the vast majority (>90%)
become serolog icall y posrnve . r.e.. HBsAg-reactive . chron ic virus ca rriers . Since
HBV infect ion of hepatocytes is es sentially ncn cyt cp et tuc in the
Immunocompe tent host. ce ll imm une respo nses directed toward infected liver
cells are cons idered to be a ma in inducer of hepa tic injury and a med iator of virus
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clear ance (Chisari and Ferrari , 1995 ; Curry and Koziel , 2000). Recent evidence
sugg ests that. in add ition to virus -specific CD8+ CTl and coll abora ting C D4+ Th
cells, non-specific cell immune responses . invo",ing NK. NKT cells and
macrophages. might be impo rtant in HBV elim inat ion and pathogenesis of liver
damage (Guidotti and Chisari , 1996: Kakjrm er et.. 2000). It is also apparent that
antiv iral cyto kine s released by the act ivated effector cell s of innate and adopt ive
imm une systems in the reg ion of their targets . suc h as IFNy , lFNa and TNFa .
can temporarily ind uce non --cytolyt ic supp ression of HBV express ion in the liver
(Sect ion 1.8.4 ' GUIdotti and Chisari, 1996 : Guidotti et af., 1996 ; Guidotti et a/..
1999) .
The mech anisms underl Ying resolution of acute HBV infect ion or rts
progress ion to chro nici ty rema in undetermined. The ava ilable data suggest.
however. that a weak Th 1 ce ll respon se to HBV antigens co inc ides w ith transit ion
to chron icity and the preva lent Th1 cyt okine pattern . con sisting of IFNy . TNFo
and 1l -2 . can be as sociat ed With resolut ion of hep atitis B (Chisari and Ferrari ,
1995 : Penna et al.. 1997 ). From studi es on other vir al infectio ns. it is evident th at
the strength of the rnltial antrvnat respo nse might be criti ca l in determmmg the
final outcome of infect ion. In reg ard to hep ati t is B. only recently has da ta on the
status of intrah epati c immuni ty in the initial (inCubation) pe riod of HBV infection
bec ome available from a chimpanzee mode l (Guido tt i et et.. 1999) and on the
peri pheral blood HBV -speci fic T cell resp on ses from patients exam ined prior to
the onset of sym ptoma tic hepatitis (W ebster et al.. 2000). Nevertheless. there is
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no Info rmation as to wha t extent the range and the strength of intra hepatic
immuOlty pred ispose the host to either reco ver or become ch ron ica lly infect ed . In
gene ral , th is type of investigation is diffteu lt to conduct in human dise ase due to
eth ica l and practical problems . in partic ula r in acquir ing serial live r samp les from
ind ividuals prior to HBV infection and from pati ents in ere-acute phases of
hepatitis who ultimately recover or dev elop chronic live r disease
T he In fect ion of wood chu cks wit h HBV·relaled 'VIIHV has a sim ilar disea se
course and ag e dependent rates of recov ery from AH or prog ression to CH. and
over all compara ble histo pathologi ca l featur es of liver inju ry as those seen in
HBV·mfeeted humans (Seeto n 1.5: Menn e and Tennan t, 1999: Mich alak. 1998).
Similar to hepatit is B mrecucn, acute VVHV nece uns IS a transie nt. self resolvi ng
disease m 85% of adult wood chu cks . white in the remaining animals rt
progresses to lrfelong serolog ically evi dent ( t.e .. VVHsAg-posit ive ) infection and
sustamec live r inflamm ation (Mich alak. 2000) . This is in contr ast w ith 'M-i V
mtecncn Induced during the pe nnata l pe riod where the majonty (-75%) of the
animals develo p CH (Cote et et.. 2000 ). In add ition. a series of rece nt studies
from our labo ratory (Mich alak et at. 1999: Coffi n and Micha lak. 1999; l ew and
Micha lak. 2001 : rev iew ed by MIChalak. 2000 ). have show n that the reco very from
adult onset of W'rlV infection is invariab ly fo llowed by lifelong per sistence of trace
qua ntit ies of infectious viru s that replicates both in the liver and the lymphatic
syste m , This ser ologica lly conce aled mtecno n is frequently , but not always.
acc omp anied by morph olog ical altera tions in the liver consistent with minima l to
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minor resid ual inflammation (Michalak et et.. 1999 ). Moreover . the occu lt v irus is
transm iss ible to offspring in whIch it induce s an occult. life-lo ng wus pe rs istence
(Coffin a nd Michalak . 1999 ) and is infecti ou s to virus naiv e animals (Mich al ak et
e t.. 1999)
In this retrosp ective study , we investigated the WHV-woodchuck mode l to
oeterrrn ne the dynamics of the int rahepatic cytokine res ponse . T cell infusion and
liver injury in adult wood chucks wh o after inoculalion w ith the same \NHV
mtecno u s pool e ither resolved AH or de ve loped CH . We also examined whether
hepa tic expression of cy10klnes. such as IFNy . TNFa. IL-2. Il -4 and IL-6 . in
healthy an ima ls pnor to INHV inocu lation or In the acute phase of 'WHy mtecnc n
ha ve a val ue in pred icti ng the self lim iting or chrome disease out co me of A H. We
assessed the extent of Intrahepatic T cell Influx by exam ining CD3 mRNA and
determined wheth er its gene expression correlates With that of any of the
aforemen tioned cvtccnes. the his tological seventy of liver injury or hepatic \NHV
load . The same para met ers were also analyzed In the livers of an imals WIth
prog resSing CH and dunng the lifelong fOllow·up after reso luti on of expe nmental
AH. Our results show that acut e 'WHV nepetms tcncwec by recovery is
ch aracterized by higher levels of intrahepati c IFNy and CD3 express ion . an
Increased transcncncn of TNFa . a greater seventy of liver inflammati on and
lower live r \NHV load s than those occu rring in the anim als who developed CH
Fu rthennore. ou r results demonstrate that the elev ated tran scrip t ion of IFNy .
TNFa and CD3 endured for yea rs in the live r after te rmin ation of AH in the
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context of continuing remnant replication of 'lNHV. This raises a poss ibility that
an tiviral cyt okine s. in particul ar IFNV. m ay playa pivota l rol e in kee ping pers istent
res idu al ne pec naveus replica tio n in the liver at the levels wh iCh are not
immin ently harmful to the infected host.
5.2 MA TERIALS AND METHODS
5.2.1 An imal s and categories ofWHV infection
Twe nty-tw o wood chucks (8 male s and 14 temete s) we re investigated in
this study . The anima ls were infected as young adul ts (yea rl ings or 2 years of
age ) with the same pool of serum-derived WHV at a dose of 1.1 x 10 '0 DNase ·
protected vge (Michal ak et et.. 199 9). A ll o f the wood chucks developed
serologteally evid ent AH . The disease was self lim iting in 15 of the anima ls and
in the remainin g 7 progr es sed to CH (Table 5-1) . Five of the an ima ls WIth a sen -
lim ited epis ode of AH (2JF. 3JF. 51M. 61M. and 7/F) we re examined in our
prev ious study aun ec at cet ermmeuon of mcecutar cner actenstce and liver
tissu e altera tion s acco mpa nymq lifelong occult VYHV pers is tence co ntinuing after
recov ery from acute infect ion (Mich alak et al .. 1999 ). Se ven of the woodchuck s
which resolved acute infection (2JF. 3IF . 51M. 61M. 71F. 111M. and 121M) and 4
that adva nced to chronic disease (2 1/F. 221M. 23/F. and 24/F) were followed
throughout their natural lifes pan. Two of the abo ve woodchucks wit h tran sien t
AH (3/F and 7/F) an d 3 with CH (21/F, 23/F and 24/F ) had elev ated GG T level s
and subsequently developed hepatocellular ca rcinoma (HCC) . Serum sam ples
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from each anima l were drawn before inoculation w ith I/IIHVand . thereafter.
biweekly up 10 6 months, monthly unt il 36 months pos t inocu lation (p .i.), an d then
bimon th ly . liver tissue fragments w ere obtained by sUfgical laparotomy o r at
auto psy , as desc ribed previously (Michalak: et al " 1999). Typicall y, the first
biopsy was obtained 4 10 6 week s pr ior to inoculation with WH V, the seco nd
biopsy d uring sero logically eviden t acut e infection, an d subs equent sam pl es
were co llect ed at approxi ma tely yearty intervals (Table 5. 1). In tota l, 103 biopsy
or autopsy liver samples were anal yZed in th is study (Table 5-1 ). The me an time
interval of tne« acquisition was 32 weeks .! 22 SE.
The serologi ca l status of WHV infect ion wa s dete rm ined by testing sera
for WHs Ag . anti-WHs and anti·VVHc (Secti on 2 .3). The serum levels of VVHV
DNA were determined by a slot blot hybrid ization ass ay and . wh en negat ive . by
PCR uSing 'NHV core gene specific pri mers followed by Southe rn blot
hybridizalio~ ana lysis of tne amp lifie d produ cts . as de scri bed (Secti on 2.9 .9;
Micha lak.et st.. 1999 ; Co ffin and Micha lak. 1999 ; Micha lak et al.. 2000)
Acco rding to serolog ical parameters . acu te phase of 'WHV infect ion was
diagnosed In animals wh o. afte r lncc utet on WIth virus , became VVHV DNA .
IJIIHsAg and ant l·VVHc posrt rve. but in who \lVHs ant igenemia lasted no longer
than 6 mon th s. Sero logica l resolution of acute infect ion was cons ide red when
WHsAg pe rmane ntly cleared from the circu latio n. W'ri V DNA dropped to lev els
dete ctable only by nested pe Ri Southern blo t hyb rid ization as sa ys , and the
an imal normally. but not always. seroconve rted to det ect able anti·WH s.
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DiagnosIs of serolog ically evc ent chronic infection was made when WHsAg
pe rsiste d In serum for longe r than 6 months
HistologIca l examination of liver tissue was performed after conventional
processing to paraffin (Section 2.5). Morp hOlogi cal assessment, no rmally graded
on a num erica l sca le from ()"3 was refined by addi ng 0.5 gra de sco res to more
acc ura te ly re flect alte ration s which . in some cases. we re intermedia te between
thos e to which the full nume ric grades were assigned (Sect ion 2.5).
Ba sed on combi ned se rOlogical and histo logical eva lua tions of IJVHV
mfecti on at the nrre of liver nssue acqvie mc n. the samples we re classified to one
of the follOWIng categories: (1 ) norma l (healthy) (n =14): (2) from acute pha se of
Infect io n (acute ) (n= 19): (3) aft er resolution of AH (resolved ) (n = 52 ), and (4 )
dUring CH tcnrorncu n =18) (Table 5· ').
5.2 .2 Nu c le ic i1cid pr epi1r i1tion
'rc tet RNA was extracted from 50-' 00 mg of mec hanica lly putvenzed
frozen hepa tic tissue or from ' x 1 0 ~ PBMC (Sect ion 2.6.2). PBMC we re
obtained from a healthy woodc huck and stim ulated with 5 I.Jg/ml ConA (Sigma)
for 72 hours befo re RNA isolation (Jin et a/.. 1996) . These ceus were used as a
source of total RNA for furthe r ident ificatio n and cloning of wood chuck cytc kme
gene specific sequences . After RNA ext raction . DNA was separated from the
non-aqueous phase of TRlz ol by ethanol precipitat ion following Sectio n 2.6 .1.
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The reco vered DNA was used to evaluate VI/HV genome express ion. Nucleic
acids wer e quant itated by spectroscopic ana lysis and sto red in sm all aliq uats at -
80~C (Section 2.6.3).
5.2 .3 Det ection o f WHY DNA and RNA in tissu e
The presenc e of WH V DNA in chronical ly infec ted animals was
de term ined by a slot- blot hyb rid ization as say des cribed in Sect io n 2.9.1. Briefly .
5 ~g of hepa tic DNA obtained from woodchuck biop sy or autopsy tissue samples
was heat den atured and immobilized onto a nylon mem brane then hybrid ized to
a full-len gth . linearized, recom bina n t 'lNHV DNA (rWH V DNA ) labeled with 12p
(Section 2.10). peR . with Sout hern blot hybridization . was perf ormed to dete ct
WHV DNA at leve ls be low the sens itiv ity of cct-btct hyb rid izat ion (i ,e., in animals
rec overed from AH HSeet ion 2.9.3.2). For estimation of the leve ls of V'lHV DNA
expres sion . autorad iographic or ph osphor images of hybrid izat ion s'9 nals were
qua ntita ted WIth two- fold senal cnuuons of r\NHV DNA using the Ch emi-l mager
4000 or the Cyclon e Phosph or Imag ing Sys tem (Sect io n 2.9 .3.3). The estimated
sen SItiVIty of a dot blot hyb rid ization assa y was approx ima te ly , 0- vg e/ml and the
ne sted PCR/Southem hybridization assa y was between 10 to , 0"vge/ml.
The presence of V\lHV liver RN A wa s dete cted after reverse transcription
and PCR amplifica tion WIth WH.V co re gene specific prime rs in pa rallel w ith th e
appr opriate spec ifiCIty and contam ination controls . South ern blot analysis was
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routine ly used to detect and confi rm authenticity of the amplified Vv'HV eDNA
sequences (Section 2.9 .3.2: Coffin and Micha lak. 1999)
5.2.4 Clo ning of woodchuck cytokine genes
Woodchuck IFNy and CD3 gene fragme nts were crcnec and the ir
nucleotide seque nces report ed in ou r prevc os study (Chapter 4: Mich alak et al..
2000). For clonmg of TN Fa . Il ·2 . IL-4 , and IL-o. woodchuck eDNA was init ially
amp lified by p eR using dege ne rate oligonucleotide primers with seque nces
de du ced throug h mterspecres co mparison of ava ilable huma n, mouse. tat and
rabbit seq ue nce s using PC Ge ne software (Inte llige netics Inc .. Mo untai n View.
CA l , Briefl y . total RNA ( 1 ug) fro m Con-Acstenufated woodchuck PBMC wa s
reve rse transcribed to eDNA (Secti on 2.7). FIve lollof eDNA In a standard
reagent mixt ure (Sect ion 2.8.3) was denatu red for 5 min at 94·C and amp lified
for 35 cycle s uSing the follow ••' g cycle parameters : 94· C for 1 min. 52· C for 2 min
and n ee for 3 min Thes e PCR amp lifICatIOns were earned out In a TWlnBIQCk,
Therma l cycl er (Ericomp rnc.). The specifiCIty of the PCR products was verifi ed
by Southem blot analYSISuStng J.2P-end labeled oligonuCleotid e probes with
sequences intern al to those of the amp lificat ion pnmers . The n. the DNA
amp licons were cloned into the dual prom oter PCR II vector using the TA -doning
system (Invitrogen) and sequenced using the f mol DNA Sequencing Sys tem
(Promega Cc rp.) or a fluorescence-bas ed automated sequence analyzer (LJ·
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CQ R)(Sect lon 2.12; MiChalak et et.. 2000). After seq uen ce determination ,
pnme rs spanning wood chuCk specific gene introns we re desig ned with the aid of
a sequ ence similanty search tool (W'W'N. ncbi .nlm.nih.govl8lASn . The
exceptons were pnme rs for woodcnucx IL·2 and Il 4 which wer e located with in
one e xon of each respect ive gene . Prime rs were optImized for length . GC
content and me lting temper atures using OMIGA softw are (Intelligenetics Inc.).
5.2.5 Det erm ina tion of cytokine gene ex pressio n
Despit e effort s. Northern blot hy bridizatio n d id not ach iev e suffic ient
sensitivi ty even whe n up to 30 1J9 of total RNA per lane was tes ted . Therefore .
ass ays based on RT· PC R wer e developed . Express ion of ea ch of the genes
stud ied was analyzed In the line ar p eR amp lifica tio n ran ge us ing 5 IJIof test
eDNA and senal 1Q-fold dilutIons of the eccrc cnete cloned gene fragmen t run as
a quanntatrve stand ard In ea ch PCR set-up (see e xample Fig ure 4 -1). For
detection of IL-2 and IL-4 sequen ces . since PCR prim ers were loca ted wnt nnone
excn of each reececnv e gene . the sam ples were DNa se diges ted for 20 mm at
37"C pnor to RT followI ng the manufacture r's Instruct ion (Am bion lnc.. Austin ,
TX) . Amplification of woo dch uck IFNy and CD3 eps ilon sequences was done
without DNase treatment using oligo nucleotide pnmers and parameters
previously descnb ed (Section 4.2.10), For amplificati on of TNF a . the sense and
antisense primers S'·A TGAGCACTGAAAGTATGA TCCG and 5'·
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CTC AGC AAA GTCGAGA TAGe were us ed . respectiv ely . The gene exp ress ion of
woodchuc k IL-6 was determined with plus S'·A TCTG CCCTTCAGGAA CAGCC
and minus 5'·AGCTIAGATGCCCACTA TGC prime rs . Woodchuck IL-2 was
amplified with the sense prime r S'·TGGAGGAAGTGC TGAATGTACe and the
antisense pnmer S'·GATGTIATACACGGGA GGCACC and IL-4 wrth sen se and
an ti-sen se primers S'·TTCTGTCTCCTAGTATGCCC and 5'·
GGAAGTCTIT CAATGTI CTCTGC . respectively. In addition , ~actln a nd
GA PDH we re amp lified as load ing controls. p...aetin was ampl ified using 1 ~ I of
liver eDNA and woodchuck specifi c primers 5'-CATCCTCACCCTGAAG TACC
and 5'-CAT ACTCCTGCTIGCTGAT CC. whe rea s GAPDH was amp lified USIng
pri mers des cnbec elsew her e (Chapter 4 : Michalak et st.. 2000 : Ju et a/.. 1995 ).
All peR amplifications were performed in a PTC·2oo mermccvcrer {MJ
Rese arch . Watertown. MA l. excect IFNy which was done In a TWInBlock therma l
cycler (Encom p Inc .I. After gel erectrocnores.s . the reranv e ba nd density af the
PCR products was compared tc plasmId quan titative stan dards USing a
computenzed Chem.. lmager 4000 System (Canbe rra-Packard Canada ltd.).
PCR product denSity far each test samp le w as found tc be In the linea r range of
the plasmid standa rd curve (r >O.93) th at w as gener ated in parallel with each
reaction set as Illustrated far IFNy In Figu re 4 -1 . Fa r IL-2 and IL4 detection . 20
~l of each amplifi cation pradu ct was immobilized an nylon mem brane (Hyband
XL: Amersham ) by rr ncrcfutrancn and subs equ ently hybrid iZed with the
appropria te d oned u P-Iabe led probe (Seeto n 2.9_31. HybridiZed blots were
exposed to a phosphor screen (Canberra -Packard Canada ltd.) for fina l
qua ntitative ana lysIS.
5.2.6 Statistical analysis and gene sequence accession numbers
The densitometric values on Vl/HV DNA. cyto kines and CD 3 expr ession
we~e analyzed usi ng the Mann-V\'hitney nc n-cerarretnc test to cetermme the
sIgnificance betw een groups . Two- tailed p values < 0 .05 were considered
stgn lflCant. The Gen Bank accession numbers for the woodchuck nucleotide
sequences cenvec In ttus study are as follows : IL·2 . AF333964: IL...4 . AF333 965 ;
IL-6 . AF333 966; TNFo . AF333967 . and (3-act in . AF232730 (see Appe ndix B)
5.3 RESULTS
5.3.1 Progression to chron ic hepatitis is as so c iated ..,.ith a higher hepatic
WHV load du ring acute infection
The average hepa tic VVHV DNA con tent co llected from acutely Infect ed
erumars In this study was not signifICantly different from that esti mated for liver
t nocs.es obta ined du nng CH. as measured by dot- blot hybridiZ ation and
oensuometnc analys ts of hybridiZation signa ls (sensit ivity 106 W'rtV vge/ml ). For
both groups . the vi rus loads were in the range of 1.5 x 107 to 9.5 x 10~ vgeffj9 of
liver DNA and they were comparable to those prev iousl y reponed (Michalak et
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al.. 2oo0 )_ However, when the average VVHVDNA contents we re ca lcu lated
separate ly for liver samp les acqu ired du ring acute infection from animal s tha t
ultimat ely reso lved AH or develo ped CH, the WHV load was 2.7·fold greater for
wood chu cks wh ich progressed to CH (p = 0.06) (Table 5.2 ). Nevert heless. there
were samp les In both groups for which the VVHVDNA values overiec ceo with
those from the other group (Table 5-2 ) and . therefore , did not provide an
mc ncencn about the possible outcome of AH. In the cases examined in th is
stu dy . the expressi on of WHV -spe cific mR NA wa s not meaningfully diffe ren t
between woodc hucks which resolved AH or progres sed 10 CH when assessed by
Northern hybridizatIon (data no t shown ) or by RT·PCR (Fig . 5-2). The reas on for
the apparen t discrepan cy betwee n v iral load and viral RNA is not known . As
expect ed . small amounts of \NHV gen om es were identifiable by nested
PCR/Southe rn blot hybndlzation (sensitivity <10: WH V vge/m l) in livers of
an imals whi ch had reco vered from AH. Th is result was consistent wrth our
pre vious findings (Michalak et al.. 1999: l ew and Michalak . 200 1: Michalak et af.•
200 0). 1J\IH·v" specnc RNA slQnals were detectab le by nested PCR amp lification
of eDNA In the malonty of liver tiss ue samp les cbt amec from the wood chucks
with SLA H and their intenSity did no t vary significa ntly throughout the lifespan of
the anima ls mvesnqetec {data no t shown). similar to observations in our pre vious
studies (Michalak et et.. 1999 : Michalak et et.. 2000).
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5.3.2 Upregula ted hepa tic IFNy and C0 3 tran sc rip tion ac com pani es
chron ic he patitis and co nti nues lo ng afte r resolution of acute WHV
in fection .
The overall lFNy mR NA levels were found to be low in livers of hea lthy
anim als but SlQnrfcantly elevated in hepatic tissue sam ples from wood chucks
wIth A H. re ach ing levels of nearly 4-times greate r than thos e detect ed in healt hy
anim als (p < O.OOS)(Fig , 5·1). IFNy gene expre ssion was elevated to
epprc xtmaterv the same levels as that seen in AH in the livers of woodchucks
with CH (p < 0.005), Similarly. the hepa tic C0 3 mR NA expression, an indicator
of T lymphocyte infi lt ratio n. was barely detectable in normal. II\II-IY-u n infecte d
anima ls . but uc reqctatee (approximately by 5· fo ld) in hepatic tissue from
wccocnucks with eithe r AH (p < 0 ,005) or CH (p < 00005). Unexpectedly . liver
samples COllected from wood chucks whiCh resolved acute Vl/HV infect ion and
were follo wed . In some cases . throug hout their entire natur al lifespan also
de-mon strated steuencany sig nifi cantly greater IFNy and CD 3 mRNA levels than
those detected in hea lthy anima ls (p < 0 .000 5l . In summ ary . the resu lts revea led
that transcn pnon of neoatc lFNy and CD3 rem ain s elevated not only in chron ic
WHV hep atms but also . althou gh at lower levels , long after apparently complet e
reco very from AH. TNFa mRNA was detected at significa ntly highe r levels in
hepat ic tissue from animal s with CH in comparison to that in healthy woodch ucks
(p < 0 .0005) (Fig . 5- 1). In general. transcription of TNFa tended to be elevated
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Figure 5· 1. Ana lysis of cyto kine an d C03 gene expression in liver sa m ples
obta ine d fr om adult woodchu cks p rior to inoculation wi th WHV , du ring
ac ute o r chronic WHV he patitis. or after res olution of aeut e infection . The
histogr ams summanze the resu lts of IFNy . C03 . TN Fo and IL-6 mRN A leve ls
identified by RT-p e R uSing total RNA (O.25 lJgfreactio n) isolated from live r
biopsies collected from he althy animals (Healthy: n = 14), during the acut e pha se
of INHV infection (Acute : n = 19), in con val escent peri od after resolution of AH
(SL: n = 52). and In the cours e of CH (0=18). The medi an and rang e of
acouemcn times for moc s.es obtamed from AH. SL and CH phases wer e 11
rang e 5-19 wee ks . 77 range 4-26 1 wee ks. and 76 range 17-202 weeks .
respectiv ely . Resu lts are presented as mea n pg equi valent ~ SE determ ined for
eacn five r sa mple by companson to peR band density standard curves
gene rated by ernpirncancn of sena t d ilut ions of the appropnate recombinant
wooc cnuck ge ne seque nce s. Data bars rnerxec with •• are significan t at p <
0005 and those with ••• at p < 0 .000 5 when compa red to the levels detect ed in
livers of healthy woodchucks .
--:.:.:::.. .. .
both du nng acute jntecnon and after resolut ion of AH . but the differences did no t
reach a stat istical signmcance. The overall hepat ic Il-6 expression appeared to
be sl ightl y increased in CH , but II remained essentially at the same levels in livers
of hea lthy wood chucks and those acqu ired during and after reso lution of acut e
infect ion (Fig . 5-1)
Alth ough IL-2 transcription was detect able in the majority of the tissue
sam ples tes ted by dot-b lot hybndization of RT-PCR products. the expressio n of
true cytokine was not meaningfully different between healthy and recovered
a mm ars and those progressing to either AH or CH (data not shown ). The
transcn ptio n of Il -4 wa s detected only rarely in livers from both hea lthy and
WHV-infected animals and t'i en levels were without any noticeab le relation to the
status of VVHV hepat itis (data not shown). Figure 5-2 illustrates a time course of
the detection of the WHV . CD3 and cytokine mRNA in serial liver biopsies
acqu ired fro m 4 anima ls who afte r WHY inoculation dev eloped AH and eithe r
resolv ed the disease (19/F and 31F) or advanced to CH (271Fand 24/F ). As
shown. the de nsity of hyblid ization sg nals reflect ing expression of IFNy . TNFa
and C0 3 mR NA mirror each other in the indivi dual liver samples .
EVide ntly . the express ion of IL-6 did not foll ow those of IFNy . TNFa and CD3 . as
the dens ity of hybndiza tion SIgna ls was approximately the same in the liver
samp les obtained from the same woodchucks prior to Vl/HV inoculation. du ring
and after AH or in the course of CH.
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Figu re 5-2. A time course of cytok ine. C03 and WHY mRNA express io n in
se ria l li ve r biop s ies c o llected from woodchucks with e xperimenta lly
induc ed WHV infection wh ich either reso lv ed acute hepa ti tis or developed
c hro nic l iv er dis ease . Tot al RNA (O.25 ugJreaction) isolated from liver btopsies
take n poor to VVHV inocu lat ion (H) and at the Ind icated nme poin ts after the
appearance of IJVHsAg In the circ ulat ion (weeks) dur ing acu te infect ion (AH)
wh ich progressed to CH or after spon taneo us res olution of acute infection (S l)
The biopsies were obtained from 2 woodchucks (19/F and 3/F ) who finally
resolved AH and 2 anima ls (271F and 24/F ) in wh ich disease advanced to C H.
The expression of the ind ividual genes or WHV mRNA was determined by RT ·
peR und er conditions eese-eee in Materrals and Met hod s (Sectio n 2.BI and the
resu lt ing erncnccn s were visualized by Southern blott ing w ith accrccnate :l<p .
labeled cloned wood chuck probes . \NHV mRNA SIQnalS were detected WIth J2 p .
labeled comp lete reco mbinant W'rlV DNA . GAO PH was used as a housekeep ing
gene _ Mock extracted sam ple s treated under «rentcar co nditions as test RNA
was used as a neg ative contr ol and acp ropnate recombinant woodchuck gene
frag ments as cc emve p eR con trols . The intensity of C03. IFNy and TNFa
signa ls approximately pa rallel each other in the ind ividu al samples obta ir.ed from
eithe r healthy anima ls or those with different stages of VYHV he pat itis
WHV RNA
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5.3.3 Inc rea sed IFNy and CD3 gene expr ess ion during acute ph ase of WHV
infe ct io n preced es rec overy from hepatitis
To determine whethe r hepatic expression of lFNy , TNFa . 1l-6. and CD3
could pred ict the outco me of acute VoIHV infect ion, we eva luated the levels of
relev ant mRNA In the liver sa mple s obtained fro m healthy anima ls before
mocuta bon W1th 'WHY and from the same wood chu cks dunng acute phase of
WH V mrecnon. and ana lyzed them accord ing to whether the ani mals ult imately
resolved AH or deve lope d CH . Figu re 5-3 sh ows th at there were cnly mini mal ,
statis tica lly non -significant differences In the Intra hepat ic expression of IFNy ,
TNFa. Il -6 or CD3 mRNA in all health y woodchucks. Howe ver , liver samples
acquired dunng ac ute infecuc n from the ammais who su bseq ue ntly cleared
hepat it is. but not those wh o developed CH. demo nstrated sIgmficantty greater
ove rall levels of IFNy mRNA (p < 0.05) and CD3 express ion (p < 0 .005) when
compa red to the samples obtained from the same animals prior to VVHVinfection
(Fig. 5·3). Furthe rmore and most Importantly . exp ressio n of IFNy and CD3 in
repeuc nssue collected du ring acute infect ion from the wood chucks who
prcscecnvew resolved AH wa s signrficantty greater than In tho se who developed
CH lp < 0 05 and p < 0 .005. respectively ). Although the average mRNA level of
TNFa demonstrated similar trends to those iden tified for IFNV and CD3 mRNA.
Its expression did not statistically vary between the groups analyzed (Fig . 5·3 ).
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Figure 5-3. Com pa rison of intr ahepati c cytokine and C03 gen e ex p ression
in he a lthy woodchucks and in an im als du rin g acute pha se o f WHV in fecti o n
who e ither resolved hep ati ti s or develope d ch ro n ic liver disease. The
histograms summ ariz e the results on IFNy . C03. TN Fa and ll-6 expres sion
ev alu ated by RT·P CR on RNA sampl es isolated from liver biops ies of health y
woodchu cks tha t ult imate ly recovered from acute in fection (H->S L; n=9) or
developed C H (H->CH: n=5) and fro m animals with serologically and
h:stologically confi rmed acute \lVHV infec tion who subseq uen tly resolved
eneease (AH-> SL: n=10) or advanced to CH (AH ·>CH ; n=8) . The mean time of
biOps y acquisition from ammals who resolv ed AH was 7.8!. SE 1.3 weeks .
whereas that fo r ammats who prog re ssed to CH was 6 .1 ;: SE 1.4 wee ks (see
Tabl e 5-2 l · Resu lts are presented as means r; SE . dete rmined as descnbed in
the leg end to Figur e 5-1. Data bar m arked wnn " is sign Ificant at p < 0 ,05 and
that with •• at p < 0.005 when compared to liver samp les from healthy anima ls
With a self limit ed or cnrcrnc outcome of AH . respect ively .
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In contrast to IFNy and CD3 . the rate of IL-6 transcriptio n remained rel atively
constant between all groups studied. Taken toget her, the results cle arly showed
that highly upregu lated express ion of hepatic IFNy and CD3 , an indicator of T
ce ll infil t rat ion. and an incre ase d transc ription of TNFa duri ng acute WHV
infect ion is an indicator of the favourable outcome of AH in adu lt woodchucks .
5.3.4 Int rahepa ti c cytokine and C0 3 ex pressi on profiles in WHV infection
progressing to rec overy or c hro nic hepa tit is .
To determine cytoki ne transcrip tion and T cell infi lt ration dyn amics duri ng
progression from acu te WHV infec tion to CH. recovery from AH. and du ring
occult lifelong WHV pe rsist ence after termination of acute infection , the res ults
on liver expression of relevant mRNA were analyzed after grouping them
acco rding to the time per iod between WHV inoculation and acquisit ion of the liver
samples . Average expression of the individual cytokines or CD3 was calcu lated
fo r each of the time cencos (Fig. 5-4 ). The results showed that on ly the animals
whi ch finall y resolved AH sho wed an early (before 119 d.p.i.] increa se in he patic
CD3 exp ression (p<O.005 ) and that this increment was sig nifica nt ly greater
(p<O.05l than that fo r woodchucks progressing to CH (Fig . 5-4 ). Interestingly, the
CD 3 mRNA level rema ined higher th an preinfection leve ls in the recov ered
anima ls for more than 3 years after resolut ion of acut e infect ion. In woodch ucks
who develope d classica l CH. the aver age hepatic CD3
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Figure 5-4 . Pro files of intr ahep3ti c cytokine and C03 gene expression in
adult woodchuck s who developed acute WHY hepa ti tis followed by
rec o very and pe rs istent oc cu lt WHV infecti on or progressed to chron ic
hepatit is . The hepatic 1FNV. CD3 . TNFo and IL-6 transcri ption levels we re
ana lyzed bef ore inocu lat ion (days post infectio n < 0) and in liver biopsies
obtai ned throughout the course of VVHV infection from animal s who ultimately
resolved AH (SL) or developed CH. The data we re sub seque ntly grouped
according 10 the time per iod s elapsed betwe en WHV inoculation and acqu isition
of lest river samp les. Each data point represents the mean (:! SE) expression of
the indica ted m RNA exam ined in 9 to 19 (m ean . 14 ) or 4 to 10 (m ean, 7)
individual liver biopsy samples collected from woodchu cks with se lf limiting AH or
CH. respecuvev. Resul ts are prese nted as pg equ iva lents,of the rescecnv e
recomb inant woodchuck gene fragments. as des cr ibed in the leg end to Figu re 5-
1, Data pcmt s ma rked witn " or + are significa nt at p < 0.05 a nd those wrth - Of
+ + at p < 0.005 when compared to the levels de tected in uvers from health y
woodch ucks who finally reco ve red from hepatitis (- . SL) or prog ressed to chronic
li\/er disease (+, CHl . The me ans marked w ith . are significantly diffe ren t at p <
0.05 between anima ls who resolved acute infect ion and th ose who develop ed
CH
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expression rose at a later stage of infection (120 d _p j .) and remained elevat ed
up to the end of foUow·u p (Fig . 5-4 ). The average IFNy gene expression tended
to increase until app rox imate ly one year into infection in animals who either
recovered from AH or deve loped CH (Fig. 5-4 ). After approxi mately one year ,
the IFNy mR NA began to dec line in the woodchuck s who cle ared hepa titis.
alth ough the ave rage leve l of IFNy exp ression never returned to th at observed in
healthy a nima ls (Fig . 5-4) , In co nt rast. the mean IFNy mRNA lev els in the
animals wh ich developed CH continued to incre ase . reaching a plateau afte r
appro ximately 3 years of infection .
He patic TNFa expression ros e from the moment of INHV infection in
anima ls that subse quen tly recov ered from AH and remained elevat ed lon g after
terrmnanc n of acute mrecnco . alt hou gh statistical slQnlficance was found only for
bIopSIes obtained between 500- 999 dpi. (FIQ_ 5-4 ), In the final pha se of follow-
up of these an imals 1:>1000 d .p.i.), the averag e TNFo mRNA returnee nea rly to
the values de tected In hea lthy woodchucks . In anima ls w ith CH, hepat ic TNF o
uenscnpnc n became eleva ted 500 dpi and remained at approxImately the same
levels to the end of the observation peri od .
In contr ast to the increases see n in hepatic CD3 . IFNy and TNFo
expression. there were no appar e nt changes In the average rate of hepat ic IL-6
transc ription throug hout the life span of the anim als that ult imately recovered
from AH. The lev el of tL-6 transcript ion showed a slow progress ive inc rease
durin g the course of CH afte r 500 d .p.i ., althoug h it never reached statistical
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significance (Fig , 54)
5.3 .5 Recovery from hepatitis is assoc iated with an exacerbated episode of
acute li ve r inflammati on
Morpholoqical severity of Vv'HV-induced liver injury was evaluated in all
liver samples examined in this study using numerical scores separately assigned
for hepatocellular. extrahepatocellular intralobular and portal alterations . and by
taking Into co ns.deratio n a global impression of the patholog ical picture of liver
damage as a whole. accord ing to the criteria descri bed in det ail in previous works
(Michalak and Lin . 1994 : Michalak et a /.. 1990 ) and in Section 2.5 . A particular
ern onese was placed on the recognition of the extent of morphological changes
In the acute pha se of hepatitis In an imals who ultimately recovered from AH or
developed CH , Table 5-2 summarizes the data on these assessments in 7
WOOdCh uCkSIn which AH was resol ved and in 6 animals with acute infection that
progressed 10 CH. The results demonstrate that the grade of necrOinflammation
in acute phase of WHV infection . referred to as histological degree of hepa titis
wa s significant ly greater (P<O.05) in the arumals whic h ultima tely reco vered from
AH (mean score 2.1) than in those wh ich advanced to CH (mean sco re 1.2 )
This diff erence was the result of the agg ravated morphological damage
diagnosed in all three compartments of liver pare nchyma ana lyzed as described
in Sectio n 2.5. Thus . the extent of hepatocellular lesions (including single cell.
sporty . piecemeal and /or bridging necrosis. degenerat ive changes and pres ence
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of aci do philic bod ies ), the range of extre bepa tocenura r changes (incl ud ing the
deg ree a nd distrib ution of intra lobu lar inflammatory ce ll infi ltrates . influx of
ma crop hages . plasma cell s and neutr c pmls . hype rplasia of sinus oidal Kupffer
cell s and lin ing en dothe lium . disorg aniz ation of retic ular network ). and the status
of po rtal atte rano ns (embOdymg oed em a of portal area s. Inflammatory
Infilt rat Ion s . bile duct prolifer ation ) we re mor e sev ere (p<O.05) in amma ls who
subsequently recovered from AH than in those who de ve loped CH (Table 5-2),
In 5 of the woodch uck s (2/F. 51M. 111M. 221M and 27/F ), the second live r samp le
collected d unng acute phase of WHV infection in 7 to 8 weeks afte r the first
biopsy was also avauanle for examination. In thes e auxil iary biops ies from the
animals which reso lved AH (2JF. 5/M and 111M). histo log ica l alte ration s were
gene rally less severe than thos e detected in the earlier phas e of AH . sugge sting
that the disease alread y subsided In thi s time penod (Table 5-2)_ Two sec ond
liver samples ava ilable from 2 woodchucks In whic h CH became established
showed erme r a Sim ilar level of acute mrlarnmauc n (221M) or much mor e severe
repauns 127fF ) th an that d iagn osed In the ear lie r biopsy from the same anima ls
\Table 5-2 )
As expected , his tolog ical examination of the liver t issue samples acq uired
dunng serol og ically evoent chronic infection. showed featu res of lingering
nec rcmtlammancn w ith a variabl e degree of liver injury us ua lly ranging from
moderate (grade 2) to severe liver dam age (grade 3)(Micha lak . 1998; Michalak
and Lin. 1994 ). Senal hve r biopsies obtained from woodchucks reco vered from
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AH showed recurring . rrururnal to very mild inflammatory chang es (not exceed ing
histOlogical deg ree of neca nns cons istent with grade 1) that con tinued throughout
life w ith periods of ncrmat or nearty norm al liver morphology. as descnbed in the
previous study from this labor atory (Michalak et af.• 1999 ). l iver bio psies from
he alth y a nima ls dId not show any pa th Olog ica l a lterations
5.4 DISCUSSION
The multipa rametnc analysi s of se ria l liver samples from adult
wo odchucks prior to and du nn q th e cou rse of WH V infecti on allowed a
recog nit ion of the life long intrahe patic dyna mics and the inte rdependenci es
between expresason of ke y antiviral cvtckmes . C DJ·posltive T cell infi ltration. liver
Injury and virus e ee In ne pacnaveus mtecncn. The resu lts showed that the
acute ph ase of V\IHV mtecnon In adult wood ch uck s SlQnrfteant ly diff ers wit h
respect to eurenepanc expression of IFNy and TNFo . the deg ree of T cell
Infiltr atio n . seve nty of liver mnarnmabon and necerc I/VHVco ntent. depe ndIng
upon whether the hos t recovered or had persistent vuat hep atit is . He nce . wh ite
the resonmcn of AH IS preceded by upreg ulated transcnption of IFNy and TNFa .
augmented liver T cell influx and incr eased hepatic tissue damage , eart y WH V
infection ultimately evolving to CH had the opposite characterist ics and is
typ ically associated With a high er vira l load. Despite diff er ences in viral load ,
the re we re no ch anges in viral gene expression during A H regardless of whether
the anima l recovered or prog ressed to CH. These results are consis tent with
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those obtained in neo nata l woodcnucks (Cote er et.. 2000 ). The authors of th is
stud y suggest the d ifference s between DNA and RNA expression may be related
to host Inhibit ion of the reve rse transcnpncn step of pregenomic RNA Into DNA or
on the cclvrnerase -mecrate c second-str and DNA synthes is . Our study also
revealed that the sero logically conce aled , lifelong persiste nce of IN'r-iV. which is a
usua l con sequence of recovery from an acute episode of adult VVHV infection
(Michalak et st . 1999: Coffin and Micha lak. 1999). is accompanied by an
enha nced intrahepatic expressscn of IFNy a nd TNFo and by the presence of the
'r-ceu marke r CD3 . Unex pect edly . T ce ll Influx was no t readily de tectable by
h istolog Ical examinatio n
In tt usad ult mod el of he cee navuu a mtecncn . acu te mtecnon induced by
the same pool and dose of VVHV either subsided or adv anced to cnromcrv In the
context of the fully deve loped Immune syst em. in which all arms of virus-specific
and Innate Immunological responses wou ld be expected to be ope rationa l This
contrasts I/IIt-iV infecti on acqUIred in the neonatal period where the
Immunologlca l lmmatunty of the host at the time of the prima ry virus exposu re
may signifICantly Influence the range and the strength of immune reecnons. and
predete rmine the path ologica l outco me of the infect ion. Furthermore. the
cece ety to produce Ind iVidual cvtokmes may change with age. as reported With
increasmq IFNy produ ction during childhood (Campbell et et.. 1999). making
extraccrencn to an adult Situat ion diffi cult. Des pite funda me ntal difference s
betwee n adults and neonates in responses to microbes and exogenous antigens
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(A rv in. 1907). the para me ters Char aetenzmg the ea rty ph ase of VI/HV in fection
prog ressing to reco ve ry or chro n ic ity unco vered in our study are . une epect env.
similar to those delineated for neonatal V\lHV infect ion (Cote et et, 2000 :
Nakam ura et al .. 2001). Thus . ev entu al recov ery fro m A H is assoc iated w ith
gre ate r levels o f hepatic IFNy and TNFa mR NA expression, increased
h istologIca l sever ity of he pa tit is . and lower in itia l vira l load in bo th adults a nd
neo nat es A simil ar pr ofi le of alte rat ions has a lso been observ ed in anothe r
study In w hicn adult wood chu cks w ith tr ans ient WHV he pahtrs were investigated
(Guo et al .. 2000 ). In ttus w Qr\( . the recovery from A H w as also preceded by an
lnflu ll: of C03-poSitive T ce lls and by a trans jentmcrease In CD4 and CDB-
cosmv e cells In the liver which were es tim ated by ex am ining exp ression of
respect ive marke r mRNA . There fore . a lthoug h freq uency of spontan eou s
recovery from 'NHV becanns and progression to CH are dramatica lly different in
ad ults and neona tes. the same pa rame ters mea su red in the ea rly ph ase of
Infect ion oeoct rts fin al outcomes Indepe nde nt of age of the aruma! host
An alysIS of the liver b iops y mater ial coll ect ed from he althy antm als prior to
VVHV inocul ation In the current stud y did not provide an indica tion In rega rd to the
ult imate outcome of neceuns . no r did we see not iceable variations In the
IndIge nous expression of cyt okine ge nes te sted in the healthy wo odchucks
invest igated . However. gen et ic pred isp osi tion to high or low cyto kine production.
including large diffe ren ce s in bot h the numbers of Thl cyt ok ine exp ressing ce lls
and in the Quan t ity of Th l and Th2 cytccne prote ins secreted between normal
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huma ns or anima ls . have bee n reported (Cartwrig ht et al.. 1999). These natural
variatio ns in the Th l and Th2 respons es migh t be an import ant e lement
pred isp o sing an infected host to a promp t and stro ng , or a del ayed and
msuffi crent . Th l cytokine resp ons e (Paul and Sed er, 1994: Hunte r an d Rei ner .
2000). There are a numbe r of microb ial infections exp licitly illus trat ing a critica l
ro le of the imbal ance between Th1 and Th 2 cvtckme react iv ity in the infect ion
outcome. inc ludi ....g lep rosy and expenme ntal mu rine le ishm an iasIs (Y amamura
er a/.. 1992 : $he r and Coffman. 199 2 )_ The same see ms to be true with res pect
to the readiness of innate Imm unItY to mount a defense aga inst invadi ng
pa thog ens (B' fOn et et.. 1999 ). In th e case of INHV infect ion. the issue of the
natu ra l c receccsrncn to a part icu lar type of immu ne response reflected in the
cvtc cne expression profi le and rts eventual essccancn with suscep t ibi lity to CH
need to be re-ex armnec when assays mea suring the cyto kine prote ins an d
ma rke rs Identify ing mdlVld ua l ce ll ty pes prodUCing tnese cvtckmee beco me
availab le
The Increased intr ahepatIC expreseion of IFNy and TNFo was
accompanied by the presence of CD 3-positJve T ce lls in the live r in all sta ges of
WH V infect ion analyzed In this study . mduding the late conv ales cent phase
Howev er. as the ov narmcs of the he patic transcnption of these two cyt okines and
CD 3 showed. the rec ove ry fro m AH was prec eded by the increased expression
of CD3 mRNA followed by uprequteuc n in IFNy an d TNFo mRN A (Fig . 5-4 ).
implying thai the liver infUSIon WIth CD3-posltive T ceus occurred pri or to
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enhancem ent in cytocne production . This resun seems to be co mpatibl e w ith
that reported by Guo et at. (2000) where the peak of live r IFNy and TNFa
expression was preceded by elev atio ns in CD3, C04 and COB m RNA in adult
woodchucks progressing to recovery.
The increased leve ls of IFNy and TN Fa mRNA in the ea rly I/IIHV infection
in the resolving an imal s doe s no t ex clude the possibility that the cyt okine
upregul ation was . at least In part . a con seq uence of activation of an innate
Immu ne respo nse COincid Ing with T ce ll influx . It 1$ known that IF Ny and TN Fa
are net only produ ced by anl lgen-.pnmed C03JCOs.positive Cl L and CD3JCD4-
po serve T cells of the Th l subtype but also by activated NK ce lts . NKT cells and
macro pha ges (BIron et et.. 1999 : Bendelac et al.. 1997 )_ Further , rt is now
evid ent that the liver IS naturally abu ndant in NKT cells (Bendela c et et.. 1997:
DOhert y et al .. 1999). whe re they may accou nt for up to 30% of intrahepatic
lymphocytes. and that NKT cells are able to secondanly act iva te NK cell s through
secretion of IFNy and they are like ly to be involved In the contro l of Intracell ular
pathogens and same tumors (Bendelac et et.. 1997: Denkers et al.. 1996: Cu i et
et.. 1997). Altogether. th is raises the poss Ibility that innate immu ne cells res iding
In the live r may contn bute to both the pathog enesIs and the reso lution of acute
nec acnaveat hepatitis . The recent data from transgenic mice and chimpanzee
mooers of HBV infection support this possibility and imply tha t T-ceu-moepencent
induction of hepatic IFNy . IFNa /13 , and TNFa may lead to tran sient inhibit ion of
HBV replication (Guidott i et et.. 1999: Kakirm er aJ.. 2000).
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At tms stage . innate immunity and its cellular com ponents have not vet
bee n characterized in the woodchuck. However . the ava ilable data indicate that
an increase in the number of ma croph ag es and proliferation of sinusoidal linin g
e pithe lium . including Kupffe r cells . are typical features of early WHV infect io n in
adult an imal s (Michalak. 1998i and that they are pro gressively prom inent when
histo logical sever ity of AH escalates. The same appe ars to be also (rue for
acute ly Infected neonates (Nakamura et al.. 2001 ). This ind icates tnat activa tion
of the m cn ccvtezro acrcpnaae lineage is a typical cons tituent of the early liver
in flammatory response to VVHV infect ion . Furthermore. our rece nt study
dem on stra ted that increased oert cnn-meotetec cytotoxi city by PBM C occu rs
seiecnvew in the ear ly phase of INHV infect ion (Chapter 3: Hodg son et a/.. 1999 ).
r t us observation sup po rts a possi ble ro le for inna te cell re sp on se . in particul ar
NK ce lls and possi bly NKT cells , in the reco ....ery from hepa titis in acutely Infected
woodc hucks, In this con te xt. the base line expression of in trahepatic IL·2 mRNA
dunng acu te VVHV hep atit is. reported simila r1yfor neonatal VVHV infect ion
(Nakamura et et.. 2001 ). migh t exc lude the presence of activated CT L or CD4-
pos rtrve Thl ce lls and . therefor e. support involv eme nt of natu ral killer·like ce lls
and macrophages_ Howeve r. following a simil ar type of arg ume nt. the apparent
absence of the upregulated IL-4 mRNA exp ression In the ea rly phase of VVHV
Infection may argue aga insl NKT cell involvemen t. since these cells are
producers of IL-4 in othe r speci es (Ben detac et et.. 1997 ). The inabi lity , at the
present time . to identify differences in IL· 2 and IL-4 express ion in seque ntial
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phases of adu lt V\lHV infection may be overcome by the ana lys is of RNA derived
from cell s isolated from liver inflammatory infiltrates or the direct qu antitation of
IL·2 and IL-4 prote ins in situ when app ropriate reage nts beco me availab le.
Des pite serolog Ical reco very. VVHV levels delect able only by
p e R/Sou the rn hybtidizatio n assays and essen tial histo logical resolution of
hepatiti s . liver IFNy and CD3 mRNA continued to be elevated throughout the
entire observation pe riod lasting for up to 5 years after resol ution of hepa titis .
white TN Fa exp ress ion rema ined upregu late d for up to almost 3 years afte r AH.
Previo us studies from our laborato ry revealed that woodchucks once infected
with WH V never comple tely eliminate the virus (Mic halak et al., 1999 ; Coffin and
Michalak . 1999: Lew and Michalak . 200 1). In the recovered animals. the hepatic
loads of VVHV DNA and RNA remain relat ively stable and very mik1 recurrent liver
alterations consistent with minimal to mod erate Inflam mation continue thr ough
life . as has been a lso observ ed in the present study . Considenng these find ings .
It was postulated that the steady. low rate of VllHV replication occumng in the
conv alescent anima ls co uld be a con sequence of the dynamic equ ilib rium in
which the persistently mult iply ing virus is kep t unde r confinement through
conti nuous immune pressure that includes. pOSSibly , immune eliminatio n of
infect ed cells (Michalak et s t.. 1999. rev iewed by Michalak . 2000). Cons iste nt
with th is interpretation is the existence of vigorous HBV-speci fic CTL reactivity in
the peripheral blood of pa tients years after recovery from AH type B (Penna et
al.. 1996: Rehermann et aI., 1996 ). Demonstrat ion of the exacerbated
202
expressio n of C03 mRN A in this study is in agreement wit h remna nt
Inflammation perpetuating in livers of the recovered animals . The contin uing
increa sed expression of IFNy and TN Fo in seria l live r biopsies from th e same
woodchu cks is consistent with this finding . Take n toget her. our stu dy suggests
that IFNy and TNFa. could be dir ectly involved in the local control of
hepa dn av irus per sistence wh ich prog resse s as an asympt oma tic. serologi ca lly
conce aled infectio n. IFNy has bee n im plicated in the control of oth er VIral
mfecno ns. ind udi ng LC MV and Fnend retr ovirus pe rsisten ce (Tisho n et al .. 1995:
fw asturo et a l.. 200 1) and ," react ivated mtecnon with herpes simp lex wu s type ,
rc ennn et al .. 1999 ) in truce
The enhanced local productio n of annvne t cvtokmes conti nuing long after
recovery from bepacnaw a! hepatitis ma y also have another importan t
consequenc e. It ma y contrib ute to prote ctio n of the liver against reinfect ion In
our previo us work . two of the adu lt woodChuck s who resolved AH afte r
acrmmstranc n of the VVHV Inoculum used in the present work and who were
Challen ged WIth the same VIruS 25 months after reco very did not show any
mo lec ular. serologica l or histologIcal evidence of re-acnvauon of INHV infection
or hepatitis (Mich alak et al.. 1999 ). Ther efo re . w e can cc nciusfveiy state that the
virologICal status and the profile of intrahepa tic cvt c kme and T cell react ivity
de linea ted in the recovered animals In this study is consistent with the toter
reststence of the anima l hos t against WH V reinfection . This obse rvation may
hold prorms e fo r the deSign of nover preventive approaches aimed at protection
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of the live r against Infection which could be beneficial. amon g othe rs . to HBV-
Infect ed liver transplan t recipients
In summary. th is study documents that the com bined qu antitative
eva luation of intrahepat ic excress .on of ant iviral cytcones . lrver T ce ll in flux, live r
histology and hepatic virus load. performed in the acute phase of hepadnaviral
mfecno n. provides an Insi ght into the fin al outcome of he patit is , t.e.. whet her
acute Infection resolves or progresses to ch ron ic liver disease . The resu lts also
show thai resid ua l asymp tomatic WH V infe ction , conti nuing long after res olut ion
of hepat iti s. is associated w ith elevated hepat ic excress.on of IFNy and TN Fo
and wit h morp holog ica lly un detectable liver T ce ll infus ion . Th is indica tes that
ant ivira l cytokrnes . In camcuiar IFNy . may be a key component in the control of
pe rs istent repaonavnus ,nfection in the liver.
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CHAPTER 6:
GENERAL DISCUSSIO N
The purpose of the pre sent series of studies was to investigate selected
aspects of the virus -host interactions tha t accompany necaenavsus infectio n and
underl ie the develo pment of diffe rent forms of veus-md uced liver disease. In
perncnar. our stud ies focused on identifying hos t immuno log ical fact ors whic h
may contribute to recovery fr om hep atitis or the estab lish ment of pers isten t
infect ion and perpetuation o f liver patho logy . In the first study we evaluated the
abi lity of circu lating lym phoid cells to eliminate target cells by either perforin or
Faa-Fas t, mediated pathw ays in both acute and ch ronic phases of WHY hepatitis
and compared it to that found In healthy animal s (Chapter 3). In the ne xt study ,
we examined the surfa ce d isp lay of MH C class I on hepat ocyte s and organ
lymphoid cells and de te rmined whether this expressio n co rrel ated With that of
related genes (Chapter 4). Ttus lead to new findi ngs wh ich ma y be instru mental
In ou r und erstanding of th e mechan isms Involved in the init iatio n and progr essio n
of chro nic liver dam ag e ar:d evas ion of the ant i-viral immunologi ca l surveillance
In chron ic hepadnaviru s inf ect ion. lastly. we eva luated the intrahepatic gene
expression profi les of the ma in antiv iral and pro inflammatory cytokines in
conjunct ion with T cell infl ux into the liver and virus load during the lifetime
follow-up of the adult onset of hepa dnavirus in fection (Cha pter 5). These studies
uncove red a numbe r of important findings . incl uding the ob servation that the
outcome of acute viral hepatitis may depe nd on the stre ngt h of the initial antiv iral
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and infl ammatory response and as such can be predicted based on analysis of
the hep atic IFNy and TNFo expression . the deg ree of T cell infl ux and the virus
load in the liver . In addit ion. they showed th at serologica lly undetectab le vi rus
pers isten ce , con tinuing long after reso lution of AH. remains associated w ith
upregul ated hepati c IFNy and TNFa transcri ption, indicating that these cyt okines
co uld playa critica l role in kee ping the viru s under tight immu nolog ical control . or
that the virus contin ually act ivated the host immune res ponse . bot h occu rring
after apparent complete resolu t ion of vir al hepatitis .
Despite the tact mat the current studie s were designed to gacn informa tion
on different. althoug h related . aspects of nece cn awue infection and associ ated
liver disease . the ir overall strength was enhan ced by the congru ity of ou r
proced ures and the urufc rmrty of th e Infect ion mod el used . For exam ple. th e vast
marcnrv of the woo dch uck s exa mined were infected as adul ts uSing the same
poo l and dose u.e.. 1,1 x 10'0 vge ) of Vv'HV. Furth er. identica l methods and
diagn ostIC cnten a were applied 10all our studies 10 dete rmine the serologi cal and
mo lecu lar Charactenstics of VlfHV mtecnon and to asses s histolog ical feature s of
liver disease , In aocmc n. we too k advantage of the fact th at ussu e materia ls
and se ra de nved from the same animals could be uti lized in d iffe rent study
protocols . Altog ether. these comm on elem ents mmemz ec th e influence of
extr aneous factors. such as virus dose or variations in virus nucleoti de sequence .
on the progre ss ion of infection and liver disea se outcomes and inc reased the
integnty of our findings
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Overall. our studies revealed that there are significant diffe rences in the
nest's molecular and immunOlog ica l response 10 hep adnavirus in the acute and
chron ic phas es of 'WHV nepenns and that specific features of this response also
char acte nzes silent 'WHV infection progressing throug hout the life span after the
recovery from hepatitis. The differences are also evident during the acute stage
of WHV infecti on between animals who eithe r resolve hepatitis or develop
cnrcrncliver disease . Thu s. bas ed on the result s of our studie s. AH is
charaet enz ed by elevations in perfonn med iated killing and the Intrahepatic
excress.cn of IFNy and TNFo . Increased trenscnpeon of TAP- l . TAP·2 and e:m.
as we ll as by upregulated MHC cl ass I he avy chain gene and prote in express ion
(Fig, 6· 1\, To wh at exte nt tne innate or viru s-speCIfic immune response
cont nb utes 10 the Increased expres sion of antivira l cytokines dunn g AH remains
unknown. In support of tbe Invo lveme nt of the innat e Immune response is our
findings . discussed in Chapter 3. th at the annvua ! cytokine Incr ease COinci ded
with a se lective elevation in pe nphe rallymph olClce ll-med iated perf onn-based
cvtc tc oetv . wh ich is a reccq ruzec ma rker of NK ce ll actIv ity (Kagl er st.. 1994:
Sayers et et.. 1398). He patlc mfl ux of CD 3-pos ltlVe lymp homonon ucJear ce lls
seen In AH cou ld be also ot erpr etec . at least in a cart. in support of the
involvement of the Innate cell imm une respon se . sin ce CD 3 expression
characterizes NKT cells in addit ion to T cell s. Howe ver. at this mo ment -ce are
not able to di ffe rentiate between T-cetls or NKT cells types. Th is would be in the
agreement with several previous repo rts wh ich suggested that innate immune
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cell s co uld be the mam source of antiv iral cyto kines dunng AH. Speci fICally. the
obs erv ations th at monocyte /macropha ge activation is a typica l constrtuent of the
earty live r Inflammatory response to \/IfHV infection (Kajino et al.. 1994 , Michalak,
1998 . Nakamura et ai.. 20 0 1). that NK ce ll cytolytic activity and prol ifer ation
occurs sho rtly after VItal mvaa on (reviewed by Buon et aI., 1999 ), and that a high
prop ort io n of NK cells In the live r be ar the CD3 marker (Bendetac et et.. 1997:
Doherty et et.. 1999). The rece nt demonstrat ion tha t NKT and subseq uent NK
cell activation are able 10 trans ie nt ly control hepadnavi rus rep lica tion in HB V
transge nic mice throu gh type I and type II IFN releas e (Kakim i et af., 2000 )
further sup ports this notio n . Ove rall . these resu lts suggesl 1hat. just as in other
type s of viral and microbia l In fectio ns. the inn ate cell Immune response. like the
adap tive Immune cell response. ma y play a pIVotal role ,n detennming the
outcome of hepadn avu ai Infection (see Chapter 5: g ,ron et al .. 1999 . Yam amura
er et.. 1992 : Sner and Co ffman. 1992 )
In con tras t to anima ls that recover from AH. woodchuck s who ultim ate ly
deve lop CH had slgnmcant ty lower elev ations in Intrahepatic IFNy . TNF a and
CD3 mR NA dunng the acute phas e of he pa tit is (Fig . 6-1 ). At this po int. we
cannot comment on the levels of PBM C med iated cyto toxicity In this grou p of
animals. however du e to the incr eased vi ral load an d decrea sed level of liver
Injury. we would predict a decrease in the ho st' s Immun e respo nsive ness to the
virus . Additio na lly. we cannot comment on the levels of gene express ion of TAP
or t3:m . nor the transcn cnc n or trans lation of MH C clas s I in animals with AH that
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prog ress to Chronicity , These issues will requ ire further inves.tigation. However ,
since IFNy is the main inducer of the rransc ncno n of these mo lecules (Wallach et
a/.• 1982 ). It wou ld be unlikely they are upregulated during acute infection leadin g
to CH . Since the level of gene trans cription is the primary regulator of protein
translation (Lewin 8 . 1997) , it is unlikel y that MHC class I display on hepatocytes
would be elevated in th is stage of WHY infection (Figure 6-1 ).
Interestingly. once woodchucks deve lop CH. the levels of IFNy . TNFa .
Il-6 and CD3 mR NA all increase. coincid ing with elevated MH C class I. 6:"1 and
TA P1 and 2 gene expression . However. there is no associ ated increase in the
hepa tocyte surface pre sentation of class I antig en . This impo rtant find ing
sugges ts there might be virus dependent ocsttrenecncnc net inhibitio n of this
prote in expression . Additiona lly , in animal s with CH the perform -based PBMC
mediated cytctoxrcrry IS comp arable to that seen in hea lthy an imals. This occurs
despite upregulat ed intrahepatic IFNy whiCh IS known to be a po tent activa tor of
NK cells (Camaud et et.. 1999 1. and inhibited MHC class I prote in presentation
on nec atocvt es and organ lymphoid ceus. This sugg ests that an acnv e
suopress -on of the NK cell response may be occurring . AddItionally. the altered
viral peptkl elMHC class I presentatio n would interfere wit h vnus-specfc
CTL -mediated elimination of infected hepatocytes and aid in ne ceunevnus
persis tence (see Section 1.7.6 and Chapter 4). A lthough viruse s . including
VVHV. may utilize several mecha nisms to interfere with MHC class I prese ntat ion
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Figure 6-1. Hypothetical mechanisms of l1epadnaviral hepatitis progressing
to recovery or chronic disease constru cted through th e results obta ined
du ring the cours e of the present stud ies. The resolut ion of hepadnaviral
induce d acute liver dise ase or its progress ion to CH is a co mplex process . The re
are inh erent differences between the leve ls of antiv iral cyt ckines and viral
re plicat ion leve ls dur ing the acute phase of disease correla ting w ith the outcom e
of infect ion Those anima ls wi th strong innate and spe cifi c cellula r immunity
have elev ated anti-viral cytokines , increased MH C expression and reduced viral
loads and ult imately reco ver. In the anima ls that reco ve r from acute infecti on the
anuvua t cvtokmes con tinu e to remain ele vated . perh ap s con trolli ng the lifelo ng
oc cu lt 'N US presence Tho se animals with an initially weak innate and spec ific
resp onse after t:epad nav iral infection have minimal antiviral cvtc on e release .
inc reased viral load and prog ress 10chron ic infection. It shou ld be noted that this
diagr am is not meant to Illustrate all poss ible mech anisms that ma y cc ntnbu te to
the path ogene sis of neceona vea t infection or its reso lutio n
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(reviewed by FrOh et et.. 1999), we hav e noted that the impa ired class I antigen
express ion on hepato cytes in chro nic WHV infect ion occ urs only in the con text of
extensive virus envelope proteins integ rat ion into the HPM (Chapte r 4 : reviewed
by Michalak, 1998 ). The pathogenic role of the large am ount of virus envelope
materia l produced during chron ic hepa dnavirus infection is un known. Some
reports have suggested that it may function as an immunom od ulator that
overwhelms the host's humoral immune respo nse ag ainst the virus (revi ewed by
Milich. 1995 ) Additionally. it has be show n that HBsAg can inhib it NK cell -
medi ated cytotoxicity in vitro (Azz ari et a/1992: De Martino et et. 1985 ) and tha t
the absence of the innate cell immune response can tolenze antig en-specific
lymphocytes (Kos and Engleman . 1995: Medz tutov and Janeway. 1998 ). In this
respect. the lack of a virus-specific cellular immune respon se is a cha racteristic
of both human and wood chuck chronic hepadn avira l infection (rev iewed by
Crusan. 2000: Menne et et.. 1997 and person al com munication). If the specific
CT L response against viraliy infected hepatocytes wa s prevented beca use of
decreased MHC class I prese ntat ion and the NK ce ll-mediated eurrunanc n of
hepatocytes not expressing MH C class I protein was suppressed by WH sAg (as
is the case with HBsAg). then this comp limentary effe ct of impeding both the
Innate and specific cellula r immune respon se might be an import ant element of
virus escape from immunceu rveutence in chronic WHV infect ion (discussed in
Chapters 3 and 4). Consi stent with the above hypothe sis are the findings that
(1l the level of WHV enve lope prot eins integr ated into the HP M of animals wit h
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CH are subst antia lly greate r th an du ring A H (reviewed by Micha lak. 1998 ). (2)
serum (o r cIrcu lating ) VVHsAg during AH in neo natal wood chucks who
progre ssed to chroniCIty w as fou nd to be sigmfica ntly grea ter th an in anima ls who
resolved hepatitis (W ang et at, In preparation ). and (3) hepa tic VVHV DNA leve ls
in neon atal (Nakamura et al. . 200 1) and adult wo odchucks (Chapter 5) during AH
prog ressing to chro nicity are significantly elevated in com parison to thos e found
in AH followed by recovery. Since aUof our anima ls were infected intravenously
wrth iden tica l dos es of the same VVHV peel. the differences in viral replica tion
levels and mtrahepatrc cvtocne production are most likely related to host
depe nde nt factors
Fo llowIng recovery from VVHV hepatiti s. hepatic antiv iral cvtckme levels
f1FNy and TNFO ) and T ceumnnranc n drop . but still rema in sign ifica ntly elevate d
compa red to unin fected he alth y animals (Fig . 6· ' and Chapter 5). This suggests
th at the occult low level virus re plica tion wh ich is known to conti nue for life after
recovery from AH In wood cnucks (M ich alak et al .. 1999 ) may continually
stimu late the nest's imm une system. In cons equ ence . this may contnbute to the
cont rol of VIruSrepucancn . or even protect aga inst reinfection . This is support ed
by the fact that strong polydonal HB V-specific T cell rea ctiv ity contin ues in
patien ts years afte r reco very fro m A H in conjunct ion with occult HB V pre sence
(Penna et al .. 1996 : Reh ermann et al.. 1996) . The virus may also be
responsible for the deve lopm ent of diseases not trad itionally ass oc iated with
nece cn avuus infect ion (e .g.• HCC)(rev iewed by Micha lak. 2000 ).
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The results of the presen t stud ies suggest thai WHV has the ability to
circumvent both spec ific and innate immu ne cell survei llance . and influence the
elim ination of infected cells . It appea rs that the main pote ntia l mechanism of
hepad nav irus persistence might be related to imm unolog icall y unopposed viral
repli cation early in infection and the subsequent excessive production of virus
envelope material. Although the intrahepatic NKI NKT cell response was not
specifically exam ined . our findings suggest th at innate immunity may cont ribute
to both the pathogenesis and resolution of AH. Th is observatio n ma y hold
prom ise for the design of nov el preventive approaches aimed at activating innate
cell immunity early in he padnavirus in fec tion an d lead to reco ve ry from AH and
prevent prog ress ion to CH . It cou ld also be particularly beneficial to HBV~
infecte d live r transplan t recipients who are renowned for rapid re-inf ection of the
dono r liver.
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CHAPTER 7:
FUTURE DIRECTIONS
The results obta ined during the cou rse of these stud ies have ra ised
sever al important questions which should be investigated further to hel p clarify
the contr ibution of the anti-WHY host imm une respo nse in the pathog en esi s of
hepa dnavirus induced liver Injury . The y are as follow s:
Woodchuck ce llular markers for the innate immune resp on se (e .g .. NK,
NKT and macrophages) mu st be developed and the immune response
im mediately following virus invas ion sho uld be ex ami ned to determine
whet her th is system plays a role in WHV elimin at ion and recovery from
ne oatrns
The issue of whether the immune response and cytosine profi le
pred isposes an anim al to CH must be reex am ined when meth od s to
determine the protein leve ls of the anti- vita! cvtcones and ind ividu al cell
types are est abl ished
The influence of the Th1JTh2-rela ted cvto kmes on the outcome of
necednavirus infect ion and virus-induced liver disease shou ld be
investig ated by taking adva ntage of exog eno us immunomodulato ry agents
which mod ify mtranecetrc cytc kme and NKINKT cell responses .
4 . The deve lopment of mark ers to identify cell subs ets of the adap tive
immune response (e.q .. CD4+ and CD8+ T cells) will allow the
examination of T cell respo nses dur ing the course of viral hepat it is
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proqressscn or recovery.
5. The molecu lar mechanis ms underlying the downregulation of the MHC
d ass I heavy chain crct em on hepatocytes and lympho id ce lts must stil i be
det ermined
A deta iled cnerectenzanon of host imm une react ions would de term ine If
the downregu lation of MHC class I presen tat ion on lymph o id celts by
tieoacnevuvs Infection influences the overall effect iveness of anti-
neoaona viratunrnune responses.
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CHAPTER 8:
SUMMARY AND CONCLUSIONS
In the cours e of the curr ent studie s. we exa mmed se lected mechanisms of the
un muncpetnoqenesrs of chronic live r injury and nepecnevuat persi stence using
the woodchuck model of he pati t is B , To facilitate this research we sequenced
seve ral relevant woodchuck genes and ge ner ated spec ific mo le cular reagents
wh ich «ere not ava ilab le cncr to the Initiation o f ttus wo rk . In add ition . we
adap ted assa ys for evaluat ing 10Vitro wood ch uck lym pho id ce ll cytotox ictty and
develo ped molecular met hod s for the c ue r rmenve det ecti on of w ood chuck
scecrnc cytoklOe ge ne ne necncton In norm al and VIrus- invaded tissues . The
use . In our studies . of biolog ical matenats coll ecte d from an imals dunng the
lifelong follow-up of adul t heca c navirar mrecncn provi ded a signifi can t
investig ative advan tage not availab le when examinin g HBV infect ed pati ents
Ov erall the results obtained can be summ anzed as tcuows
t . We have donee! and sequ enced se veral (14) wood chuck genes and gene
fragments releva nt to the hosrs Immune responses . inCluding Fas t..
pe rfo nn. MHC class I heavy cha in. p:- rmcroglObu lin. TAP 1. TAP2 . the
epsilon subu nrt of C D3 . IFNy . TNFo . IL-2 . IL-4 . IL-6 . GAPDH and l3-ad in .
These nucleo tide seq uences were subm itted to the Nati onal Cen te r for
Biotechnology Inf ormati on . Nat iona l Libra ry of Medicine . National
Institute s of Hea lth. USA (GenBank) and are ava ilab le to interes ted
Invest igators in the scentrnc community . This shou ld aid comp arativ e
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genetic studies and foster futu re research on the immunopathogenesis of
hepadnaviral infection in the woodchuck·WHV system ,
2. By analyz ing lympho id cells from WHV-infected and healthy woodchucks.
we have demonstrated that these cells ki ll cell ta rgets through both the
Fas/FasL and periorin-granzyme pathways. We have found that thei r
cytopathic capacity ca n be examined using heter ologous cells , such as
mouse P8 15 (which constitutively express Fas) and human K562 (which
are Fas negative) as targe ts . Comparative analysis reve a led that
lymphoid cells from animals with acute WHV hepatit is have an augme nted
capac ity to elicit perforin-dependent killing. In contrast, lym pho id cells
from animals with chronic V\lHV hepati tis . independent of the severity of
liver disease and duration of chronic ity, had the same or lower cytotoxic
potentia l as those from heal thy cont rols. Since perfor in mediated killing is
the primary mechanis m of NK cell cytotoxicity, these findings suggest that
nonspecific cellular immunity might be important in the early contro l of
WHV infect ion. This also suggests thai decreased perforin-granzyme
mediated killing can contribute to the establishmen t of CH in hecacnavrra!
infection
We have discovered that. in contrast to woodc hucks with A H, chron ic
WHV hepatitis is characterized by a profound deficiency in the expression
of MHC class r molecu les on the surface of infected becetocytes and,
notably, orga n lymphoid cells. This inhibi tion occurs despite upregu lated
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hepatic gene expression of MHC class I heavy chain. ~·microglobulin .
TAP 1 aOOTAP2. Further, the decrease In class I antige n display is not
re lated to seventy of liver injury . the e xtent of tymphocyti c infi ltrations. the
le vel of mtrebec et c IFNV expression or INHV load in the liver. Therefore.
our results Imply that the defecti ve cresentenco of MH C class I molecu les
on cells support ing Vv'HV repl ication in ch rome infecti on is due to virus
Ini tia ted posnranscript iona l mterterence . This event may diminish the
susceptibili ty of infected he patocytes to Immunocytotysis by virus -spec ific
T lymphocytes. tnnoe r vrrus clearance . and deregu late the class I MH C·
depe nden t functions of the ho st's Immune system and . therefore . may
support necee nevuus pe rs iste nce
AnalySIS of cytoklOe gene exp res s-on and C03 mR NA. a marker of "r-ceu
Infiltr ation . during the cours e of VVHV Infect Ion In adult anim als revealed
that he patic IFNy and CD3 mRN A levels we re s'9nrftca ntly upregul ated
dunng the acute phase of infection only In anima ls Who ultImately reso lve
viral neoanne Furthe r. th e results sugge st that hep atic TNF o gene
exp res sion fOllows a Sim ilar trend . but Il -6 leve ls rem am relative ly
constant. An imals that wou ld de ve lop cnrc mc V\lHV hep atitis had
minimally elevated he patic levels of IFNy a nd TN Fo transc ript ion.
Increas ed necetc WH V load and a lesser degree of liver infla mma tion
dunng acute infect ion . when com pared to an imal s with self limiting
hepatitis , These find ing s suggest that th e outcome of AH may be de cided
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very earl y in the course of hepadnavirus infection by the stren gth and
swift ness of the local cytcone and cellu lar immune responses . Theref ore .
it is conce iva ble that an enhanced innate and/o r specific respo nse to the
Invading virus favo urs recov ery from AH. wh ere as a diminished or delay ed
response and increased viral load predispose to the development of CH .
Furthermore . the hepa tic levels of IFN y and CD3 mRN A remained
Signifi cantly elevated in animals years aft er reco very from a self limi ting
epi sode of VVHV hepa titis. suggesting tha t stimu lation of host immunity
con tinues long afte r reso lution of acute infection . This is in agr eemen t
With ou r prev ious cbservencne tha t traces of replicating \l\lHV pe rsist fo r
life in livers and lymph atic system of convalescent. apparently hea lthy
emmers This finding also POints 10 Ihe potential significance of anti viral
cyt okines . In particular IFNy. In the control of long term occ ult
hepadn av irus persisten ce In the live r
Over all , our studies on the mech anisms by which immune effecto r cell s mediate
cytotoxicity and the ch aracte ristics of the cytokine res po nse suggests that an
ea rty and strong loca l immune res pon se permits the term ination of acute
necec nawet hepa ti tis . presu mab ty du e to the innat e Im mune response and
adequate pnrnmq of specific ann-viral reactivity. In cont ras t. weak or de layed
immune respo nses may allow enhance d v iral replication lead ing to CH that is
sustained . by the posttra ns criptiona l inhib ition of MHC class I expression on
infected hep atocytes and lymphoid ceus. Th is permits VoAiVto evade virus
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specific CTL , comprom ises the host's entire immune system and allows
perpetuat ion of chrome necaona veus Infecti on and continuatio n of liver dise ase
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APPENDIX A:
MOLECULAR BIOLOGY BUFFERS. REAGENTS AND PROTOCOLS
ACK buffer: 0.15 M NH..CI. 1 mM KHCO ], pH 7.3. in 0.1 mM EDTA
Agar plates: LB medium containing 1.5% Baeta-Agar (Oifco Laboratories . Detroit
M il was autoctaved. The solution was allowed to coo l to so· e and antibiotic
(kanamycin or tetracyc line ) was adde d to a final concentrat ion of 50 IJg/ml.
Ammonium actetate (10 M) : 77 .08 9 ammonium aceta te in water to 100 ml
Denhardt's solution (SOX): 1% Ficoll400 (Sigma), 1% polyvinylpyrrolidone
(Sigma) an d 1% bovine serum albumin.
Denaturing so lu ti o n (DNA ): 1 5 M NaCI and 0 .5 M Na OH .
Denaturing solution (RNA): 100 1.1 1of t OX MO PS , 350 1-11of 12.2 M
fo rm aldehyde (Fisher) . and 1.0 ;.I of formamide (Fisher) in ' .5 ml tota l vo lume .
EDTA (0.5 M): 18.61 g Na2EDTA*2 H:O in 70 ml wate r, adjusted to pH 8.0 with
10 M NaOH (- 50 ml), then water add ed to 100 ml.
Formamide stop solution: 10 mM NaOH in 95% tormenuce with 0.05%
bromophe nol blue and 0 ,05% xylene cvenore.
Forward reaction buffer (5X): 350 mM Tns pH 7.6 with 50 mM MgC I2, 500 mM
KCI and 5 mM l3·mercaptoet hano l.
GTE (glucoselTris /EDTA) : 50 mM glucose and 10 mM EDTA in 10 mM Tris· HCI
buffer , pH 8.0
Hybrid ization buffer (DNA): 5X 55PE (see below ). 5X Denhardt's (see above ).
1%, 50S . and 100 ~g/ml denatured salmo n sperm DNA.
Hybridization buffer (RNA ): 50% forma mide (Fishe r), 5X SS PE, 5X Oenhard t's.
1% 50S. and 100 !Jg/ml denatured salmon sperm DNA.
LB medium: 1% (w/v) peptone 140 . 0,5 % (w fv ) yeast ext ract , 100 mM NaCI (ICN
Biomedical Inc.), and 0.1% glucose (Fisher Scien tific) . Adj ust to pH 7.0
Lysis buffer (DNA): 100 mM NaCI, 10 mM Tris-H CI buffe r, pH 8.0 with 25 mM
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EDTA. pH 8.0. 0.5 % SOS and 0.1 mg/ml proteinase K (freshly prepared ).
l oa ding buffer (RNA): 50% glycerol. 1 mM EDTA. pH 8.0 . with 0.15%
bromo phenol blue , 0 15% xylene cyano l and 1 IJI of a 1 ~9/~ 1 ethidium brom ide
added to each sample
L oadi ng dye (DNA ): 0.25% bromophenol blue . 0 .25% xylene cvencr and 15%
Picou 400 in ddd wate r.
MOP S buffer: 0.4 M 3-(N.morpholi no)-propa nesulfonic acid . 0 .1 M sodiu m
acetate and 0.01 M EDTA (Sigma)
Neutralizing solu tion (DNA): 15 M Na CI in 1 M Tris-HCI buffer. pH 8.0.
PEG so luti on : 30% (wI ll) polyethyle ne glyco l (PEG) 8000 (Sigma). 1.6 M NaCI
(Fisher). Filterthrough a 0.45jJm fitter
Ph en ol (b uff ered ): Add 0 1% (wI ll ) of a-hy dro xyquin oline (S igm a) to 25 ml of
me lted phe no l and adjust pH with 25 m l of 50 mM Tris ba se (Sigma) . Mix for 10
min and allow phases to sep ara te . Disca rd the excess Tns base . Add an equal
volume of 50 mM T ris-HCI buff er. pH 80. to the rem ain ing phenol. Mix fo r 10
min. allow the phases to separate. and d iscard aqueous layer Repea t 3 times
and store at 4 ' C in 50 mltubes « 2 mo nths)
REa ct 3 buffer (10X) : 500 mM Tris . pH 80. w ith 100 mM MgCI: and 1 M NaCI.
RNa se de co nta m ination :
Tr eament of water: To prepare RNase-free water ddd H,Owas treated
with 0.1% (vlv ) diethyl pyrocarbonate (DEPC; Sigma ) at 37°C overnight
and then autccta ved fo r 45 min .
Treatment of eq uipment: The electrophoresis tank . gel cast ing trays and
combs were decontamin ated usin g 0.1 M NaOH con ta ining 0.01 mM
EDTA and the n rins ing seve ral t imes w ith DE Pc-t reetec water.
Disposable Eppenoorf homog enizers (Fisher Scie ntifi c) were rinsed
overnight at 37"C in 0.1% DEPC an d then autoclav ed
SOS (10%): 10 g sod ium dodecyl (lauryl) sulph ate in 100 ml water . fi lte r th rough
a c.zum tuter
SOC med iu m : 2% (wlv) tryptone. 0.5% (w/v ) yea st ext ract , 10 mM Na CI (Fisher
Scientific). 2. 5 mM KCI , 10 mM MgC I:. 10mM MgSO. and 20 mM gluco se
(Sigma)
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Sodium Acetate (3 M ; pH 5.2) : 40 ,8 9 sod ium acetate -a H:O in 80 ml w ater, add
wate r to tO O ml and adjust pH to 5.2 w ith 3M acetic acid
sse (sod i um chlo rid e/sod ium citrate; 2QX): 3 M NaGI (Fisher) in0 .3 M
CeH~O.N a 3 ·2 H:O. adjusted to pH 7_0 with 1 M He l
SSPE (s ta ndard sodium phosphate EDTA; 20X) : 3 M NaG!. 0 .2 M
NaH :P O/ 'H:O. and 20 mM ED TA
rAE (t OX) : 10 mM EDTA in 400 mM Tris-He l buffer , pH 8.0
TBE ( tOX) : 108 9 Tris base . 55 9 boric ac id . 40 ml 0.5 M EDTA (pH 8 .0l , add
dd d wate r to tt. .
TE Buffer: 10 mM Tr ts-C! (pH 8 .0). in 1 m M EDT A (pH 6.0)
X-Ga l: 40 mg of s-bromo-a -cnto ro-a-m octv t (3-0-g alacto-pyranoside res uspended
In 1 mr of d imethytformamide (DM FO)
All reagents were obtained from G ibco BRl unless otherw ise noted .
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APPENOIXB:
WOODCHUCK GENE SEQUENCES CLONED DUR ING THE STUDY
Appendi x Sequence Name Genb ank Ac cess ion Nymbe r Release Date
B 1 Fas Ligand AF15 2368 Feb 7, 2000
8. 2 Perfor m AF298158 Oct 22 . 2000
B 3 MHC class I AF232723 May 9 . 2000
B4 TAP· ' AF232724 May 9. 2000
B.5 TAP-2 AF232725 May 9. 2000
B6 !32-microglobutin AF232726 May 9. 20 00
8 .7 C03 c AF23272 7 May 9. 2000
86 IFNy AF232728 Ma y 9. 20 00
8 9 GAPO H AF232729 Aug 17. 2000
8 .10 !l-aet in AF23 2730 A ug 22 . 200 0
B.11 IL-2 AF333964 May 12. 2001
B.12 IL" AF333965 May 12. 200 1
8. 13 IL-6 AF333966 May 12. 2001
8. 14 TNFo AF333967 May 12. 200 1
The fOllOWing appe ndice s document woodcnucx seq uence s tha t were cloned in
th is laboratory dunng the co urs e of the prese nt study . These sequences are also
available by their accession number in a sim ilar form at at Nationa l lnstrtute of
Health Genbank. accessible at www .ncbi .nlm ,nih.goy.
cos
lOCUS
DEFIN ITION
ACCESSION
VERSIO N
SOURCE
FEATURE S
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Ap pend ix 8. 1
A.F152368 ~B bp mRNA ROO 07-FEB-2000
Marmo ta mon ax Fas l'9and mRNA.. pal"bal ces
A.F152368
AF152368 1 Gl5051980
woodc hu ck
Loca t,or'llQ ualifie rs
1 508
lorganlsm: "Marmota rncnax"
Idb_n ef="taxon 9995"
'tISSI.>e_!ype "' 'l1ea ltl'ly liver"
<1 "508
no te" ··apo pU)SlS ll'lduc lfl9 prot e ," . COOS 1'9 8nd. APQ.1bgand"'
ICOdcn starr=2
PI'ClOtJd="FaS!lgar'ld-
,pro tetn 1d""AA03838 7 r-
td tu rre t.:-GJ 505198'"
'!l"iJnslauon =-L FHLQ KElPElRESINQ R NTEPSL EKQ IGMPSSPSOKKAL RRAAHLTG KPN SRS SPL
EVVEDTYGISL.I$GVKYQKGGLV1NOTG LYFV'I' SKlYFRGQ SCN NQ PLSH KV'YV KN St<YPQ OLVlM
EGKMM NYCTIGOMW ARSSYLGAVFNFTSNDHLYVNVSElSLlNFEES'"
BASE COU NT 142 8 130c 122 9 1'41
ORIGIN
1 gctcneea c etgcagaa gg aaetgc:caga aetccgc:gag reaatea atc aaagaaatac
S1 aga acca lC1 nggagaagc aaatag geea eeeeaenea eeetctqate aaaaggcaet
~2 1 9ag93989c9 gccca tttaa caggtaagcc caactcaaqg tccagcccgc t99aat9g ga
~ 8 ' agacacclac ggaamcc c IgatClctgg agtgaaglat caga"gggtg gcettg lga l
241 caalgacact gggClglaCl ttglgtatlCcaaaatatec ttccggggl c aglcclgcaa
301 eaacceccee clgagccaca i1ggletaCgl gaagaaclcl aa gullcccc ag9acetg9t
361 gC:gCllggClg ;g C2aga tga IgClactactg eaeta o ggc ta9i1lg1g99 CCC9C39C3g
421 cUlto9g99 gCtgtgttca ecececces taatqeccat ttatalglC33Cgla ld ga
48 ' ;ClClr::tCtg i1tcaamtg asga.nevl
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Ap pendix B.2
LOC US
DEF INITION
ACCESSIO N
VE RSION
SO URCE
FEATURES
cos
AF2981SB 718 bp mRNA ROD
Marmota l'TlI)nall perlonn mRNA partia l cos
AF2981 58
AF2981S 8 1 GI 10945604
WOOdCn ucll.
location/Qualifiers
1 ,715
'ofga nl$m"'-Marmotil mona.:
'dO xrefz "ta>con999S"
"' -; 718
1unc t lOn="1ormS oores In merTll)ranes -
'COdOl"l_ 5ta rt"' 1
'pl'lXlua=-pe r1ol'ln"
'pro lem od"'"AAG246 11 ' "
'db_xref;, -<;I '~S605·
,'tranSlabOn "' -F~TaRFLRPDGTCTlCKN PLaKGALORLPLAlTH'lv'RGQGSSCRRQVAKAJ<lSS
TEEVAREAASSINNDWRVGLOVTPPEPSSKVHMSVAGSHSKAADFAAQKTHO OOvSFSTOTVEC
HL YSFHWHKPPLHPDFKRAlGDLPPHLNTSTEPOYLRLl HNYGTHFI RSVE LGG RVSAL TALRTC
ALA LDG LTADEVGOCLAVEAOVSIGGHAESS SEFK,ACEEKKO RHKMIT SFHQTY'"
BASE COUNT 149 a 252c 2059 ' 12 1
ORIGI N
, ttCCc.aglgg aca ca ca gag gncetg cgg cccg acggca cctgcaCCC!ctqtaaaaac
61 cccc:\Ica ga agggcgccet gcagcgtClg cccetggcr~c lcaccca ctg gc9199Sca9
121 ggclccagc l 9cag9cgcca agtagccaag gccaaaalca gClccaccga gg~9lggcc
~8 ' c999a9gcgg cctccaqcat caacaatgac tggcgggtgg 9gct99acgt aaceccccc
24 1 ~agcc:cagca gcaagg tgca calgtetgtg getggetcgc aetcca aggc agcggaettc
301 gcag cccaaa esecccecca ggaceag tae agctteagca cgga cac ggl 99ast glcac
361 et~tt tcca lglgg! gc.aa.accc ccecccecc etgiItttcaa gagggcaetl
42 1 99993CC1gcccccecacct caacacetce accgagcctg ~ceteaggClcalCCitC
481 aac".a<:ggc.acccaetteal ccggtccgtg gagetggQt9 gccgagtetc agccctcacg
541 gccetae gca CClgtgcaet ggcettgga l 999etcacgg ocgaeg.aggl 99QG93Clgc
501 Cl99Cl9t99 aggctt.aggl 9ageateWl99cc:a!gCC9 agteetealC cgagtteaag
55 ' go:tgcgagg ag aaga<f9Ca~ atga :aaect craccacca aacetaa:
cos
ACCESSION
VERSION
SOURC E
FEAT UR ES
scc ree
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Appendix B .3
LOCUS AF23272 3 276 tip mRNA ROO 09-MAY -2000
DEFINITION Ma rmo ta mor'Iax MaJOt1'I1$I00000panbllJty complex ClaSS I l'Ieavy d'Ia ,n mRNA,.
p<il1l31 CdS
.m..F232723
A.F232723 1 GI 7739665
WOOOCh..c><
l oca tlOlVOualrflers
1 276
-organ,sm ="Marmo ta mona.-
-ee . ref=--ea...on9995"
- C1 "'27 6
onole:~alpt1a 3 regen"
'cooon_sta rP 3
'Pfod uet=" maJOr l'1,stoco mpatlblhty co mple x ClaSSl neavy I:lIa ln"
IPfote,n .d"'"AAF68955 1"
Id tl_ xre;;' -GI 7739666 "
Il ranSlallOn ","PPKTHVT HHPSPEGEVT LRCWALGFY PKEITLTVIIRROGEDO TO EMELVETRPSGD
GNFOKWAAVVVPAGEEQ RYTCRVHHEGLPEPLTLRW
BASE COUNT 55 a 75 c 87 0; 49 I
O RIGI N
1 atcetccaea gacccatglg aet eaeeacc: etagCCetg<lag gag ag glC aett=taaq51t
5 1 gctgggccct gggettetae cetaaggaga «acccaec nggcgac;a 9al9999a99
1 2~ acca gaceca ggaga lggaa ettgtggaga ccec eccrtc 19999.1lgga aaettccaga
181 aatgg gca.gc tgtgg lgglg ce:t9ctgg ag aggagcagag ataeaeClgc cgtgtg cacc
::4 1 aig aggggc: 9CdQagccc eteaCCCtga gatggg
CDS
ACCESSION
VERSION
SOU RCE
FEAT URE S
source
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App end ix 8 .4
lOCUS AF232i2A 1359 bp mRNA ROO 09- MAY-2000
DEFIN ITION Marmora monax transporter assoc.atec "",ttl antigen processing TAP_l
mRNA. partial cos
AF232i2A
AF23272A 1 GI7739667
woodchuck
l ocat ion/Qualifiers
1 1359
lorganlsm="MarmOla monax
Idb n et="ta lton 999S"
- <:1 " 1359
.cco on sta rt= l
Iproduct="transporte r assccatec wllh antigen proces sing TAP- 1"
iprote,n_ ld="AAF68956.1'·
Idb_",ret="GI773966 8"
't rans la l,on=''WIl QOKTATTLTRNITl MCILTIASAllEFVG DGIYNSTMGRVH$ HFQG KVFQ AVLRQ
ETEFFQQNQ TGNITSRVTOOTS TLCES lSEEL5ILM\lVYlVRGLCLlGLML'NG SlSLTLV'TLAAlPL
LFLLPKKLGIWVCOSLGVQVRDSLAEASQVAIEALSAMPTVRSFANEEGEAOKFROKl EEMKTLN
Q KEALA YAV NLCTTQV$GLLlKVGI LYIGG Q MV ITG T ISSG NLV AFVL YQI QFTVAVKVLLSAY PRVQ
K.4IG SSEKIFEYLDRTPRCPPRGLlIPSNMKSLVQFQQVSFA,YPNDPDVLVLQGLTFTLYPGKVT AL
VGP NGSG KSTVAAL LONLYQPTMGQLLLDGEPLPQY EHRYLHR QVAAVGQ EPOLFGRSI QENIA
YGLIQ KPTMEEIKSAAIQSGAHSFISGLPQ GYDTEV GEAGGQLSGGQRQAVALA RALIRKPRVUL "
BAS E COUNT 325 a 345 c 373 9 315 t
ORI GIN
1 199artctac aaga lilagac aqctactac t rtaacccgaa acatcactct tatgtgcatt
61 etcaccatag Ccaglgcact gctggagttc glgggcgatg gga tetataa cagcacaa tg
121 gggcglg:ac ataqtcactt tcagggaaag gtgmcagg etgtcctgcg ccagga gacg
1a 1 gagmttcc agcagaacca aacaggtaac a teacctcte gagtaacaga tcececncc
241 accctglglg agteletgag tgaggagctg aqcatattqa :glggtacct ggtgcgagga
301 ctgtgtetclt ggggclcat getetggggg tcactq tccc tcaecetggt caccctgg et
361 qccctqcctc tgcnnccl tetgcetaag aag etgggaa aatgg tgcca glcaetggga
421 glacagg tgc gggaetclCtggcagaggcc agccaggtgg ccalc gaggc cetgtcaget
4a 1 atgcctacgg tccggagett 19ccaalgag gaaggcgagg cccagaaglt taggcagaag
541 clggaggaaa rqaaqecact caaccaaaaq gaggccet gg cctatgcagt caacctgtgc
601 accactqarq tCtcagggct gctgetgaag glgggaatcc tataea ltgg tgggcagatg
~61 glgataacag ggactataag cagtgggaac C1tgltgcat ttqttctcta ccagatacag
721 ttcac cgttg clgtcaa ggl getgcmct qcctatcccc gggtacagaa ggetataggc
781 tcctcagaga aaatamga atatetggac cggacccctc getgccca cc cagggglcta
841 ttgattccct caa acatgaa gagcettg tc cagttccaag atgtetcett tqcctatcct
901 aatqatcca q acqrcctaqt gctacagggg ctqacattca ccctatatcc tggtaaag tg
961 acagcacta g tgggaccca a tggatcaggg aagagcaetg tggctgccet gctgcagaat
1021 cetecca cc ccaccat ggg ccagc tgetg etggalgggg eqccccrtcc tcaatatgaa
1oa 1 catcacta cc tgcaeagaca ggtggetgca glgggacaag aaccacaqct gmggaaga
1141 agtattcaag aaaatattqc etatggtctg atccaqaaqc caactatgga ggagataaaa
1201 aglgclgcaa taca gtetgg agcccatagt ttcatttctg ggctccccca gggctatgac
1261 acagag gtag gtgaggetgg gggccagClg lca ggaggtc agcgacaggc agtggccttg
1321 gcccgagca t 19attcggaa gccacgtgta ctcancta
CDS
ACCESS ION
VERSION
SOURCE
FEATURES
source
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Appendix 8 .5
LOCUS AF232725 1121 bp mRNA ROD 09-MAY-2000
DEFI NIT iON Marmota monax transporter associated with antigen proceSSing TAP·2 mRNA.
ceruarcos
AF232 725
AF232725 1 G1:7739669
wccccnuoc
Location /Qualifiers
1 11 21
Ic rganism: "Marmota monax'"
Idb xref: "taxon9995"
- <1..:>112 1
Icodo n_start::3
'prccucte'transponer associ ated With antigen proceSSing TAP·2"
rc rc tem 'd="AAFS8957. ' "
ldb l(ref;,"GI.7739670"
ItranslatJon="GGDFD PDAFVSAIFFMCl FSVGSSLSAGCRGGSFTFIMSRINLRTREQl FSSLLRQD
LSFFOEIKTGELNSRLSSDTTLMSRVv\.PLNANV ll RSLVKV1Gl YGFMLSVSPRl TFLSMLEMP LLJA
VEKLYNMRHQAVLlEIQOEVAKAGOWREAVGG lOTVRSFGA EEDEVC LYKKA VERCROLWNR
ROLERAL YLLIRRVLTLGVQVLVLSCGLQQ ILAGEVTRGGLLSFLLOOEDMGNYVRALVFGFGOML
SNVGAAEKVFRYLDRKPNLPEPGTLAPPTLOGJVEFODVSFAYPNRPDQPVLKGLTFTLHAGEMT
ALVGPNGSGKSTVAALLONLYQPTGGRLLLDGEPISNYEHHYLHSQVALVGQEP"
BASE COUNT 21101 291 c 358g 261t
ORIGIN
1 Igggcgg\ga lttlgacccI galgClttlgtcaqcqccat amncalg tqcctqrtct
6 1 ccgngggag ctcqctqtct gcaggttgcc gagggggc(Ccrrteccec atca tqtcca
121 qeatcaactt gcggacccgg gagcagcm IctccICCCI gCIgcgtcag gaCClcagn
181 tcttccagga qattaaqaca ggggagttga actcacggcI gagetcagat ecceccctca
241 Igagccgc Ig gcttccma aalgeeaatg taatcttqcq gagcctgglg aaagigalcg
301 ggctg latgg cnca lgCtg agcgtgtcac cgcgaetcac cncctctcc algctcgaaa
361 tccccecct aa tagcagtg gaaa agcIgt aca ata lgeg cca tcaggcl gtgclgel gg
421 aga leea gga 19aagtggcg aaggcaggge aggtggtgcg ggagg cagtt ggcggge lge
481 agaecglgeg cagtmggg gcega ggagg atgagglelg cctc ta taaq aag getgtgg
541 agegglgecg geag ttgtgg tggcgaeggg acctggaaeg 1ge1etgtae elge na tae
601 ggagggtgel gacctt gggt glgcaggt gc Igglgetgag clgcg ggctg cagcagatee
661 tggctggcga gglcaegagg ggcgggetge tctccmct getcga eea g gaggacalgg
721 ggaaetaegt tegagctetg gtamggtt ttggtga ta t gClgagca ae 91g9gagetg
781 eaga gaag gl mcagatae elggaeag aa agecca acc:lgeetgagcca gggaetetgg
841 cccctcccac aetgcagggg attgtggaat tcca agacg t ctcarnqca terccca atc
901 gccetgaeca accIglgete aaggggetga cq ttcaccc t eca cgctgga ga gatgacag
961 egelggtggg acecaalggl tetgggaa ga gcactgl gge tgcce lgetg caga atetgl
1021 accaqcccac aggegggc 99 etgctgttgg a tggggagcc caretca aae tatgagcacc
1081 ectacctaca cagccagglg gcmggng ggcaggagce c
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lOCUS
DEFINITION
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Appe nd ix 8 .6
AF232 726 331 bp mRNA ROD l)S..MAY- 2000
Marmota mDNll be fa-2-l1"11Cf09lotlullnmRNA. p.artJal CdS
AF232726
AF23272a 1 Gl n 39671
*OOdchuek
LocatlOnlOuaa.fiers
1 331
lorganlsm· -Marmota mor'Ia"'-
.'db_u ef='1axon 9995-
<1 :0331
Il'IOl e","M HC Class I lig ht cnaet"
.ccc ce sta","3
Product..·beta·2·mlCl'og~bu l in·
IprOlell'l_od"'"A,AF6895S.1"
:db_u e"'''GI77 3967 2"
ItranSlal lon""V ALALFMl LFLTGLOAOPRSPKIQVYTRHPAENGKPNFLNCYVSGFHPPQIQIDLl KN
GO KIEKVE QSOLSFSKDVVSFYLL VHTE FT PNDKD EY ACRVTHETlKEPKIV'
BASE CO UNT 95 41 84 c 72 9 80 t
ORIGI N
1 C99199C9ft ggccngttc afgetactC1 ttetgaccgg !ctggacget gacccgcg tt
6' ctccqaeaat lCa~mal aeacggcacc eagctgagaa !ggaaaaccg aececctca
121 actgetaegl atetg9gttl eeeeeeeee agatt::aaal agate:t9ttg aaaaacg gac
181 agaag alaga aaaag!C9ag caglCgg acc ICtCttlcag Coaa9gaCI99 tccttctatc
241 ttclggtgc.a caetgaattc accccca.llg ataaagatga atacqcalgC-ag otgttilCaC
301 atgaaaet:t gaaggagco: .agatag lga a
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App end ix B.7
AF23272i 535 bp mRNA ROD 09-MAY-2000
Marmota mo na» C03 epsi lon cnam mRNA . ceruer cas
AF23272i
AF23272i 1 G I 773 967 3
CDS
LOCU S
DEFINITION
AC CESSION
VERSION
KEYW:)ROS
SOURCE
FEAT URES
WOOdChu Ck
Loca tion/Qualifiers
1 535
orgamsm="Marmot3 mona x·
idc_xref'=."!axon999S"
<1 >535
'note: 'i CR a ccessory molecu le"
'COdon sta rts t
'prooucr-"CD3 ecsuce chain "
'pratem_ld="AAF68959 t-
Jdb_ xref="G I 77 396 74"
Il ranslatlOn="l GLCLLSVGAWG a EDDEENDOLTQ IQYKVSISGTDVMLTCPPKALOGTIN'oVERNDK
KLEG ENDEQULKNFSEMDNSG VY ACYTIPRQKEN IHFLYlRARVCENCV EVDlTAV ATVlWDIiV
TLGLLMlVYY'NSKNRKAKSKPVTRGAGAGGRPRGQKKERPPPVPNPOYEPIRKGO"
BASE COUNT 168 a 117 e 141 9 1091
O RIGI N
, ctggga c::tct gcctettatc agnggtget tg9999ca99 aaga tgatga agaaaalgat
6 1 gacc tClacac agatacaata caaaqtctcc aletcgggaa etgalgtga l gctgaca tgc
121 cctccea aea Clclgca ggg cacaetaeet tgggaaa gaa atqacaaaaa acta gaaggc
181 gaaaa lgacg eecaactqat actqaaqaat mtcagaaa tggataacag 199na lla c
241 gcclgetae a caa ccccaag aca aa aa gag aatatccatt ttctqtacc t gagagClaga
301 gtglglgaga aClgcgtaga ggtggatctg acggClgtgg ceacagtcal cgtagtcgac
361 alcattgtca ctetgggcttgctgalgctg gmattaClggagcaagaatagaaaggcc
421 aaqtccaaac ctgtgaca cg tggagcaggc gClggtggca ggcccagggg acaaaagaag
481 gagag gcca c caccroncc caacccggac tatgag ccca tccgga aag9 cca gc
CDS
lO CUS
DEFINITION
ACCESSiO N
VERSIO N
SOURCE
FEATURES
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Appendix B.8
AF2327 28 530 bp mRNA ROO 09-MA Y-2000
Mermcta mc nax Interferon gamma mR NA, complete cas
AF232728
AF232 728 1 GI 77 39675
wood chuc k
Location/Qua lifie rs
1530
,organ,sm="Marmota rocn ax-
idb_xref: "ta xon 99~5"
22 522
lnot e::"IF N gamma"
.coooe start= 1
Iprod uct= "lnterferon gamma"
Iproteln 'd="AAF68960 1"
Idb xref:"GI 77396 76"
'Iranslat lon="MKYT SYFlAFOLCIILGSSSCYS OOTVNKEIEOLKGYFNASNSNV SDGGSLFl DILDK
WKEESDKKV1QSQIVSFYFKL FEHLKDNKlIQRSMDTIKGOLFAKFFNSSTNKLOOFLKVSQ VQVN
DlK1QRKAVSELKKVMNDL LPHSTLRKRKR SaS SIRGRAASK"
BASE COUN T 176 a tcae 1W g 1411
OR IG IN
, ggcetaact c tctctqaaac gatgaaatac aca agttatt tettggcrn tcaqcrctqc
61 atcartttqq gttcttCtag ctgttactcc caggacacag ttaataaaqa aatagaagal
121 ttaaaaggal amcaalg c aaqtaattca aa rqtatcaq atggeggg tc fCtettettg
, 81 gatatltlgg ataaatqqaa ag<J9gagagt gacaa aaaag taatecagag ccaaattqtc
241 tcmctact tcaaactcn tgaacacna aaag acaaca aqatcatcca aaggagcatg
301 gacaccatca aggggga tci ttrtqctaaq ttcncaaca gcagtaeeaa taagCl:gcag
361 gacttcctaa aggtglClca agtlcaggt.a aalg aCCl:ga aqatccaqcq taaagcagtg
421 aglgaac lca agaaa gtgat g;,atgatCl:geac caca cr ctaccctaaq gaagc gaaaa
481 aggag tcagt Ctlcgancg gggtcggaga gcatcca aat aacagtcete
CDS
LOCUS
DEFINITIO N
ACCESS ION
VER SION
SOURCE
FEATURES
264
Appe ndix B.9
AF232729 535 bp mRNA ROO 17-AUG -2000
Marmota rncnax glyceraldeh yde 3·phosphate dehydrogenase mRNA . partial Cds
AF23 2729
AF232729 .201:9838357
wccccncck
Loca tion/Qualifiers
1,535
lorganism::"Marmota monax '
Idb xref:: "laxo n:9995"
- <1,.>535
Icodo"_sta rt=J
Iproduct='Oglyeeraldehyde J-phosphale dehydrogenase: GAPDH"
{protein_ ld"' -AAF68961,2"
Idb xret="GI9838358"
Il ranslat lOn="DPANIKVVGDAGA EYWESTGVFnMEKAGAHl KGGA KRVIISAPSADAPMFVMGV
NHEKYDNSLKIV$NASCTTNCLAPLAKVIHONFGIVEGlMTIVHAITATQKTVDGPSGKLWRDGR
GAAQNIIPASTGAAKAVG KVIPELNGKLTGMAFRVPTPNVSWOLTCR LEKAAK"YOO"
BASE COUNT 120 a 144 c 144 9 127 1
ORIGIN
1 gagatc ccgc caacatcaaa 1999919al9ctggtgctga atatgttgtg qaqtccactq
6 1 glg(C!ll;<lctaccatggagaaagccggggctc:atltgaaggglgglgccaaaagggtc:a
121 1c:atttctgcaccl!ctgctgalg=ccalgltlgtgatgggcgtgaacl;<ltgagaagl
181 algac:aaclc cctcaaean glcagl;<lalg cctcctqtac caccaactqc ttaq ccc ccc
241 199ccaa ggl catccatqac aacrnggca nglggaagg ac rcatqacc aeaglccatg
301 ccatcac tqc laeteagaag aClglggalg gcccclctgg gaaacIgt99 cgtgatg9cc
361 gtggggetgc cca qaatatc atcc ctqce t ccac tgglgc 19ccaagg ct glgggcaagg
421 tcatccctqa actgaalggg aaqctcacrq gcalggctlt ccgtglgcec actcccaatq
481 19tca gtlgl ggat ctga cc tgccgcclgg agaaagetgc caaatacqat gacat
cos
LOCUS
DEFINITION
ACCESSION
VERSIO N
SOURCE
FEATUR ES
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Appendix 8 .10
AF2327JO 1355 ee mRNA ROD 22-AUG-2000
Ma~ mona" beta-actln mR NA Dar'bal CdS
AF2327JO
AF2327303 GI9 664779WOO<lch=
locallOl'VQual,fiers
, 855
·organrsm. -Marmota rnona.~
'00 J[re"'"ta.0I'l 9995~
- c l >855
«ecce sta~ l
'orod uCP ""beta..Ctln "
'proteIn 1O" "AAF689622"
lob xre~·GI 9864760'
.'tranSlal lon=·'IEHGIVT NVvtlOMEK1WH HTFYNELRVAPEEHPVLLTEAPLNPK,ANREKMTQIMFETF
NTPAMYVAIQ AVlSlYASGRTIGlVMDSGDGVTHTVPIYEG YALPHAILRLDLAGRDLTDYLMKJLT
ERGYSFTTTAEREIVRDIKEt<:LCYVALCFEO EMATAA SSSSLEK SYELPDGQ VITIGNERF RCPEAL
FQPSF LGME SCGIHETIFNSIMKCDVDIR KDl YANTV l SGGTIMYPGIADRMOKEITALAPSTMKI
KIIAPPERKY SV'MGGSiLA SLSTFQOM"
BASE COUNT 187 ill 262 c 223 9 183 I
ORIGI N
1 i1ttgagl:alg gC3ICgtC3Ccaa et99ga c gacalggag a ilIgam ggea eea eaeene
61 tat:aacga gc Igcglgl9gc lCCfgagg39 cacec:glgc 19ctgaeeg a 99ctccect9
121 aao::etaagg ccaaccglQiI gaa9at~ ca gatea lgl tlgagao:t'l caececccca
181 gcca lgtatg tggc:atCCil ggctgtgctg t=tgtatg e::te1ggccg taCQct ggc
241 atlgtgatgg aetcc ggtga !;g ggtc:acc cacacagtgc cca!etatga gggg tatgcc
301 ettccccacq ccatcetgcg lCt99acetg getggccgg g itCCtgac.aga eaccu:atg
361 aa ga:cetga etgagcgtgg etaeaqettc eccaccacaq ccg otgcggga aa!~tge;t
421 gaeatcaagg agaagctgtg etaegtlgcc etg gacttcg agcaggaga! ggccaetgea
481 gceteta 9d ccu:e:et99a gaagageta c gagetgcctg at;g tcag gt gateaee.ltl
541 ggcaatgagcga~ CC:etgag p eterteeag c ettettlcet gg;catggaa
!SO,teagtggca teea!gaUC ~caac tce.atca !ga agtgtgacg t t;acattcgc
561 aag gacetet a~acac a gtgetg ta gglggc:oc:caccatgtaccc: agg ca nga
72' gaeagga tgc aga ag; ag al cacagccctg gcacccagca ca atgaagat caa qatcatc
:'91 9a=9 agc:;eaagla :tagt;t9 ; attgg cgga cca tcctggc aaetgtCC
~1 ac..-nc:agc agatg
cos
lOCU S
DEF INlTlQ N
ACCESSIO N
SOU RCE
FEATUR ES
sccree
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Appendix B.11
AF333964 237 bp mRNA ROO 12-MAY- 2001
Marmota monall It'lte r'eulun -2 mR NA. partia l CdS
AF333 96-'
'""""""'"LocatlONOuall!'>e,."
1 23i
'orgarltsm: "Marmo l.3lmonalt -
Idb_xre f="taxon 999 5·
<1 209
lnot e : "lL·2"
ICOdon_sta rt= 3
IprOdUCT"-I r'lterleu~lt"2·
'IranslatlOn: "EEVLNVPQSKNFHLKDTRNFISNINVTVL KLKGSATTFTCEYAQETANIVEFl NTVVIT
FCaSIl5KLT'"
BASE COU NT 75 a 57 c 499 56 t
ORIGI N
1 Ig9a9ga a91 getgaafglil CClcaaagca aa ee cmca etlg aaagal accag9aaa
51 tca tca gca a catcaat:gtg aClljimetga aaaaaagg9 alCcgccac:g acgttcactt
121 gtga gtae gc cca ggagaca gcgaacattg tagaarltet ga acacatgg atcace mt
181 gcca aag cal ca tetcgaag ctC3cttgag aattaggtgc eto::cg lgti taacatc
cos
LOCU S
DEFINITIO N
ACCESSION
SOU RCE
FEATUR ES
"'"=
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Append ix 8 .1 2
AF33396S 417 tlp mRNA ROO 12-MAY·2001
Ma nnClta monaJl ,"!el'1eu kln~ mR NA. pa rtia l cds
Af 33396 5
000=""
LocalJOl'IIQuallfiers
1 4 17
'organ,sm" "Marmota monaJl~
'do_xref'="la xon 99&S"
, >417
Inote " ' L-4-
.coeoe 5tart: '
Iproducr. -, n leneuk'~·
'tranSlatlOn",-MGLSSQLlA TLFCLLVCPGNFTHGCNvnEEIIKTlNTLSGKKLVPKTTCMEVMVAnV
FAVPKNTT EKEILCTATlVLRQTYODHPVSRCLNKNGKl OILKLLRG LYRNl RSMAOLHNCPVS ES
RORTlKDFLESLKRI"
130 .. ' 4 1 1nOle=" lfIse" lOn relall ve to other mterteukm-a gen es "
BAS E COU NT 124a i tt c 92 9 90 t
ORIGIN
1 alggglCtca getcecagClgan gccae:t etettet gtc tecta gla!g tcC1ggca ac
5 1 ttcaceeac:g galgcaaegl laccttag aa ga gall;a tea ail aett'lgaa cacaetetca
121 gggaaaaagc nglgccaaa gaetacalgC atggag gtga tgglagcag 3 cg tcmget
la l gteeCCaagaacacaaccg a gaaggaaa lc etaqcacgg etaea~gt gcttcggc.ag
241 acetall:aag aCGaCCC99t ;~919t ttgaaca aaa atg~aaet 19aca ttete:
301 aaaCtCdga gaggitClc-.a caggaao:tC cgaag cat gg =agttgca caaetgt=
361 glgag lgaa l =ggcagag aacangaaa gactt ::etgg aaag~ aaggatc
CDS
LOCUS
DEFINIT ION
ACCESS ION
SOURCE
FEAT URES
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App endi x 8 .13
AF333966 654 eo mRNA ROD 12-MAY-200 1
Marmota rre oax Interleukln-6 mR NA, partial cds
AFJ33966
woodchuck
l ocation/Qualifiers
1654
lorganlsm="Marmota monax·
Idb xret="taxon 999S"
22645
mo te:"IL-6"
ICOdon_ sta rt= l
'prod ucr-"lnterleuK,n-6"
Itranstallon="MKFFSIASLGl LlWATAFPASELQREDGENSVTRNKPTRASSGKTAGO ISYlIKEVF
EMRKELCKNDETCIKSHVAVSENNLNLPKMTEKDGCFQTGYNRDNCLVRITSGLlEFQVVLRYIR
NKFQEGNN RDRAEHVQFSSKAlIEILKQEVKDPN KlV FPSPTAN1NLLAK LESQ NDWQKVMTMOLI
LSNFEDFLQFTLRAVRKA"
BASE COUNT 1963 153c 153 9 150t
ORIG IN
, atctqccctt caggaal:agc C<llgaagttcttctcaattq cctcctt999 gClgclccta
61 glgglggcta etgccttccc cgcctcagaa cnca gagag a398 199898 gaa tagtgtt
121 actcqaaata aaccaacacg 19cetcttet 9gaaaaaccg caggacagat ncctacctc
181 ateaaggaag tcttcqaaa t gagaaaagag ctgtgca aga a lgatgagac ctqtatcaaq
241 agccalgfgg cagtgtccga aaa ca atctq aaccttccaa agatgactga aaaagatgga
301 tgcttcca aa ctggatacaa tcgggacaac IgCCttgtgc gaatcacctc tgggcttc tg
J61 gagmcagg tctaee tga g gta catcc gg eeceecrnc aggaaggcaa taacagggac
421 agagClga ac a lglgcagtt cececcaaa gccctgattg agatcctgaa acaagaggtg
481 aaqqatccca ataaaataqt cttccctaqc cca actqcaa atatceecct attggca a aa
541 ctggag tcac agaatgattg gcagaaggtc atqaccatqc aactcstcrt gagcaaettt
601 gaggamcc tgcag ttcac cClgagagClgncgg aaag ca tagtgggc a tct
CDS
LOC US
DEFINITIO N
ACCESSION
SOURC E
FEATU RES
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App end ix 8 .14
AF33396 7 712 ec mRNA ROD 12-MAY-200 1
Marmota monax tumor necrc srs factor alpha mRNA. complete ccs
AF333967
wood chlJCk
Location/Qualifiers
1 ,712
lorganls,m"'"Marmota monax"
Idb_ u ef="laxon 999S"
' .702
mOle'O'TNP'
zcodon starte t
Iprod ucr-" tumor necrosis facto r alpha"
'l ranslatlo n,,"MSTESMJROVELAEEALPKEAWG POGSSRCLCL5 LFSFLLVAGATILFCLLHFGV IG
PQREE FLNNLP lSPQAQMlTLRSSS QNMNDKPVAHWAKNEDKEQ LIJlM,.SRRANAlLANGMElI
DNOLW PANGLYI.VYSQV LFKGOGCPSYVLLTHTVSRFAV$VQDKVNLLSAI KS PCPKESlEGAE
FKP'A'YEPtYlGGVFElaKGDRLSAEVNLPSYLOFAESGaVYFGVlAL~
BASE COU NT 150 a 2 11 c 1959 156 t
ORIGI N
1 atgagcac tg aaagt atgat ccgggacgtg gagc lggccg aggaggca ct ccccaagg ag
6 1 9C3199 999C cceagggctc cagccggtgc ctgtgcctca ccctcnctc cncctacn
121 gtggcaggag ccactacqct cnctgcctg ctgcacmg gag tgatcgg cccccagagg
18 1 ga agagttc c tgaataacct ccctctcaqc ccccaggccc a qatqctcac ac tcaga tca
24 1 tcttcteaea ae<l1gaalga caagcetgta gcccalgttg tagcaaaaaa tgaagacaag
301 ga gca gctgg 19l9gctaag tcglcglgcc a atqccctcc Iggccaa lgg calgg agclg
36 1 ataqacaaec agct ggtggt gcclgcaaac gggetalacc ttgtcta ctc ccecctcctc
42 1 ncaagggcc aaggclgcce ctcctacqtq ctcctcaccc acactglcag ccgctttgct
48 1 gletCnalc aggacaaggt ceecctcctc tctqccatca agagcccng cccaaaggag
541 agcctggagg gggc tgagtt caagccclgg tatgaaccca IClalcta gg aggg glcttc
60 1 gagclgcaga aggglgatcg aclcaglgcl gag glcaacc tgcccagcta tctccecrrt
66 1 getgagtccg ggcaggtetacmgg ggtcattgclctglgaaggg aa tg ga



